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CHAPTER ONE
GENERAL BACKGROUND AND INTRODUCTION
1
Chapter One 
General background and introduction 
Hypertension is thought to be related to alterations in the 
structure and function of vascular smooth muscle cells. Erne 
et al (1984a) have found an elevation of platelet intracellular 
free calcium levels in hypertensive patients compared to 
normotensive subjects. They have extrapolated their results from 
platelets to vascular smooth muscle cells, and have proposed from 
these findings that intracellular free calcium levels within 
vascular smooth muscle cells may also be elevated in 
hypertension. This elevation of intracellular free calcium may 
be the cause of hypertension, as it will produce an increased 
contraction of the vascular smooth muscle. The aim of the work 
contained in this thesis was to investigate the relationship 
between blood pressure and intracellular free calcium levels in 
platelets and vascular smooth muscle cells. This was measured in 
both humans and animals in situations during which blood pressure 
is altered. The general introduction for this work firstly 
considers the second messengers which control intracellular free 
calcium levels and may therefore be involved in alterations in 
calcium concentration. The functional roles of platelets and 
vascular smooth muscle, with an outline of the involvement of 
calcium in the activation of these tissues, is then discussed. 
The pathophysiological properties of hypertension will be 
examined, followed by some theories of the mechanism which is 
responsible for the development and maintenance of hypertension. 
Alterations in intracellular free calcium levels of various 
tissues in both human and animal hypertension will be reviewed.
2
1.1 Second messenger systems which regulate intracellular
free calcium levels
Cells respond to a wide variety of extracellular stimuli 
which activate receptors on the outer surface of the plasma 
membrane. These stimuli produce a plethora of physiological 
responses in the target tissues as a result of this interaction 
with specific cell surface receptors. However it is amazing to 
consider that this vast range of external stimuli all appear to 
evoke numerous different responses on many different cell types 
via a relatively small number of second messenger systems. 
Second messenger systems are crucial in the control of each cell, 
and help to determine how the cell will respond to the organism's 
requirements.
The general system which is required for stimulus-response 
coupling is illustrated in Figure 1.1. The agonist, which can be 
a hormone, neurotransmitter or any other regulatory or growth 
promoting factor, will interact with its specific receptor on the 
cell surface. This stimulates a transducer within the plasma 
membrane which relays a signal to the effector. The effector in 
some way will alter the level of second messengers within the 
cell, leading to a biochemical response which will ultimately 
result in a physiological, cellular response.
The internal signal pathways within cells are remarkably 
universal. The identity of these second messenger substances is 
therefore of vital importance for furthering the understanding of 
the control of cellular activity. The two major second messenger 
pathways which are involved with the control of intracellular
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free calcium levels are the adenylate cyclase pathway and the 
phosphoinositide pathway.
The phosphoinositide pathway employs a combination of second 
messengers that control calcium ions; inositol
1,4,5 trisphosphate, and inositol 1,3,4,5 tetrakisphosphate. The 
adenylate cyclase pathway employs cyclic adenosine monophosphate 
(cAMP) as a second messenger, which is also involved in the 
regulation of calcium.
1.1.1 Control of intracellular free calcium by the
The major metabolic pathways responsible for the formation 
and degradation of inositol 1,4,5 trisphosphate and inositol
1,3,4,5 tetrakisphosphate are illustrated in Figure 1.2., and 
will not be discussed in great detail. With respect to 
Figure 1.1., agonist stimulation of the receptor will activate
and Gomperts, 1985). The major reaction which occurs after 
agonist stimulation is the breakdown of phosphatidylinositol 4, 
5 bisphosphate into inositol 1,4,5 trisphosphate and 
diacylglycerol (Berridge, 1983). Phospholipase C also causes the 
breakdown of phosphatidylinositol and phosphatidylinositol 
4 phosphate, but it is thought that these are minor reactions.
Berridge (1983) observed that inositol 1,4,5 trisphosphate 
was a major product of receptor activation, proposed that this 
molecule could have second messenger properties and postulated 
that it may in some way mobilise calcium from internal stores. 
Streb et al (1983) were first to demonstrate that inositol 1,4,5
phosphoinositide pathway
o
via a GTP binding protein (Cockcroft
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trisphosphate released calcium from a nonmitochondrial 
intracellular store which was probably the endoplasmic reticulum.
It has now been established that inositol 1,4,5 
trisphosphate has its second messenger action by binding to 
specific receptors on the endoplasmic reticulum and causing 
release of intracellular stores of calcium into the cytoplasm 
(Berridge and Irvine, 1984). This elevation of intracellular 
free calcium will produce some type of cellular response.
Irvine et al (1984) then discovered the existence of an 
isomer of this molecule, inositol 1,3,4 trisphosphate. It was 
thought to be either involved as a second messenger in longterm 
responses, such as the onset of proliferation in the cell. 
However no specific second messenger role for this isomer has yet 
been found, and it is likely that it is merely a metabolite of 
inositol 1,4,5 trisphosphate.
The next inositol phosphate molecule to be isolated was 
inositol 1,3,4,5 tetrakisphosphate (Batty et al, 1985). These 
workers suggested that this molecule was likely to be a second 
messenger, and was the probable precursor of inositol 1,3,4 
trisphosphate, which further confirms that inositol 1,3,4 
trisphosphate is purely a metabolite, and does not play an 
important role in signal transduction. Inositol 1,3,4,5 
tetrakisphosphate is inactive in mobilising calcium from 
intracellular stores in a variety of cells. However, Irvine and 
Moor (1986) then discovered that inositol 1,3,4,5 
tetrakisphosphate activated sea urchin eggs by a mechanism 
dependent on the existence of extracellular calcium. They
5
suggested that inositol 1,3,4,5 tetrakisphosphate was an 
intracellular second messenger, and that its function was to 
control calcium fluxes at the plasma membrane.
It has been generally accepted at this time that the 
elevation of calcium caused by receptor stimulation occurs not 
only as a calcium influx across the plasma membrane, as 
previously thought, but also by mobilisation of calcium from 
internal stores. Until the discovery of inositol 1,3,4,5 
tetrakisphosphate, it was thought that inositol 1,4,5 
trisphosphate stimulated calcium release from the endoplasmic 
reticulum, and when these calcium stores were near depletion this 
lack of calcium stimulated extracellular calcium influx into the 
endoplasmic reticulum due to the close proximity of the 
endoplasmic reticulum to the plasma membrane (Putney, 1986). 
This theory depends on the emptying of the endoplasmic reticulum 
being a signal that leads to its refilling from the extracellular 
space. This is an interesting theory, but since the discovery of 
a role for inositol 1,3,4,5 tetrakisphosphate, it has disappeared 
from the current trends. It is now thought that inositol 1,3,4,5 
tetrakisphosphate is involved in the transfer of calcium between 
the extracellular space and the endoplasmic reticulum, and this 
is somehow dependent on the prior or simultaneous discharge of 
calcium from the intracellular store by inositol 1,4,5 
trisphosphate (Taylor, 1987). Therefore, inositol 1,3,4,5 
tetrakisphosphate acts alongside inositol 1,4,5 trisphosphate by 
replenishing the depleted calcium stores in the endoplasmic 
reticulum with calcium from extracellular sources, although the 
precise mechanism of this action has yet to be elucidated.
6
Other inositol phosphate molecules which may play a part in 
calcium regulation have been isolated from various cells. Heslop 
et al (1985) have discovered inositol pentakisphosphate and 
inositol hexakisphosphate in GH^ cells but as yet there is little 
evidence for an association in receptor activation and calcium 
mobilisation. Wilson et al (1985) have identified two cyclic 
products of receptor activation, one of which, inositol 1 : 2- 
cyclic 4,5 trisphosphate, may have a second messenger function.
In summary, this section has dealt with the evidence for the 
roles of inositol 1,4,5 trisphosphate and inositol 1,3,4,5 
tetrakisphosphate in the regulation of intracellular calcium. 
Other isomers of inositol trisphosphates, tetrakisphosphates and 
other larger phosphate-containing inositols may be involved. 
However for the purposes of calcium release, only the metabolic 
pathways of inositol 1,4,5 trisphosphate and inositol 1,3,4,5 
tetrakisphosphate are thought to be important at this time.
1.1.2 Control of intracellular free calcium by the adenylate 
cyclase pathway 
The role of cAMP as a second messenger has been well 
characterised (Levitzki, 1987). With respect of figure 1.1, the 
adenylate cyclase pathway contains both a stimulatory and 
inhibitory GTP binding protein as transducers, which are coupled 
to different receptor populations (Gilman, 1984). Receptor 
activation of one of these pathways will produce a corresponding 
alteration in the activity of the enzyme, adenylate cyclase, 
which is the effector unit. This will result in the subsequent 
alteration of cAMP levels within the cell. The phosphoinositide
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and adenylate cyclase pathway, resulting in calcium mobilisation 
and cAMP production respectively, nearly always function in 
concert, but the patterns of interaction vary between cell types.
Five patterns of synarchic regulation have been identified 
(Rasmussen and Barrett, 1984).
1. Coordinate control, in which an agonist interacts with 
two separate receptors to cause an elevation of both cAMP and 
calcium, resulting in a synergistic response.
2. Hierarchical control, in which an agonist stimulates an 
elevation of calcium, and either a second agonist or a higher 
concentration of the first agonist stimulates an elevation of 
cAMP, which enhances the initial response produced by calcium.
3. Redundant control, in which two different agonists 
interact with two different receptors, producing elevations of 
cAMP and calcium respectively. Both systems will produce the 
same response, either independently, or together.
4. Antagonistic control, in which a rise in calcium 
initiates a cellular response, and a rise in cAMP inhibits the 
calcium induced response.
5. Sequential control, in which an increase in calcium can 
lead to an increase in cAMP, or vice versa.
The interests of this thesis lie in the control of calcium 
in platelets and vascular smooth muscle, where cAMP acts by 
antagonistic control to regulate intracellular free calcium 
levels. The other control mechanisms will not be discussed 
further.
There is evidence that cAMP acts as an inhibitory second
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messenger by the suppression or reversal of the elevation of 
intracellular free calcium levels. Most of this evidence has 
been elucidated by the use of platelets.
Stimulants of adenylate cyclase activity are known to 
decrease platelet reactivity and suppress agonist induced 
elevations of intracellular free calcium (Feinstein et al, 1983). 
Therefore, it is not surprising that enhancement of platelet 
activation is associated with a decrease of cAMP levels. One of 
the mechanisms by which cAMP has its effect is thought to be by 
inhibition of phospholipase C, thus preventing the breakdown of 
phosphatidylinositol 4,5 bisphosphate (Billah et al, 1 979). 
Cyclic AMP also has effects on the intracellular storage of 
calcium in the endoplasmic reticulum. It increases the 
sequestration of calcium into the endoplasmic reticulum (Kaser- 
Glanzmann et al, 1977) and may prevent the discharge of calcium 
from the endoplasmic reticulum. It is also possible that cAMP 
may act at the plasma membrane and cause an increased efflux of 
calcium out of the cell, or an inhibition of the influx of 
calcium.
It is therefore clear that, regardless of the mechanism 
involved, cAMP mediates the recovery from, or opposes the action 
of, the effects of calcium.
1.2 Vascular smooth muscle
Vascular smooth muscle is directly involved in the aetiology 
of hypertension. In this section, the properties and the 
mechanism of action of vascular smooth muscle and its 
pathophysiological role in hypertension will be discussed.
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1.2.1 Properties and structure of vascular smooth muscle
The properties and structure of vascular smooth muscle cells 
vary throughout the cardiovascular system, as each type of blood 
vessel has a separate function. Therefore the properties of the 
smooth muscle cells at each site are modified for a specific 
purpose. In general, vascular smooth muscle cells are spindle 
shaped with a centrally placed nucleus. They are normally 2- 
10 urn in diameter and 15-200 urn long. Bundles of these muscle 
fibres are arranged concentrically around the blood vessel.
Within each cell are three distinct types of filaments,
thick myosin filaments, thin actin filaments and intermediate
sized filaments. The first two types are known to be involved in
1r
cell contraction, the latpr does not appear to play a role in the 
active generation of force and probably functions as maintaining 
the structural framework of the cell. Vascular smooth muscle is 
under the control of the autonomic nervous system, but it can 
also respond to the local effects of hormones and other agents 
(Vander et al, 1980).
1.2.2 Function and mechanism of action of vascular smooth 
muscle cells
The function of these muscles is to maintain a constant mean 
arterial pressure and to regulate organ blood flow. The degree 
of contraction is adapted accordingly via baroreceptor reflexes 
in situations which change the mean arterial pressure, such as 
altered posture, exercise, stress and shock.
Vascular smooth muscle possesses an inherent tone and the
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degree of contractility can be altered by a number of pathways. 
Vascular smooth muscle cells contract in response to an elevation 
in intracellular free calcium concentration. This increase in 
calcium is known to occur by three mechanisms in vascular smooth 
muscle.
An influx of extracellular calcium can occur through 
receptor-operated calcium channels or voltage operated calcium 
channels in the plasma membrane. This influx occurs as the 
intracellular charge is negative with respect to the outside, and 
the extracellular concentration of calcium is greater with 
respect to the intracellular levels. Calcium may also be 
released from intracellular stores by inositol trisphosphate, as 
outlined in section 1.1. These three membrane systems are 
probably present in every vascular smooth muscle cell, but it is 
likely that different regions of the vascular tree contain these 
systems in different proportions. A variation of the dominant 
mechanism in distinct areas of the cardiovascular system will 
result in a contrast in the response time to stimuli, as each 
membrane system has a separate transduction time; voltage 
operated channels produce a fast response relative to the 
stimulation of inositol trisphosphate synthesis (Hofman, 1985).
This elevation in intracellular free calcium levels, by 
whichever method is the dominant, will activate the actin and 
myosin filaments causing contraction of these structures and thus 
cell shortening. This will lead to a reduction in the diameter 
of the blood vessel, reducing the blood flow to the area it 
supplies and allowing the blood to be redirected to an area of 
higher requirements.
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In this area of higher requirement a different regulatory
mechanism is acting. Here, vasodilation of blood vessels is
caused by an increase in either cAMP and/or cGMP. cAMP acts by
either increasing the uptake of calcium into the intracellular
stores or by decreasing the calcium sensitivity of the
contractile apparatus. cGMP is believed to act on calcium 
o
transport mechanisms to cause a reduction in cytosolic calcium 
levels, possibly in part by sequestration of calcium into the 
sarcoplasmic reticulum (Twort and van Breemen, 1988).
1.2.3 Pathophysiological role of vascular smooth muscle cells
In the pathological state of hypertension, the elevation of 
blood pressure is caused by an increased peripheral vascular 
resistance due to an increase in the inherent tone of the 
vascular smooth muscle. This elevation of blood pressure in 
essential hypertension is not corrected and reduced by 
baroreceptor reflexes, as the baroreceptors appear to be reset at 
a higher level in hypertension, and therefore baroreceptors 
regulate blood pressure at a greater mean arterial pressure in 
hypertension.
An alteration in one or more of the second messenger systems 
which control intracellular calcium levels in vascular smooth 
muscle cells may occur. It is possible that a reduction in cAMP 
or cGMP levels will cause an increase in the contractile state of 
vascular smooth muscle. An elevation of intracellular free 
calcium may also increase smooth muscle contraction. The 
putative role of calcium in hypertension will be discussed in a 
later section.
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1.3 Platelets
Platelets are often used as a model for vascular smooth 
muscle cells as they are a blood element population which is 
subject to convenient and multiple sampling. This section 
describes the physiological and pathological role of platelets, 
and the similarities and differences between platelets and 
vascular smooth muscle cells.
1.3.1 Properties and structure of platelets
Platelets are blood elements which are formed in the bone 
marrow by fragmentation of portions of the cytoplasm of 
megakaryocytes. They are cell fragments and not cells, as they 
lack nuclei, and therefore cannot synthesise protein or RNA. 
Platelets are shaped like biconvex discs, and are approximately 
2-3 um in diameter and 0.7 urn thick. Their lifetime in the 
circulation is about 8-14 days. Platelets contain organelles 
such as mitochondria, endoplasmic reticulum and granules. The 
mitochondrion functions as the metabolic centre of the platelet, 
and the endoplasmic reticulum is the major intracellular storage 
organelle for calcium. Three types of storage granules are 
present in platelets. The dense granules contain amines (chiefly 
5HT), adenine nucleotides (ATP and ADP) and bivalent cations 
(Ca^+ and/or Mg^+). The alpha granules contain beta 
thromboglobulin and platelet factor 4, which are both pro­
aggregator y agents, and platelet derived growth factor (PDGF) 
which is a smooth muscle mitogenic protein. The lysosomes are 
granules which contain acid hydrolytic enzymes which act as
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scavenger enzymes when the platelet lifespan is complete. 
Platelets also possess an open canalicular system which increases 
the surface membrane of the platelet by multiple invaginations on 
the surface (Gordon, 1981).
1.3.2 Platelet function and mechanism of action
The physiological role of platelets is haemostasis. 
Platelets do not normally adhere to normal, undamaged endothelial 
cells which line blood vessels, or other blood cells into which 
they frequently collide. They have a negative surface charge and 
are therefore separated by mutual repulsion. However, they have 
a propensity for adhering to many foreign and rough surfaces, and 
if the endothelium of a blood vessel is damaged to expose the 
collagen present in the underlying connective tissue, platelets 
will adhere to the damaged site. This triggers the release of 
platelet granules into the local extracellular fluid and the 
coagulation cascade is initiated. Second messengers play a 
critical role in platelet activation. Release of agents from 
platelets and from other sources will cause receptor stimulation 
in platelets, and subsequent activation of second messenger 
systems such as phosphatidylinositol 4,5 bisphosphate breakdown, 
leading to an elevation of intracellular free calcium as 
described in section 1.1. Normal circulating platelets contain a 
circular bundle of microtubules which are thought to act as a 
cytoskeleton which is responsible for the disc-shaped appearance. 
During platelet activation the elevation of calcium in the 
cytoplasm causes the disappearance of this structure as calcium 
depolymerises microtubules. The platelet can then change shape
14
from a disc to a sphere. Platelets also possess a contractile 
apparatus which consists of actin and myosin. An increase of 
calcium within the platelet stimulates protein phosphorylation of 
myosin light chain by activating calcium dependent protein 
kinases. This phosphorylation process is necessary for the 
interaction of myosin with actin and thus contraction of this 
apparatus. This also adds to the shape change and aggregatory 
responses of platelets. Rapid shape change therefore occurs, and 
the platelets become spherical and long thin pseudopods form 
which, along with the granule release, facilitates further 
adhesion of more platelets to both the damaged site and other 
activated platelets. Both calcium and fibrinogen are necessary 
to form intercellular bridges between platelets. The clump of 
platelets which has formed plugs the wound, and after several 
minutes the coagulation cascade is completed. Fibrin strands 
form around the platelet plug, trapping other blood cells, and 
this fibrocellular mass retracts into the wound, packing it 
tightly. After a few days macrophages will invade the wound and 
clear the debris and PDGF will induce proliferation of 
surrounding vascular cells and synthesis of new connective tissue 
(Gordon,1981).
1.3.3 Pathophysiological role of platelets in cardiovascular 
disease
Overactivity of either the haemostatic function or wound 
repair process of platelets will lead to the pathological 
conditions of thrombosis and atherosclerosis respectively.
Thrombosis is thought to originate from overactivity of the
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coagulation cascade. An imbalance of the autacoids 
thromboxane A2 (TXA2 ) and prostaglandin I2 (PGI2 ) may also be 
responsible. TXA2 is a powerful vasoconstrictor and aggregatory 
agent produced by platelets, whereas PGI2 causes inhibition of 
platelet aggregation and vasodilation. Therefore, an 
overproduction or increased release of TXA2 , or a reduction in 
the synthesis of PGI2 could lead to thrombosis.
The precise role of platelets in atherosclerosis remains to 
be unequivocally established. This condition is characterised by 
focal lesions on the intima of a blood vessel that consist of 
plaques containing varying amounts of fibrous tissue and lipid. 
Platelets have the ability to contribute to this by secreting 
PDGF which will induce smooth muscle proliferation in the 
arterial wall, and also by forming mural thrombi that can be 
covered by endothelium and thus incorporated into the arterial 
wall.
Therefore platelets play important roles in haemostasis and 
occlusive vascular disease, and the function of platelets is 
clearly important clinically in these conditions, and possibly in 
many other related cardiovascular diseases.
1.3.4 Platelets as a model for vascular smooth muscle cells
In many studies involving investigations in cardiovascular 
research, platelets have been used as a model for vascular smooth 
muscle cells due to easier availability and sampling techniques. 
This is particularly useful in human studies where smooth muscle 
samples are difficult to obtain. It has been proposed (Erne 
et al, 1984a) that platelets closely reflect any functional
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alterations which occur in vascular smooth muscle cells. 
However, the validity of using platelets as a model for vascular 
smooth muscle is debatable, as although many common features 
exist, such as a calcium-dependent contractile apparatus (Hinssen 
et al, 1978) and the alpha2-a<3renocePt°r adenylate cyclase system 
(Erne et al, 1983), there are major differences. As has been 
previously discussed, these two types of cells have different 
physiological and pathological functions, with platelets involved 
with coagulation and thrombosis, and the blood vessel in 
haemostasis, hypertension and atherosclerosis. Unlike smooth 
muscle cells, platelets do not possess a nucleus, therefore 
cannot synthesise new receptor protein. Pharmacologically, they 
will respond differently to the first dose, tolerance and 
withdrawal effects of drugs (Hamilton and Reid, 1986). Voltage- 
operated channels, which play an important part in the regulation 
of calcium content of vascular smooth muscle cells (Castells, 
1980) have been found to be absent in platelets (Doyle and Ruegg, 
1985). Finally, platelets do not play a major role in the 
initiation and maintenance of hypertension, therefore it is 
obviously more advantageous to use vascular smooth muscle cells 
as they are the site at which pathological changes will occur in 
hypertension.
1.4 Hypertension
Some of the many pathological alterations which occur in 
hypertension will be discussed in this section.
1.4.1 Platelet abnormalities in hypertension
Although platelets do not appear to be directly linked to
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the pathogenesis of hypertension, they may play a minor role in 
the control of vascular tone by releasing vasoconstrictor agents. 
Platelets are thought to reflect the physiological and 
pathological alterations in vascular smooth muscle cells, and for 
this reason platelets have been extensively used in research to 
elucidate the mechanistic alterations of vascular smooth muscle 
in hypertension.
Many alterations in the physiology of platelets have been 
discovered in human essential hypertension. "In vitro" platelets 
from hypertensive patients are more sensitive to a variety of 
agonists and have an enhanced rate of aggregation than platelets 
from normotensive controls. This may possibly reflect an 
increased activation of platelets "in vivo". This theory is 
further substantiated by the finding of increased plasma levels 
of beta-thromboglobulin, which is released from the alpha 
granules of platelets during activation (Mehta and Mehta, 1981). 
A decrease in the 5HT content of platelets, which could be due to 
an increased release and a defective 5HT uptake mechanism, has 
also been observed in hypertension (de Clerck, 1986). No 
alterations in platelet number or size have been documented 
(Mehta and Mehta, 1981), but platelet lifespan is shortened in 
hypertension.
These changes have been observed in some, but not all 
hypertensive patients and are not always strictly related to the 
degree of blood pressure elevation. However, it does appear that 
some type of functional defect is apparent in platelets from 
hypertensive patients.
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1.4.2 Vascular smooth muscle abnormalities in hypertension
The mechanism which results in the development of essential 
hypertension is unclear. Research has been carried out on the 
structural changes which occur in vascular smooth muscle in 
hypertension. Different blood vessels perform different roles in 
cardiovascular regulation, therefore the structural alterations 
which occur in hypertension vary.
Large and medium sized arteries are involved in this 
regulation as capacitance vessels. In hypertension, the media of 
these blood vessels is thickened. An increase in the synthesis 
of the major connective tissue components, elastin and collagen, 
is found in smooth muscle cells, which contributes appreciably to 
cell shortening. These smooth muscle cells also undergo major 
changes that account for an increased thickening of arterial 
vessels. Hypertrophy and hyperplasia, which are an increase in 
cell size and cell number respectively, have been identified in 
hypertensive blood vessels. Hyperploidy, which is an increase in 
the DNA content of cells due to a failure of cells that have 
completed mitosis to divide, has also been observed. The intima 
of these blood vessels is also thickened and this is due to a 
number of factors. Endothelial cells undergo a change of shape 
and are enlarged. Smooth muscle cell migration from the media 
into the subendothelial space, and increased production of 
collagen and elastin probably also from the media, will cause 
thickening of the intima. Blood cells may also infiltrate and 
accumulate in the subendothelial space (Leitschuh and Chobanian, 
1987).
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Smaller arteries and arterioles function as resistance 
vessels and have a more important role in hypertension. Vascular 
hyalinisation has been found in both the media and intima within 
these hypertensive blood vessels. As with the larger arteries, 
smooth muscle proliferation and thickening of the media is 
present (Leitschuh and Chobanian, 1987). This medial thickening 
could again be due to hypertrophy or hyperplasia. However, from 
a haemodynamic point of view, it does not matter whether medial 
thickening occurs via hypertrophy or hyperplasia, the final 
outcome is similar in both situations. Folkow (1978) described 
this thickening of blood vessel walls in hypertension as the 
adaptation of smooth muscle cells to adjust in size and/or number 
to compensate for the increased load, or elevation of blood 
pressure. This is a positive feedback mechanism as the 
thickening of the media and intima of blood vessels will result 
in the arteries becoming less distensible and the ratio of lumen 
to blood vessel wall thickness will decrease. These two factors 
will contribute to an increase in peripheral vascular resistance. 
This formed Folkow's theory on the role of structural adaptation 
in the initiation and maintenance of hypertension. In addition 
to a greater vascular wall thickness, Webb and Bohr (1 981) have 
observed a rarification of resistance vessels in hypertension. 
This is thought to be caused by overperfusion of tissues due to 
the elevation of blood pressure causing the autoregulatory 
response of a decrease in the number of arterioles, thus reducing 
perfusion. This structural adaptation of arteriolar number is 
not thought to be as important as the increase in vascular wall 
thickness. However it is unclear how these structural changes
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are initiated, what the relative importance of each alteration 
is, and whether they are the cause or effect of an elevation in 
blood pressure in humans.
1.4.3 Principle hypotheses of the development and maintenance 
of essential hypertension
Essential hypertension is diagnosed when no other secondary 
cause, such as phaeochromocytoma, renal artery stenosis, or 
primary hyperaldosteronism, can be identified. The primary 
pathogenic causes of essential hypertension have not yet been 
elucidated, but a number of hypotheses have been proposed to 
explain the development of hypertension. The principle theories 
involve vascular hypertrophy, whole body autoregulation and a 
defect in sodium and calcium handling of cells.
Vascular hypertrophy has been discussed in the previous 
section with respect to the structural alterations which appear 
in hypertensive blood vessels. However it has not been 
discovered whether this vascular hypertrophy is a cause or result 
of the elevation of blood pressure. This first theory assumes 
that hypertrophy of vascular muscle is a primary causative 
mechanism in the development of hypertension. The initiation of 
hypertrophy could be abnormal regulation of cell growth in the 
blood vessels, and amongst the stimuli for this process could be 
the local release of the smooth muscle mitogen PDGF from 
platelets. This would generate the initial rise in blood 
pressure, and the positive feedback mechanism would lead to a 
sustained elevation of blood pressure (Lever, 1986).
Lee (1987) concluded that hyperplasia of smooth muscle
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cells in the media of several strains of hypertensive rats was 
the primary structural alteration which occurred prior to the 
onset of hypertension. All the other structural changes such as 
intimal alterations were proposed to be secondary alterations 
subsequent to the development of hypertension and could be 
involved in the later maintenance of elevated blood pressure. 
These findings of Lee (1987) do not wholly contradict this 
theory, if it can be assumed that the effect produced by 
hypertrophy of blood vessels in the above theory could also have 
been produced by hyperplasia. As has been observed earlier, the 
final haemodynamic effects of hypertrophy and hyperplasia are 
similar. Therefore there appears to be some support for this 
theory.
The second main hypothesis is that a defect in renal sodium 
excretion, causing an increase in plasma sodium, will result in 
an increase in blood volume. From Starling's theory, this will 
then cause an increase in cardiac output, an elevation in blood 
pressure and consequently an increased tissue perfusion. Body 
tissues have an intrinsic capacity to regulate blood flow by 
varying the arteriolar resistance in direct proportion to the 
perfusion pressure. Therefore an increase in tissue perfusion 
will result in an increase in peripheral vascular resistance and 
this will take over from the cardiac output alteration in the 
maintenance of elevated blood pressure (Guyton et al, 1972). 
There is some proof that autoregulation occurs in hypertension, 
but no direct evidence that this is the main process which 
results in the elevation and maintenance of hypertension.
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The final theory of a defect in the sodium and calcium 
metabolism in hypertension has aroused the most interest 
recently. This theory also depends on an increased sodium 
retention by the kidneys. The resulting volume expansion is 
thought to cause secretion of a natriuretic factor which promotes 
Na+ excretion by inhibiting the Na+ pump in the kidney tubule, 
thus preventing Na+ reuptake. However this natriuretic factor 
also inhibits the efflux of Na+ from vascular smooth muscle 
cells. This is achieved by inhibiting the Na+/K+-ATPase 
transport mechanism, and therefore causes a decrease in 
intracellular K+ concentration. How this alteration in Na+ and 
K+ ions causes increased vasoconstriction is unclear, but it is 
possible that the change in K+ distribution across the cell 
membrane causes partial depolarisation of the membrane. However, 
the other suggestion which has been favoured by many workers was 
proposed by Blaustein (1984). The elevation of intracellular Na+ 
concentrations may activate a Na+/Ca^+ exchange mechanism across 
the plasma membrane, causing an increase in intracellular C a2+  
and thus a rise in the resting tone of vascular smooth muscle 
cells.
The factors of which the discovery has been crucial to 
substantiate this theory are, a defect of the kidneys, the 
existence of a natriuretic factor, a Na+/Ca^+ exchange mechanism 
and an elevation of intracellular free calcium levels in tissues.
Dahl et al (1974) demonstrated that a genetic defect existed 
in the kidneys of spontaneously hypertensive rats by removing 
these kidneys and transplanting them into normal rats, which 
subsequently developed hypertension. This may also prove true of
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human essential hypertension.
Hamlyn et al (1982) illustrated that an inhibitor of Na+/K+- 
ATPase activity could be detected in the plasma of individuals 
who were either normotensive or hypertensive. A highly 
significant positive correlation between levels of the inhibitor 
of Na+/K+-ATPase activity and mean arterial blood pressure was 
shown, and this provides evidence for the involvement of a 
circulating Na+/K+-ATPase inhibitor in the genesis of essential 
hypertension.
Evidence for a Na+/Ca^+ exchange mechanism in vascular 
smooth muscle cells has been put forward by Reuter et al (1973). 
These workers suggested that this mechanism is an important 
factor in the regulation of vascular tone.
Another factor which may contribute to the elevation of 
intracellular free calcium that is the consequence of Blaustein's 
theory of hypertension, is an altered calcium handling of cells. 
This could account for some of the vascular changes in 
hypertension. However, there are many Ca^+ handling processes 
within vascular smooth muscle cells. An increase in calcium 
influx or a decrease in calcium extrusion in hypertensive cells 
has been proposed (Buhler et al, 1986), which may involve defects 
in calcium channels. Alterations in the intracellular control of 
calcium levels may also be responsible for the development of 
hypertension. A decrease in calcium binding to the inner plasma 
membrane or a defect in the intracellular storage of calcium 
could be involved (Kwan, 1985). Alterations in second messenger 
systems have been observed in hypertension. In platelets,
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Dimitrov et al (1986) have found that increased basal levels of 
phosphatidylinositol 4 phosphate and phosphatidylinositol 
4,5 bisphosphate existed in hypertension, along with decreased 
levels of phosphatidylinositol. These findings suggest that at 
rest, there is a tendency for the futile cycle to shift towards 
phosphatidylinositol 4,5 bisphosphate and may therefore be more 
easily activated. Marche et al (1985) reported that 
phosphatidylinositol 4,5 bisphosphate was elevated in 
erythrocytes from hypertensive patients. The results of these 
studies suggest that a modification phosphoinositide metabolism 
can be considered as one of the causes of an elevation in 
intracellular free calcium levels in hypertension. The evidence 
for an elevation of intracellular free calcium levels in tissues 
from hypertensive humans and animals which forms the final piece 
of evidence for Blaustein's theory of hypertension will be 
discussed in the following section.
Essential hypertension is a multifactorial disease. While 
it appears that most evidence supports Blaustein's theory of 
hypertension, it is probable that none of these hypotheses is 
solely responsible for the initiation and maintenance of 
hypertension. These theories do not wholly contradict each other 
and it is likely that all have a role in hypertension.
1.5 Role of calcium in essential hypertension
Evidence that raised intracellular free calcium levels exist 
in hypertension, to prove Blaustein's theory, has been sought 
after by many workers in a number of tissues.
The findings of these studies are reviewed in the following
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section.
1.5.1 Intracellular free calcium levels of vascular smooth 
muscle cells in hypertension
Measurement of intracellular free calcium levels in vascular 
smooth muscle cells is more technically demanding than measuring 
calcium levels in blood elements. The main problem is obtaining 
smooth muscle samples, and for this reason there are no reports 
in the literature concerning these measurements in human tissue. 
The technical problems encountered during the measurement of 
calcium levels in smooth muscle cells are also more complex, as 
cell suspensions or cultured monolayers are required for the use 
of fluorescent calcium indicators. For this reason, blood cells, 
and in particular, platelets have been used as a model for 
vascular smooth muscle cells. However, there are some reports of 
calcium measurements in vascular smooth muscle cells from 
hypertensive animals.
In 1966, Tobian and Chesley observed that the calcium 
content of arterioles from hypertensive rats was 13% higher than 
that of normotensive rats. Zidek et al (1982a) found no 
difference between Ca^+ activities measured by a calcium 
selective electrode in vascular smooth muscle cells cultured from 
normotensive and hypertensive rats. Nabika et al (1985a) also 
could not detect any alteration in intracellular free calcium 
levels of cultured cells using the Quin 2 fluorescence technique. 
However vascular smooth muscle cells from hypertensive animals 
which had been isolated enzymatically were found to have higher 
Ca^+ activities than cells isolated from normotensive animals
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(Zidek et al, 1983a). These workers postulated that "in vivo" a 
humoral factor may be causing the elevation of calcium levels in 
cells, and the loss of this factor during cell culture will 
result in calcium levels returning to normal. They suggested 
that enzymatic isolation of cells, rather than the cell culture 
technique, reflected a closer similarity to the changes which are 
occurring "in vivo". In a later publication (Losse et al, 1984), 
it was suggested that a metabolic abnormality may develop during 
the culture period, as Ca^+ activities were higher in both 
normotensive and hypertensive cultured cells compared to cells in 
which the Ca^+ activities had been monitored immediately after 
isolation. Intracellular free calcium levels were raised before 
the development of hypertension in DOCA-salt hypertensive rats, 
although the total aortic calcium levels were unchanged 
(Nickerson and Yang, 1988). However, after hypertension had 
developed, both of these parameters were found to be elevated. 
These workers suggested that the increase in intracellular free 
calcium levels may be the cause of the elevation of blood 
pressure in hypertensive rats.
It appears that cell culture may not be a useful technique 
for the preparation of cells to detect ion alterations in disease 
states. Caution is required when interpreting results from 
cultured cells. Using enzymatic digestion, intracellular free 
calcium levels are raised in vascular smooth muscle cells of 
hypertensive rats. It is possible that elevated calcium levels 
may also be found in the blood vessels of essential hypertensive 
patients.
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1.5.2 Intracellular free calcium levels of platelets in 
hypertension
Platelets have been used as a model for vascular smooth
e
muscle cells in hypertension research as they are a homogenous 
population of blood elements which are available for easily 
accessible and multiple sampling.
The initial communication that reported an elevation of 
platelet intracellular free calcium levels was by Erne et al 
(1984a). Intracellular calcium levels were found to be increased 
in borderline hypertensive patients, and further elevated in 
essential hypertensive patients, compared to normotensive 
controls. Platelet calcium levels were found to have a close 
positive correlation with blood pressure. These workers also 
stated that beta-adrenoceptor antagonists, diuretics and calcium 
channel antagonists reduced both blood pressure and platelet 
calcium levels in hypertensive patients. Shortly after the 
publication of these results, Bruschi et al (1985) also 
demonstrated an elevation of platelet calcium levels in 
hypertensive patients and rats. However these workers did not 
attempt to find a correlation between blood pressure and platelet 
calcium levels. Le Quan Sang and Devynck (1986) confirmed these 
results. However, the correlation that they obtained between 
blood pressure and platelet calcium levels, although significant, 
was very weak compared to the data of Erne et al (1984a). These 
initial reports caused considerable interest and many workers 
tried to reproduce these results.
Lenz et al (1985) noted that although a significant rise in 
basal platelet calcium levels could be observed in hypertension,
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there was a large overlap between norraotensive and hypertensive 
patients. These workers also found only a weak correlation 
between platelet calcium and blood pressure, and concluded that 
there was no positive evidence for an elevation of platelet 
cytosolic free calcium levels in a large proportion of patients 
with essential hypertension.
The findings of other workers are similar (Lechi et al, 
1986a; Cooper et al, 1987; Hvarfner et al, 1988). Hvarfner et al 
(1988) found an elevation of platelet calcium levels in 
hypertension, with a weak correlation between this parameter and 
blood pressure, but again the overlap between normotensive and 
hypertensive groups was found to be considerable. In contrast 
Lechi et al (1986a) found no correlation between blood pressure, 
and again a remarkable overlap in platelet calcium levels was 
reported between the two groups. The results of Cooper et al 
(1987) had similar findings. These workers concluded that a 
clear trend for an elevation in platelet calcium levels in 
hypertension exists, even if this increase is quantitatively 
small. The very high correlation between platelet calcium levels 
and blood pressure which was reported by Erne et al (1984a) has 
therefore been questioned by many other research workers. It 
appears that the elevation of intracellular free calcium levels 
is not as large as was previously thought in platelets from 
essential hypertensive patients.
Animal studies of the relationship between blood pressure 
and platelet intracellular free calcium levels have been carried 
out mainly in rats. In the same communication that illustrated
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an elevation of platelet calcium levels in hypertensive 
patients, Bruschi et al (1985) observed that spontaneously 
hypertensive rats had higher platelet calcium levels than Wistar 
Kyoto rats at eight and twenty weeks old. However four week old 
hypertensive rats had similar platelet calcium levels to 
normotensive rats. In this study there was a tendency for 
platelet calcium levels in spontaneously hypertensive rats to 
increase with age, and this was roughly parallel to the elevation
A-
of blood pressure. Baba et al (1987) reported higher platelet 
calcium levels in spontaneously hypertensive rats compared to 
Wistar Kyoto rats at four, 11 and 28 weeks old, but this elevated 
level was not age related. These workers found no difference 
between normotensive rats compared with either DOCA-salt 
hypertensive rats or two kidney, one clip hypertensive rats. 
These latter findings have been confirmed by Murakawa et al 
(1986) whose results showed that there was no difference in 
platelet calcium levels between thirteen week old DOCA-salt 
hypertensive and Sprague-Dawley rats. However, in contrast to 
Bruschi et al (1985) and Baba et al (1987), they found no 
difference between thirteen week old spontaneously hypertensive 
and Wistar Kyoto rats. Zimlichman et al (1986) also found that 
platelet calcium levels from twelve week old spontaneously 
hypertensive and Wistar Kyoto rats were similar. Finally, in 
contrast to all other findings, Umegaki et al (1986) found a 
decrease in platelet calcium levels in stroke prone spontaneously 
hypertensive rats compared to Wistar Kyoto rats.
It appears from these contrasting human and animal reports 
that a controversy exists over the degree of the increase in
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platelet intracellular free calcium levels in hypertension- This 
may be due to different experimental techniques in the 
measurement of platelet calcium levels or in the definition of 
hypertension. However, with one exception (Umegaki et al, 1986), 
all reports appear to agree that probably a small increase of 
platelet calcium levels occurs in hypertension which in some 
studies may have been undetected.
1.5.3 Intracellular free calcium levels of other cell types 
in hypertension
The other cell types in which intracellular free calcium 
levels have been estimated are erythrocytes and leucocytes.
Intracellular Na+ and Ca^+ activities have been measured in 
erythrocytes of patients using ion selective electrodes (Zidek 
et al, 1982c). These workers found that intracellular Na+ 
activity is increased in hypertension, particularly in essential 
hypertensives with a family history of hypertension. 
Normotensive subjects with a familial disposition to hypertension 
also had raised Na+ activities. However, Ca^+ activities were 
found to be increased only in hypertensive patients, regardless 
of whether or not there was a family history of hypertension. 
These findings indicate that an elevation of Na+ activity is due 
to a genetic factor, whereas a raised Ca^+ activity is a common 
denominator in a variety of hypertensive states. These elevated 
Ca^+ activities were decreased in hypertensive patients after 
treatment with either the calcium antagonist, nifedipine (Zidek 
et al, 1982b), the loop diuretic, piretanide (Zidek et al, 1984), 
or with beta adrenoceptor antagonists (Baumgart et al, 1986).
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However other workers have not been able to reproduce these 
elevated calcium levels of erythrocytes in hypertension. Morris 
et al (1988) found that intracellular free calcium measurement 
using fura 2 in erythrocytes of spontaneously hypertensive rats 
was similar to that of normotensive Wistar Kyoto rats. In 
addition, Engelmann and Duhm (1986) found that total 
intracellular calcium in hypertensive patients was slightly, but 
not significantly reduced compared to normotensive controls.
Intracellular free calcium levels in lymphocytes of 
hypertensive patients have been found to be elevated by Oshima 
et al (1988). However, no significant correlation between blood 
pressure and calcium levels existed. No alteration in 
intracellular free calcium levels in hypertensive subjects has 
been reported for either neutrophils (Lew et al, 1985) or 
mononuclear leucocytes (Shore et al, 1985).
Erythrocytes and leucocytes have been used as models for 
vascular smooth muscle cells for the same reasons as platelets; 
they are easily available for multiple sampling. Although 
platelets are not an ideal model for vascular smooth muscle 
cells, they do possess more physiological similarities than 
erythrocytes and leucocytes. When this fact is added to the 
inconsistent reports outlined above, some doubt is cast on the 
usefulness of these blood cells in reflecting the alterations 
which occur in vascular smooth muscle cells in hypertension.
1.6 Aim of work
The background of this thesis has described the second 
messenger control of calcium, and the function and mechanism of
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action of platelets and vascular smooth muscle, as these are 
necessary for the understanding of the role and control of 
calcium in the tissues which are studied in the following 
chapters. The proposed theories for the development and 
maintenance of hypertension, and the postulated role of calcium 
in this process are also necessary to understand the importance 
of intracellular free calcium levels. Finally, the evidence for 
and against an elevation of intracellular free calcium levels in 
hypertensive animals and humans is summarised.
The initial aim of the work for this thesis is to examine 
intracellular free calcium levels in hypertensive humans and 
animals, and in other conditions which are known to affect blood 
pressure, either acutely or chronically. It is hoped to come to 
a final, albeit personal, conclusion on the involvement of 
intracellular free calcium levels in the initiation and 
maintenance of hypertension.
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Chapter Two
Method for the Measurement of Human Platelet Intracelli 11 a r Free 
Calcium Levels and Preliminary Investigations
2.1 Introduction
This chapter is intended to provide an overview of some of 
the more common techniques which have been utilised to measure 
platelet intracellular free calcium levels, with a special 
emphasis on the Quin 2 technique which has been applied 
throughout the work contained in this thesis. The variations in 
methodologies within the Quin 2 technique are discussed with a 
description of the method used for these studies, and this is 
followed by some preliminary investigations which were carried 
out prior to the experiments in the following chapters.
2.1.1 Methods for measuring cytosolic free calcium 
concentration
There are many methods for measuring cytosolic free calcium 
levels which have been developed over the years. The incentive 
for the development of new and better techniques has originated 
from the discovery of the critical role for free cytosolic 
calcium in the control of the function of cells. The methods 
include calcium selective microelectrodes; calcium sensitive 
photoproteins, such as aequorin; chlortetracycline, a fluorescent 
antibiotic; and the fluorescent polycarboxylates, Quin 2, Fura 2 
and Indo 1. All of these methods have advantages and 
disadvantages and the choice of method for a study should depend 
on the technique that best fits the cell type and the aim of the
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experiment.
2.1.2 Ion selective microelectrodes
Calcium selective microelectrodes have been used to measure 
cytosolic calcium, and this technique has some advantages in 
certain preparations, but there are many technical difficulties. 
They are most commonly used in robust and well anchored cells 
which can tolerate the penetration of the electrode. The 
mammalian ventricular muscle cells are the smallest cells which 
have been convincingly impaled using microelectrodes. This 
highly specialised technique measures cytosolic calcium levels at 
a specific but undetermined area of the cytosol which could 
result in measurements of localised changes in calcium and not 
overall alterations. One of the major disadvantages of this 
technique is leakage at the seal between the cell membrane and 
electrode exterior at the site of penetration resulting in an 
influx of calcium ions due to the large inwards calcium gradient. 
This causes a large change in calcium concentration at the 
electrode tip and inaccurate estimations. Another problem is 
that electrode response times to submicromolar changes in calcium 
are of the order of seconds. This technique is difficult in 
small fragile cells such as platelets, but one group of workers 
(Zidek et al, 1983b) have measured calcium activities in 
erythrocytes using this method.
2.1.3 Aequorin and chlortetracycline
Use of luminescent or fluorescent dyes are more common 
methods for the measurement of cytosolic free calcium, especially 
in small cell populations.
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Aequorin is a protein extracted from luminescent marine 
coelenterates. It has been used both alone and in conjunction 
with Quin 2 for the measurement of cytosolic calcium, as aequorin 
is sensitive to calcium concentrations of 0.5 - 10 uM which 
overlaps with the Quin 2 sensitivity area (Johnson et al, 1985). 
However, it is thought to reflect localised changes in 
cytoplasmic calcium levels, whereas Quin 2 monitors average 
calcium levels (Salzman et al, 1985). Aequorin has to be 
introduced into the cells either by microinjection, liposome 
fusion or cell permeabilisation by hypo-osmotic shock. None of 
these loading techniques is ideal. Microinjection involves 
injecting one cell at a time which may have some applications but 
is tedious in large cell populations. Liposome fusion releases 
only trace quantities of the trapped dye into the cytoplasm and 
incorporates foreign lipid into the target cell membranes (Tsien,
1983). In some cells controlled reversible cell lysis can be 
used, but this grossly perturbs the membrane integrity and 
soluble cytoplasmic constituents and therefore will cast doubt on 
the functional viability of the cell. However, one group of 
workers have favoured a non-destructive permeabilisation 
technique and have reported that the cells are not damaged by 
reversible lysis (Johnson et al, 1985).
Chlortetracycline is a fluorescent antibiotic that has been 
used without the need to permeabilise cells. It does not measure 
calcium activity in a manner which could be calibrated, but gives 
a qualitative impression of areas of high calcium levels adjacent 
to membranes, either at the outer face of the plasma membrane or
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the inside surface of calcium accumulating organelles. 
Chlortetracycline has been used as an indication of membrane 
associated calcium (Lechi et al, 1986b) and calcium accumulation 
in the dense tubular system (Ahn et al, 1987). It is also 
kinetically useful for reporting calcium movements into or out of 
calcium sequestering organelles.
2.1.4 Quin 2 properties
The most popular techniques used for measurement of 
intracellular calcium until the 1980s were the use of indicators 
such as aequorin or chlortetracycline. The major problems of 
these calcium probes were insufficient selectivity against 
competing ions such as H+ and Mg^+, complex stoichiometries of 
interaction with calcium, and difficulties in cell uptake of the 
indicators. Tsien (1980) described a new generation of 
fluorescent indicators which were synthesised for the sole 
purpose of overcoming the problems of the old indicators. The 
prototype which was further developed from this initial paper was 
Quin 2.
The molecular structure of Quin 2 is based on the structure 
of EGTA (see figure 2.1). EGTA has a high selectivity for Ca^+ 
over Mg^+, which is probably due to the Ca^+ binding cavity of 
EGTA being too small for the larger Mg^+ ion as the carboxyl 
groups restrict the size of the cavity. EGTA also binds to Ca^+ 
in a 1 : 1 stoichiometry therefore Quin 2 inherits both the high 
specificity and 1 : 1 stoichiometry for calcium ions from the 
structural relationship to EGTA. Quin 2 is a hydrophilic 
molecule and is adapted by the addition of four
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EGTA (ethylene glycol bis (/3-aminoethyl 
ether) -  N, N, N1, N1, tetraacetic acid)
COO" “OOC
"OOC COO"
CHoO
CH3
Quin 2 (2 methyl-6-methoxy 8 nitroquinoline)
Figure 2.1
Structural similarities between EGTA and Quin 2
acetoxymethylester groups giving the molecule lipophilic 
properties and allowing it to cross the cell membrane. In the 
cytoplasm, Quin 2 acetoxymethylester (Quin 2-AM) is hydrolysed by 
endogenous esterases to remove the acetoxymethyl ester groups 
leaving the parent tetracarboxylate anion which is membrane 
impermeant and is therefore trapped inside the cell. Quin 2 will 
detect any free calcium ions in the cytoplasm and will bind to 
these ions producing an increase in the fluorescence signal which 
is related to the free Ca^+ concentration. This non disruptive 
loading procedure was a major advancement in the measurement of 
intracellular free calcium in cells.
Quin 2 has been observed to be present in the cytosol and 
nucleus of c e t i S  , but has not been identified in the 
mitochondria, the lysosomes, the endoplasmic reticulum or the 
secretory granules, and there is little or no detectable binding 
to membranes. The concentration of Quin 2 within the cell is 
dependent on the extracellular concentration during the 
incubation and the length of the incubation, but most reports 
quote concentrations of 0.5 - 2 mM. The effective dissociation 
constant (K^ ) of the Quin 2-Ca^+ complex is 115 nM in a cationic 
background mimicking cytoplasm. Fluorescence is measured at 
339 nm excitation and 492 nm emission. At 339 nm excitation 
Quin 2 produces a fivefold increase in fluorescence when fully 
saturated with Ca^+ compared to the C a?+ free form of Quin 2. It 
is sensitive to Ca^+ levels of 10 nM - 1 uM. During experiments, 
Quin 2 has been found to leak out of cells at a rate of < 5% per 
hour and this is probably due to either cell death and lysis or 
normal leakage due to permeability of healthy cells.
2.1,5 Disadvantages of Quin 2
Tsien did not regard Quin 2 as anything more than a 
prototype for indicators with more superior properties and even 
at an early stage these workers had the foresight to anticipate 
the drawbacks of Quin 2 and discussed some aspects of its 
properties that could be improved.
Fluorescent indicators measure Ca^+ most accurately around 
their values, which implies that Quin 2 will be most effective 
around 115 nM which is close to basal cytosolic calcium levels, 
but will lose its resolution around 1 uM, so it is less effective 
for measuring levels stimulated by powerful agonists. Indicators 
with higher values are required to monitor calcium levels 
greater than 1 uM. Quin 2 also possesses a high affinity for 
Ca^+ giving the molecule a high buffering capacity, and will 
therefore dampen the calcium transients and underestimate the 
calcium levels which could be achieved in unloaded cells. The 
excitation wavelength of 339 nm at which changes in fluorescence 
intensities occur for Quin 2 are similar to the wavelengths at 
which autofluorescence of cells occurs which is probably due to 
NADPH. Higher levels of Quin 2 are therefore required inside the 
cell to overcome this autofluorescence than would normally be 
required if the indicator had alterations in fluorescence at a 
longer wavelength, producing less autofluorescence. It would 
also be more advantageous to produce a shift in the wavelength at 
which the peak in fluorescence occurs after binding to Ca^+, 
rather than the change in fluorescence intensity which is 
produced by Quin 2. Finally, the acetoxymethylester groups which
are released into the cytoplasm produce acetate and formaldehyde 
groups; it would be of benefit to replace this with an ester 
group with less potential toxicity to the cell.
Since the initial reports on Quin 2 have been made, more 
disadvantages have emerged. Quin 2 was found to enhance 
aggregation and 5HT secretion from platelets at an intracellular 
concentration of 3.4 mM but at higher concentrations of 14 mM, 
inhibition occurred (Lanza et al, 1987). Hatayama et al (1985) 
found that 3 mM intracellular Quin 2 inhibited platelet function 
regardless of concentration and time of incubation and Rao et al 
(1986) showed that incubating platelets with 40 uM Quin 2 AM, 
resulting in intracellular levels of over 2 mM, inhibited 
platelet aggregation to all physiological agents. Quin 2 has 
also been reported to alter ^2p incorporation into the 
phosphoinositides (de Chaffoy de Courcelles et al, 1987), so 
there would appear to be adequate evidence showing an effect of 
Quin 2 on platelet function.
2.1.6 Fura 2 and Indo 1
In 1985, Grynkiewicz et al produced two new fluorescent 
indicators, Fura 2 and Indo 1. These dyes had the added 
advantages over Quin 2 of a 30-fold brighter fluorescence, a 
higher dissociation constant, a considerably improved selectivity 
for Ca^+ over Mg^+ and other divalent cations, and changes in the 
excitation wavelength upon calcium binding. This dual wavelength 
ratio measurement for the Ca^+ free and Ca^+ bound species of the 
molecule cancels out any effect that cell thickness, 
intracellular concentration of dye or instrument sensitivity may
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have on the final result, and is therefore a more accurate 
measurement than the one wavelength calibration for Quin 2.
These properties, coupled with the slightly longer 
excitation wavelengths and slightly lower affinity for calcium 
resulting in a lower buffering capacity for calcium should make 
these indicators the optimum choice for intracellular free 
calcium measurements.
However, these dyes are not without defects. Fura 2 has 
been found to leak out of the cells at a considerably greater 
rate than Quin 2 (Lanza et al, 1987), and Highsmith et al (1986) 
found that Fura 2 has a tendency to enter subcellular organelles 
such as the nucleus, sarcoplasmic reticulum and secretory 
vesicles in cells from skeletal muscle. This group of workers 
discovered another product of fura-2-AM, fura 2' which produces a 
fluorescent signal from the sarcoplasmic reticulum. This infers 
that the assumption that all the fluorescence is produced by 
fura 2 is invalid and may lead to artifactually decreased 
cytoplasmic calcium estimations. However this has only been 
observed in skeletal muscle and may not relate to platelets. At 
present, more groups appear to be changing from Quin 2 to Fura 2 
due to Fura 2's many advantages (Cooper et al, 1987; Pollock and 
Rink, 1986).
For Indo 1, dye leakage and intracellular localisation may 
be less problematic, but it has not been used as extensively as 
Fura 2, although it has been used in platelets (Davies et al, 
1988).
The work for this thesis began in the same year as
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Grynkiewicz et al (1985) published the first observations for 
Fura 2 and Indo 1. It was decided that the longer established 
technique of Quin 2 would be used, while accepting the drawbacks 
and limitations of the dye, rather than use a dye about which 
little was known.
2.2 Methodology for labelling of human platelets with
Quin 2_
Published work has shown that there is a wide variation in 
the methods used for the labelling of human platelets with 
Quin 2. This section gives a detailed account of the method used 
throughout this thesis, followed by a discussion of the 
alternative methods which have been utilised by other workers.
2.2.1 Method of preparation of human platelets for cytosolic
free calcium measurements
Blood was obtained from an antecubital vein of patients or 
volunteers, and collected into plastic tubes containing 0.13 M 
trisodium citrate with a ratio of nine parts blood to 1 part 
anticoagulant. Tubes were stoppered, inverted to mix the blood 
with the anticoagulant, and the blood was separated by 
centrifugation at 150 g for 15 minutes at room temperature. The 
supernatant platelet rich plasma was aspirated into clean tubes 
without disturbing the buffy coat layer.
Platelet rich plasma was then incubated at 37°C for 30 
minutes with 20 uM Quin 2-AM. After incubation the Quin 2 
labelled platelets were separated from plasma and any extraneous 
dye by gel filtration on a Sepharose 2B-CL column equilibrated 
with a modified HEPES-buffered Tyrodes' solution (see Table 2.1).
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Table 2.1
Buffer used in the preparation of human platelets
mM g/litre
NaCl 129 7.54
Na citrate 10.9 3.21
NaH003 8.9 0.75
Glucose 0.56 0.10
HEPES 5.0 1.19
KCl 2.8 0.21
kh2po4 0.8 0.11
MgCl2 0.84 0.17
CaCl2 2.4 2.4 mis of a
1M solution
The pH of the buffer is adusted to 7.4, and 0.35% bovine serum 
albumin is added immediately before use.
HEPES is - N-2-Hydroxyethylpiperazine-N^-2-ethanesulfonic acid.
Washed platelets were collected, mixed, covered and incubated at 
37°c before use.
Cuvettes were filled with diluted samples of the platelet 
suspension and were incubated before use. Cuvettes were placed 
in the cuvette holders which were thermostatically heated to 37°C 
by a Churchhill pump. Immediately before measurements were made, 
the extracellular calcium concentration was adjusted to 1 mM by 
addition of CaC^. Longer incubations with CaCl2 did not appear 
to have any effect on cytosolic free calcium levels, therefore 
immediate addition of CaCl2 was favoured.
Fluorescence was measured on a Perkin-Elmer luminescence 
spectrometer LS-3 with standard monochromator settings of 339 nm 
excitation and 492 nm emission.
Basal platelet intracellular free calcium concentration was 
calculated from the following equation,
2+ F Fmin
[C a z + ] i  (nM) = 115
F - F max
where F is the basal fluorescence obtained from unstimulated 
platelets and Fmax is obtained by lysing the cells with 50 uM 
digitonin, thus releasing the Quin 2 into the extracellular fluid 
where it will bind to the extracellular calcium producing a 
maximal fluorescence signal. Fm n^ is obtained after lysis of the 
platelets by addition of excess EGTA at a pH of 8.3, which will 
bind preferentially to calcium resulting in free Quin 2 and a 
minimal fluorescence signal. The Fm n^ value is pH dependent due 
to the equilibrium of EGTA with H+ and Ca^+. 115 is the
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dissociation constant of the Quin 2-Ca^ + complex.
2.2.2 Variations of methodology
A variety of minor modifications can be made to the general 
method for labelling platelets with Quin 2 in an attempt to 
improve the technique. The anticoagulant in which blood is 
collected is either sodium citrate (Erne et al, 1984a) or acid 
citrate dextrose (Lechi et al, 1986b) as the citrate 
anticoagulants interfere less with the structure of the platelet 
membrane than other anticoagulants such as heparin or EDTA 
(Frojomvic and Milton, 1982). The advantage of acid citrate 
dextrose is that it prevents the pH of the blood from rising as 
high as when sodium citrate is used (Day et al, 1975). However 
low pH levels can affect platelet function, so sodium citrate was 
used as an anticoagulant.
Optimal centrifugal conditions for preparing platelet rich 
plasma have not been carefully determined. Some investigators 
use high g forces for a short time (1000 x g for 4 min, Pollock 
et al, 1984) whereas others use low g forces for a longer time 
(130 x g for 15 mins, Zimlichman et al, 1987). Slow spin speeds 
with a longer time were chosen here as it was thought that less 
mechanical damage would occur to the platelets at slower speeds.
Some workers wash the platelet rich plasma, either by 
centrifugation (Zavoico and Feinstein, 1984) or by gel filtration 
(Lindner et al, 1987) before incubation with Quin 2-AM. However 
Erne et al (1984b) have shown that incubation of platelets with 
Quin 2-AM in the plasma prolongs the functional integrity of the 
sample and other groups have used platelet rich plasma with
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satisfactory results (Haller et al, 1987), therefore it was 
decided that this additional washing step was unnecessary. The 
loading concentrations of Quin 2-AM in the extracellular fluid 
ranged from 5 uM (Erne et al, 1984a) to 50 uM (Bruschi et al, 
1985) and incubation times varied between 20 and 40 minutes, but 
not in accordance with the concentration of Quin 2-AM as might 
have been expected. Preliminary experiments illustrated that an 
incubation of 30 minutes with 20 uM Quin 2-AM, identical to Le 
Quan Sang and Devynck (1986) gave acceptable results with 
intracellular concentrations of Quin 2 in the normal range.
Platelets must be separated from plasma and any remaining 
Quin 2-AM in the plasma as both these factors produce a 
fluorescence level which will interfere with the intracellular 
Quin 2 signal. Some groups of workers have used centrifugation 
to isolate platelets after Quin 2-AM incubation (Hallam et al,
1984) whereas others have used gel filtration (Lindner et al, 
1987).
The gel filtration technique was introduced by Tangen et al 
(1971). This is a superior method of separation compared to 
centrifugation as the platelets are well preserved both 
morphologically and functionally. During centrifugation, large 
forces exert stress on the platelet and damage can be inflicted 
by compacting the platelets into a pellet and by resuspending the 
platelets. Gel filtration is a simpler and more rapid technique. 
An extensive study on the effect of centrifugal washing and gel 
filtration on human platelets has been conducted recently by 
Groscurth et al (1987) who concluded that gel filtration had less 
harmful and fewer irreversible effects compared to
47
centrifugation. However these workers observed that the major 
disadvantages of gel filtration are the degree of dilution of the 
resulting platelet suspensions and the contamination of platelets 
by large plasma molecules.
Horn and Rubin (1988) have observed that over a range of 
platelet counts, 50 x 10^/1 to 200 x 10^/1, no alterations in 
intracellular free calcium measurements occur, and only very low 
platelet counts of 25 x 10^/1 result in artifactually higher 
cytosolic free calcium levels. The dilution problem of the gel 
filtration technique is therefore not a major problem in these 
studies, as platelet counts after gel filtration were found to be 
between 150-250 x 10^ /1.
Many workers omit calcium from the buffers used for platelet 
isolation to prevent unnecessary platelet aggregation during 
preparation (Haller et al, 1987; Lindner et al, 1987). However a 
calcium containing buffer has been used in the following studies 
as Erne et al (1984b) observed that loading and storing of 
platelets in a calcium deficient medium results in an enhanced 
leakiness of the platelets to calcium, and a disturbance of the 
cytosolic free calcium concentrations. For the same reason, 
bovine serum albumin was added to the buffer as it prolongs the 
integrity of platelets. Once separated from plasma, platelets 
rapidly become depleted of ATP and potassium, so the buffer also 
contained glucose and potassium chloride in an attempt to prevent 
this occurring (Baenziger and Majerus, 1974).
Platelet suspensions which are ready for fluorescence 
measurements in the cuvette holders should not be constantly
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stirred as aggregation will interfere with fluorescence 
monitoring, but when additions are made to the cuvette the 
investigator should ensure that the drug is mixed thoroughly.
A detergent is usually used to lyse the cells to obtain a 
maximal fluorescence reading. Erne et al (1984b) noted that an 
undesirably high concentration of triton X-100 would be required 
to produce complete lysis of platelets, therefore digitonin was 
recruited for this purpose.
The temperature to which the platelets are exposed 
throughout the experiment is critical. To maintain the 
functional integrity of the platelets, the sample should be 
constantly stored at 37°C. There are only two stages at which 
the sample is at room temperature; during centrifugation and gel 
filtration. Room temperature is more beneficial than 5°C for 
maintaining platelet function as at 5°C, shape change and 
increased aggregation have been observed (Day et al, 1975). 
Mustard et al (1972) have shown that centrifugation at 37°C would 
be more favourable than room temperature. However most workers 
still use room temperatures for centrifugation. The column used 
for gel filtration theoretically could have a heating element 
attached to maintain the Sepharose at a constant temperature of 
37°C, but this is technically difficult and would also restrict 
view of the column, so this procedure is carried out at room 
temperature.
It is felt that any known factor which may have a 
detrimental effect on platelet function during the methodological 
procedures has been counteracted and that that conditions under 
which platelets are prepared for cytosolic free calcium
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estimation have been fully optimised to the limits of current 
knowledge.
2.2.3 Preparation of Sepharose Column
Whatman No. 1 filter papers (2-3 sheets) are placed in a 
large Buchner funnel which is attached to a suction pump. 
Sepharose 2B is poured into the funnel without suction. A litre 
of acetone is added and the sepharose is stirred. The acetone is 
allowed to drain for 10-15 minutes before switching on the 
suction to drain the remainder. The sepharose is washed 
thoroughly with at least four litres of saline until the acetone 
has disappeared. The sepharose is then stored in saline with 
0.1 M sodium azide as a preservative. New columns are poured 
using approximately 50 mis of sepharose in a column of 4 cm in 
diameter. This column is thoroughly washed with two litres of 
saline to remove any sodium azide before use.
2.2.4 Quin 2-AM preparation
Quin 2-AM is obtained as a solid of 50 mg in a vial. This 
is dissolved in 7.43 mis of dimethylsulphoxide (DMSO) to obtain a 
solution of 10 mM. Aliquots are stored at -70°C before use. The 
concentration of DMSO when Quin 2-AM is added to platelet rich 
plasma did not exceed 0.2% v/v.
2.2.5 Materials
Quin 2 and Quin 2-AM were supplied by Lancaster Synthesis, 
Morecambe, Lancashire. Sepharose 2B-CL was obtained from 
Pharmacia, Uppsala, Sweden. All chemicals in the buffer were 
obtained fom BDH Chemicals, Poole, Dorset, except Bovine Serum
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Albumin (BSA, Fraction V) and HEPES (N-2-Hydroxyethylpiperazine- 
N'-2-ethanesulfonic acid) which were obtained from Sigma, Poole, 
Dorset. 5-hydroxytryptamine (5HT), adenosine 5' diphosphate 
(ADP), digitonin and EGTA were also obtained from Sigma. The LS- 
3 fluorescence spectrometer and cuvettes were purchased from 
Perkin-Elmer.
2.3 Preliminary investigations
This section of work is concerned with the preliminary 
experiments which were carried out to define and optimise 
experimental conditions before the studies in the following 
chapters could be initiated.
2.3.1 Standard dose-response curves to 5HT and ADP
The agonists which were chosen for this project were 5HT and 
ADP. 5HT was selected as it is implicated in the disease states 
of pre-eclampsia and migraine which are studied in Chapter 6. 
Pharmacologically, the platelet receptors for 5HT conform to the 
5 HT2 (or S2 ) subtype that are present in other tissues (De Clerck 
et al, 1984). Stimulation of this receptor results in an 
increase in inositol phospholipid breakdown (de Chaffoy de 
Courcelles et al, 1988) and an increase in cytosolic free calcium 
levels which is predominantly derived from an influx of external 
calcium ions through the opening of receptor operated channels 
(MacIntyre et al, 1985). ADP was selected as it is an endogenous 
agonist of platelet activation which coupled to a different 
receptor and stimulates elevations in intracellular calcium 
levels by alternative mode of action to 5HT. ADP acts through
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the P2 t subtype of purinoreceptors on platelets which have not 
been identified on other tissues and are thought to be unique 
(Gordon, 1986), These purinoreceptors for ADP are coupled to 
inhibition of adenylate cyclase and to elevation of cytosolic 
free calcium. This effect on calcium levels is associated with 
both an influx of external Ca^+ via opening of receptor operated 
channels and by mobilisation of internal calcium. These effects 
are both independent of inositol phospholipid coupling, as ADP 
does not produce an increase in phosphatidylinositol bisphosphate 
hydrolysis (Fisher et al, 1985).
Figure 2.2 shows examples of typical responses of the rise 
in human platelet intracellular free calcium represented by an 
increase in fluorescence levels. These concentrations of ADP ard 
5HT produced half the maximal response. Figures 2.3 and 2.4 
show the dose-response curves for platelet intracellular free 
calcium concentration when stimulated with 5HT and ADP 
respectively. Volumes of agonists added to the cuvettes were 2- 
10 ul. For each concentration of agonist a fresh sample of 
platelet suspension was used. The basal cytosolic free calcium 
levels have been subtracted from the stimulated levels to 
illustrate the absolute changes which occurred. For both curves, 
normal volunteers, either male or female were used with 
5 s< n  {  11 for each point.
2.3.2 Influence of time factor on fluorescence and cytosolic 
free calcium levels
The effect of time of preparation on the fluorescence and 
intracellular free calcium levels was investigated. The two
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Figure 2.2
Alterations in fluorescence levels which occur after 
additions of agonists in human platelets
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Figure 2.3
Dose-response curve for 5HT stimulation of platelet 
intracellular free calcium concentration in humans 
Basal levels have been subtracted 
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Figure 2.4
Dose-response curve for ADP stimulation of platelet 
intracellular free calcium concentration in humans
Basal levels have been subtracted 
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separate effects which were measured were the effect of storing 
whole blood at room temperature, and of storing washed platelets 
at 37°C. The protocol for these experiments is shown in 
Figure 2.5.
At zero time, 60 mis of blood were withdrawn from one 
volunteer into three separate collecting tubes. One sample (A) 
was prepared immediately and the first basal calcium levels were 
measured from this sample at 60 minutes. Sample A was then 
stored at 37°C and subsequent basal cytosolic free calcium levels 
were measured at 180 and 270 minutes from this sample. Sample B 
was prepared 90 minutes after blood withdrawal, with 
intracellular calcium levels measured at 150 and 285 mins, and 
preparation of sample C began 180 minutes after blood withdrawal 
with calcium levels measured at 240 minutes. Basal and 
stimulated intracellular free calcium levels were measured at 
each time point. All results are with an n = 5. Platelets were 
stimulated with 5HT (2.5 x 10“ M^) and ADP (5 x 10- M^) which are 
the EC^q values for the dose-response curves. Figures 2.6 and 
2.7 show the changes in basal fluorescence and basal cytosolic 
free calcium levels respectively which occur during storage. 
Basal fluorescence and calcium levels were found to increase with 
time. Storage of washed platelets at 37°C produced less of an 
increase in basal fluorescence than storage at room temperature 
in whole blood. However storage at room temperature in whole 
blood had a lesser effect on basal calcium levels than subsequent 
storage of washed platelets at 37°C. Figures 2.8 and 2.9
_7
illustrate the effect of 2.5 x 10 'M 5HT on fluorescence and 
intracellular free calcium levels respectively. Fluorescence
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TIME (mins^ SAMPLE ACTION TAKEN
0 A.B.C Blood withdrawn
0-60 A Preparation
60 A 1st measurement of [Ca^+Jj
90-150 B Preparation
150 B 1 st measurement of [Ca^+jj
180 A 2nd measurement of [Ca^+jj
180-240 C Preparation
240 C 1st measurement of [Ca2+]j
270 A 3rd measurement of [Ca2+]j
285 B 2nd measurement of [Ca^+Jj
Figure 2.5
Protocol for the influence of time on fluorescence and 
intracellular free calcium levels 
[Ca^ +]jL is intracellular free calcium concentration
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Figure 2.6
Alterations in basal fluorescence during storage 
Fluorescence is measured in arbitrary units 
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Alterations in basal intracellular free calcium levels
during storage 
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Figure 2,8
Alterations in 5HT (2.5 x 10~^ M) stimulated fluorescence 
levels during storage 
Fluorescence changes are measured in arbitrary units 
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Figure 2.9
Alterations in 5HT (2.5 x 1QzZm ) stimulated intracellular 
free calcium levels during storage 
For each point, n = 5 
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changes decreased with time, with less decrease when platelets 
are stored in whole blood at room temperature. Washed platelets 
stored at 37°C demonstrated a rapid decline in the fluorescence 
changes which could be elicited. Platelet intracellular free 
calcium levels showed very little change after storage for three 
hours in whole blood at room temperature. However in washed 
platelet samples which had been stored at 37°C, cytosolic free 
calcium levels had begun to increase about three hours after 
blood withdrawal.
Figures 2.10 and 2.11 illustrate alterations in fluorescence 
and intracellular free calcium levels respectively after 
stimulation with 5 x 10“^M ADP. The fluorescence graph is 
similar to Figure 2.8 for fluorescence changes induced by 5HT. 
Fluorescence changes appear to be better maintained by platelets 
stored in whole blood at room temperature, with a decrease in the 
fluorescence changes occurring with time. ADP stimulated 
intracellular free calcium levels showed a tendency to increase 
with time in the platelets stored as whole blood. No trend was 
observed with the washed platelets stored at 37°C.
2.3.3 Reduction in responses with time
Platelets become less responsive to agonists with time. 
Changes in fluorescence and intracellular free calcium levels in 
response to 5HT (2.5 x 10“ M^) and ADP (5 x 10“ M^) with time were 
measured.
Figures 2.12 and 2.13 show the reductions in fluorescence 
and stimulated intracellular free calcium levels respectively 
with time after 5HT stimulation, where zero time is 60 minutes
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Figure 2.10
Alterations in ADP (5 x 10~^ M) stimulated fluorescence 
levels during storage 
Fluorescence changes are measured in arbitrary units 
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Figure 2.11
Alterations in ADP (5 x 10—Zm ) stimulated intracellular 
free calcium levels during storage 
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Figure 2.12
Reduction of fluorescence responses to 5HT (2.5 x 1 QcZm) 
stimulation with time 
Fluorescence is in arbitrary units
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Figure 2.13
Reduction of intracellular free calcium responses to 5HT 
(2 . 5  x 1 QhZm) stimulation with time
after blood withdrawal. These two graphs show a roughly linear 
reduction in responses with time.
Figures 2.14 and 2.15 show the change of fluorescence and 
intracellular free calcium levels respectively with time after 
ADP stimulation. As for the fluorescence graph for 5HT, 
fluorescence changes stimulated by ADP showed a linear reduction 
in responses with time. However, the ADP stimulated 
intracellular free calcium levels showed an exponential reduction 
with time. This was probably due to the high levels of 
stimulation which were initially obtained for ADP in comparison 
to 5HT stimulation which produced an exponential decay when 
converted from fluorescence levels to cytosolic free calcium 
levels.
2.3.4 Daily intra-subject variations
The variability of basal platelet intracellular free calcium 
levels was calculated for two male volunteers. One sample of 
blood was collected each day for four consecutive days from each 
volunteer. These results are shown in Table 2.2a with the 
coefficients of variation for each subject, and they would 
suggest that basal platelet cytosolic free calcium levels were 
reproducible from day to day. As part of the work for 
Chapter six, non-pregnant females had basal platelet calcium 
levels measured four times with at least six weeks between each 
measurement. More variation is seen between these four 
measurements for each of the four volunteers, as illustrated in 
Table 2.2b.
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Figure 2.14
Reduction of fluorescence responses to ADP (5 x 1 QzZm) 
stimulation with time 
Fluorescence is in arbitrary units
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Figure 2.15
Reduction of intracellular free calcium responses to ADP 
(5 x IOcZm ) stimulation with time
Table 2.2
Variation in basal platelet intracellular free calcium levels
within subjects
a. Day to day variation
platelet calcium levels (nM) mean +
Subject 1 2 3 4 SEM (nM) CV (%)
1 62.5 66.9 69.6 60.9 65.0 + 2.0 6 . 2
2 79.5 73.2 71.4 62.5 71.7 + 3.5 9.8
b. Month to month variation
platelet calcium levels (nM) mean _+
Subject 1 2 3 4 SEM (nM) CV (%)
1 79.2 58.7 51.4 63.3 63.3 + 5.9 18.6
2 49.7 85.0 59.2 85.6 69.9 + 9.1 26.0
3 60.8 50.2 42.6 78.3 58.0 + 7.7 26.7
4 81.9 61.0 56.8 69.0 67.2 + 5.5 16.4
56
2.3.5 Concentration of Quin 2 which is trapped inside the 
platelets
A standard curve for Quin 2 was constructed (see 
Figure 2.16). This was achieved by preparing platelets in the 
usual manner without incubation with Quin 2-AM. These 
unlabelled, washed platelets are then lysed with digitonin and 
known concentrations of the Quin 2 free acid were added to the 
lysed platelets in the cuvette and the fluorescence was measured. 
The concentration of Quin 2 which is trapped inside platelets 
which have been incubated with Quin 2-AM is calculated by lysing 
the platelets with digitonin and reading the fluorescence of this 
from the standard curve to obtain the concentration of Quin 2 in 
the cuvette which has been released from the platelets. The 
initial concentration inside the platelets is estimated from the 
platelet count and the mean platelet volume, and is usually in 
the region of 0.5 - 1.5 mM.
2.3.6 Autofluorescence changes
To correct for any changes in autofluorescence of the 
platelets after various additions, drugs were added to 
unlabelled, washed platelets and the changes in autofluorescence 
were measured. No alterations were observed in the fluorescence 
of samples after addition of 5HT, ADP or EGTA. Small elevations 
of up to one fluorescence unit were observed after addition of 
digitonin, but these were not of a great enough magnitude to 
include a correction factor in the calculation.
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Standard curve for Quin 2 
Fluorescence is in arbitrary units
2.4 Discussion of preliminary investigations
These preliminary experiments were carried out in an attempt 
to control for various factors which may affect the final 
results, and to be aware of the limitations of the experimental 
procedures.
Dose-response curves were constructed in normal human 
volunteers. These experiments allowed calculation of EC5 Q values 
which were used in other preliminary experiments, and gave a 
range of concentrations for use in further studies as well as 
standard dose-response curves for comparison with other results. 
ADP was found to produce a greater maximum response than 5HT for 
stimulation of platelet cytosolic free calcium levels, and the 
standard curve for ADP shows that the maximum response has not 
been attained as the curve has not reached a plateau. This was 
due to experimental limitations as higher concentrations of ADP 
could not be obtained.
The time factor experiments were of particular importance as 
it was necessary to transport blood samples from other hospitals 
to the laboratory. Rao et al (1986) and Erne et al (1984b) have 
illustrated an increase in basal platelet cytosolic free calcium 
levels with time. From these results it was decided that blood 
should be transported and prepared immediately after withdrawal, 
and that all experiments should be completed within three hours 
of blood sampling as after this time alterations in fluorescence 
readings and calcium levels begin to occur.
A decrease in responses of platelet cytosolic free calcium 
levels to agonists has been observed (Erne et al, 1984b). These 
workers observed that the most rapid loss of reactivity was
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observed for 5HT, within about 150 minutes of blood withdrawal. 
For this reason, in subsequent chapters the 5HT dose-response 
curve is constructed before the ADP dose-response curve, as ADP 
has been shown to retain its reactivity until about 300 minutes 
after blood withdrawal (Erne et al, 1984b). The experiments 
showing a decrease in responses with time were in agreement with 
the time course experiments indicating that all experiments 
should be completed within three hours of blood withdrawal.
The intra-subject variation values measured were to 
illustrate the level of variation between samples from the same 
person on different days. These results showed that there is 
more variation if the samples are taken a number of weeks apart 
rather than a day apart, but no firm conclusions or reasons can 
be made from this observation. These changes could have been due 
to sex differences, hormonal changes or variations in dietary 
habits.
In this chapter the technical and methodological aspects of 
Quin 2 measurement of platelet intracellular free calcium levels 
have been considered. The advantages and drawbacks of this 
method have been discussed along with the reasons for choosing 
Quin 2. The limitations of this method have been accepted, and 
the attempts made to optimise the methodology have been outlined.
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CHAPTER THREE
EFFECTS OF ETHANOL AND EXERCISE ON PLATET.ET INTRACELLULAR 
FREE CALCIUM CONCENTRATION IN HUMANS
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Chapter Three
Effects of ethanol and exercise on platelet intracellular 
free calcium concentration in humans
3.1 Introduction
While developing the experimental procedure for the 
measurement of human platelet intracellular free calcium 
concentration, it was noticed that some of the normal volunteers 
had high platelet cytosolic free calcium levels on some occasions 
only. Two factors appeared to be common in these volunteers: 
they had either consumed alcohol within about two hours previous 
to the measurements being made, or they had been exercising. One 
of the aims of the preliminary studies was to attempt to identify 
any factors which might affect platelet cytosolic free calcium 
levels, and standardise these factors in the subsequent 
controlled studies. Therefore it was decided that further 
investigation of the effects of alcohol ingestion and exercise on 
platelet intracellular free calcium levels was warranted.
3.1.1 The effects of ethanol
Alcohol consumption is a well recognised risk factor for 
cardiovascular disease. Although it has been argued that alcohol 
consumption protects against the development of coronary heart 
disease, perhaps by elevating high density lipoprotein 
cholesterol, this advantageous effect is greatly outweighed by 
the risk of other cardiovascular diseases, such as stroke, 
cerebral infarctions and hypertension, and also an increased 
incidence of cancer and cirrhosis of the liver (Criqui et al,
1981).
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In untreated hypertensive men who had a regular alcohol 
consumption, withdrawal of alcohol produced a reduction of both 
systolic and diastolic blood pressures. Reintroduction of 
alcohol produced significant elevations of blood pressure (Potter 
and Beevers, 1984). Puddey et al (1987) also observed a similar 
trend in treated hypertensives who were normally moderate to 
heavy drinkers. After four weeks of consuming low alcohol 
products, reductions in blood pressures were significant, and on 
return to normal alcohol intake, the blood pressures returned to 
baseline. Alcoholic patients, however, demonstrate blood 
pressure elevations during the initial withdrawal from alcohol 
(Bannan et al, 1984).
In normotensive volunteers, a decrease in systolic and 
diastolic blood pressures is observed when alcohol consumption is 
reduced (Puddey et al, 1985). The effect of acute alcohol 
consumption on normotensive volunteers however is controversial. 
Grollman (1930) found that small quantities of alcohol increased 
blood pressure, whereas other workers have found no significant 
elevations in blood pressure (Kupari, 1983; Miyazaki, 1974).
It has been postulated that alcohol consumption may play a 
major role in the genesis of the early stages of blood pressure 
elevation. A review of the recent literature on this topic by 
MacMahon (1987) concluded that a significant positive association 
between the level of alcohol consumption and blood pressure 
existed, and this was independent of other factors which could 
affect blood pressure such as age, weight, exercise and smoking. 
Regular moderate alcohol consumption in normotensive men produces
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a direct and reversible pressor effect (Puddey et al, 1985), but 
in the longterm alcohol may cause irreversible damage to the 
cardiovascular system. It is unclear how alcohol consumption can 
produce these effects.
De Marchi et al (1986) proposed that possible alterations in 
calcium metabolism may be involved in the development of alcohol 
associated hypertension, as hypertensive alcoholics had a 
reduction in plasma ionised calcium levels and an increased 
urinary loss of calcium. This theory has been elaborated by 
Potter et al (1986). They speculated that alcohol acutely 
inhibits Na+, K+-ATPase activity at a cellular level, thus 
producing an increase in cytosolic Na+ within cells. This in 
turn could lead to an -inhibition of the slow Na -Ca pump, 
resulting in an elevation of cytosolic free Ca^+. The plasma 
hypocalcemia may reflect the transfer of calcium from the plasma 
to the tissues. These workers postulated that even a small 
elevation of cytosolic free calcium levels may facilitate 
vascular smooth muscle contraction, either directly, or by 
potentiating the vasoconstrictor actions of circulating 
neurohormonal agents such as noradrenaline. At low 
concentrations of ethanol, the action of noradrenaline is 
potentiated leading to an increase in sympathetic activity, 
therefore ethanol may act synergistically with the alterations in 
intracellular calcium to cause the pressor action of alcohol.
Although the main aim of these experiments was to assess the 
effect of acute or recent alcohol ingestion on platelet 
intracellular free calcium levels, it was also hoped that any 
alterations in platelet intracellular free calcium concentration
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which were observed may reveal a mechanism for the elevation of 
blood pressure which can be observed during chronic ethanol 
administration.
3.1.2 The effects of exercise
The effect of exercise on platelet cytosolic free calcium 
levels was also studied to observe if any alterations occur.
Exercise is thought to protect against coronary heart 
disease (Eichner, 1983). However this protective effect is 
thought to occur mainly in healthy individuals; if any underlying 
cardiovascular disease is present, exercise may exacerbate the 
condition. Regular exercise over a long period of time reduces 
both systolic and diastolic blood pressure and produces a 
decrease in peripheral vascular resistance and plasma 
noradrenaline levels, indicating a reduction in sympathetic 
activity. This has been observed in both normotensive and 
hypertensive subjects (Jennings et al, 1986).
In studies which have recorded the acute effects of exercise 
on haemodynamic parameters, an increase in heart rate and 
systolic, but not diastolic blood pressure has been observed 
(Pickering et al, 1982; Wilcox et al, 1982). During the recovery 
period after exercise, both systolic and diastolic blood 
pressures are significantly lower than the basal levels measured 
before exercise and the heart rate returns to near normal levels 
(Wilcox et al, 1982). The reason for this decrease in blood 
pressure below basal levels post-exercise is that venous return 
is reduced due to the discontinuance of the mechanical pumping 
effects of the skeletal muscles, and vasodilation of the skeletal
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muscle and cutaneous blood vessels occurs, resulting in a fall of 
both systolic and diastolic blood pressure.
In addition to observing if exercise affects platelet 
intracellular free calcium concentrations, the effect of the 
acute elevation of blood pressure during exercise and the 
decrease after exercise could also be examined, to assess if 
these acute haemodynamic changes produce an alteration in 
platelet cytosolic free calcium levels, and perhaps elucidate the 
mechanism for the development of an elevation in blood pressure.
3.2 Protocols, methods and materials
3.2.1 Alcohol pilot study
A pilot study was carried out to assess the effect of
alcohol on basal platelet intracellular free calcium levels.
This pilot study involved 11 subjects, five female and six 
male, who attended on two study days.
The design is shown in Figure 3.1. On each day subjects 
donated 2 0  mis of blood for platelet intracellular free calcium 
measurement before lunch. On the control day they were allowed a 
non-alcoholic beverage of their choice and on the alcohol 
treatment day each subject received 300 mis of white wine to be 
consumed during their lunch hour. Another blood sample was taken 
90 minutes after lunch.
After completion of the pilot study a number of justified 
criticisms of the study design were realised. Food intake over 
the study period was not controlled between subjects, and some 
could have been consuming more food than others during their
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PILOT STUDY DESIGN
T
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blood sample blood sample
Figure 3.1 
Protocol for the alcohol pilot study
lunch hour which could have, affected the rate and amount of 
absorption of the alcohol. There was also no correction of 
alcohol intake for body weight, therefore each subject was 
consuming a different amount of alcohol relative to their body 
weight. The actual alcohol levels present in each subject at the 
time of blood withdrawal were not measured. There was no proper 
control for the alcohol as subjects were allowed any volume of 
any non-alcoholic drink they preferred. In particular, caffeine 
containing beverages were not restricted. There were also no 
restrictions on activity before or during the study period. 
There are probably other chemicals in white wine which could have 
affected measurements. Peterson et al (1986) have reported that 
wine contains a number of substances including calcium, magnesium 
and amino acids. It would be more appropriate to use pure 
ethanol to control for factors that may affect any measurements 
being recorded. These factors which could have affected the 
results obtained in the pilot study were controlled for in the 
main alcohol study.
3.2.2 Main alcohol study protocol
The subjects consisted of 24 volunteers, 13 female and 11 
male, all of whom were normotensive and non smokers. The mean 
(+ SEM) age was 26 _+ 1 years and the mean weight was 65 _+ 2 kg. 
None had taken any drugs, including those that would affect 
platelet function, for at least seven days prior to the study 
days. All volunteers had avoided caffeine containing beverages 
from 11 p.m. on the previous evening. To assess each subject's 
average daily alcohol consumption, a one week retrospective diary
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of their alcohol intake was compiled at least one week after the 
final study day. All subjects were found to have a low to normal 
average alcohol consumption with a median of 1 1 g/day (range 0 - 
6 8 g/day). All gave written informed consent to participate in a 
protocol which was approved by the local Ethics Review Committee.
The experimental schedule is shown in Figure 3.2. Subjects 
were asked to attend on three study days, and were allowed a 
light breakfast before 8 a.m. on each day.
The first two treatment schedules (Figure 3.2A) involved 
volunteers attending the research unit at 9.30 a.m. and having 15 
minutes semi recumbent rest. Five blood pressure plus heart rate 
measurements, breath alcohol levels and a blood sample for 
platelet intracellular free calcium levels were then taken. At 
1 0  a.m., subjects received the treatment which was either 0 .8 g/kg 
of absolute alcohol BP, diluted to 400 mis with fruit juice or 
1.4g/kg of dextrose monohydrate dissolved in 400 mis of fruit 
juice. These were the acute ethanol and control treatments 
respectively. Treatments were administered over a 45 minute 
period and 45 minutes after the completion of treatment another 
set of haemodynamic, breath alcohol and platelet calcium 
measurements were taken. On the third treatment day 
(Figure 3.2B) subjects took 0.8g/kg of absolute alcohol diluted 
to 400 mis in fruit juice between 8 p.m. and 1 0  p.m. on the 
evening previous to measurements. This was regarded as a recent 
ethanol treatment. They attended the research unit at 9.30 a.m. 
on the following morning, had 15 minutes semi-recumbent rest, and 
then a set of haemodynamic, breath alcohol and platelet calcium 
levels were taken.
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TREATMENT EITHER -  0.8g/kg absolute alcohol BP (ACUTE)
OR -  1.4g/kg dextrose monohydrate (CONTROL)
B -
2000 2200 945
-0.8g/kg absolute alcohol BP (RECENT)
Figure 3.2 
Protocol for the main alcohol study 
Arrows indicate where haemodynamic measurements and blood 
samples were taken.
Shaded area is the period of treatment.
Blood pressure and heart rate were measured using a Sentron 
semiautomatic sphygmomanometer.
1.4g/kg of dextrose monohydrate was administered as a 
control as this had the same calorific value as the 0 .8 g/kg of 
absolute alcohol which was administered on the acute and recent 
treatment days. These three treatment days were allocated in a 
random order fashion, with at least two days between each 
treatment day.
3.2.3 Exercise study protocol
The subjects consisted of 21 volunteers, nine female and 12 
male, all of whom were normotensive and non-smokers. Their mean 
SEM) age was 25 _+ 1 years and the mean weight was 69 + 3 kg. 
All subjects gave written informed consent to participate in a 
protocol which had been approved by the local Ethical Review 
Committee. Volunteers who had ingested any drugs, including 
those that would affect platelet function, within the previous 
week were excluded from the study.
The experimental schedule is illustrated in Figure 3.3. 
Subjects were asked to attend the Research Unit at 12 p.m. after 
a standard lunch. They had avoided strenuous exercise in the 
previous 24 hours, and caffeine-containing beverages since 
11 p.m. on the previous evening. An intravenous cannula was 
inserted into a forearm vein and flushed with heparinised saline 
(150 mM). After 60 minutes rest, basal blood pressure and heart 
rate readings were measured and blood samples were collected for 
the various biochemical measurements described below. Blood 
pressure and heart rate were measured on a Sentron semi-automatic
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Figure 3.3 
Protocol for the exercise study 
Haemodynamic measurements and blood samples were taken on four 
occasions.
1 - immediately before exercise
2 - immediately after exercise
3-30 minutes after exercise
4-90 minutes after exercise
sphygmomanometer, taking the mean of five readings with the 
exception of the measurements made immediately after exercise, 
when only one reading was taken to ensure that an elevation in 
these parameters had occurred with exercise.
Subjects were then exercised on a bicycle ergometer at 120W 
for 30 minutes. The purpose of this constant exercise load was 
to elevate blood pressure, and it was not intended to produce a 
predefined level of work on each subject. Blood pressure and 
heart rate readings and blood sampling were repeated immediately 
after exercise, and 30 minutes and 90 minutes after exercise. 
All measurements were taken in the semi-recumbent position.
3.2.4 Platelet intracellular free calcium levels
Platelet intracellular free calcium levels were measured as 
described previously in Section 2.2.1. Only basal levels were 
measured due to the limited time available between samples in 
these studies.
3.2.5 Breath alcohol levels
Breath alcohol levels were measured from breath analysis 
using a Camic infrared breath analyser.
3.2.6 Plasma catecholamine levels
Adrenaline and noradrenaline levels in the plasma were 
determined by a radio-enzymatic assay based on the method of da 
Prada and Zurcher (1976). The method was dependent upon the 
determination of the methylation of the catecholamines with 
tritiated S-adenosylmethionine by the action of purified 
catechol-o-methyltransferase. The limit of detection for
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noradrenaline was 0.1 nM and.for adrenaline it was 0.03nM. The 
inter- and intra-assay variations were respectively, 15% and 13% 
for noradrenaline and 2 0 % and 15% for adrenaline.
3.2.7 Plasma lactate concentrations
Blood samples were analysed for lactate concentration using 
an enzymatic ultra-violet method with a kit supplied by 
Boehringer Mannheim GmbH Diagnostica which is based on the method 
of Noll (1974). The coefficient of variation for this assay was 
7%.
3.2.8 Plasma calcium concentrations
Total plasma concentrations were estimated using a two 
reagent method based on the work of Gitelman (1967) by a 
Technicon RA-1000 calcium kit. The coefficient of variation for 
this assay was 2 .1 %.
3.2.9 Materials
The Sentron semi-automatic sphygmomanometers were obtained 
from Bard Biomedical. Sources of all other reagents and 
equipment have been mentioned previously.
3.2.10 Statistical analyses
For the alcohol pilot study, comparison of pre and post 
treatment data were carried out using the Wilcoxon matched pairs 
test, as the results had a non-parametric distribution. Data 
obtained from the controlled alcohol study were analysed by
repeated measures analysis of variance. Further comparisons
between treatments were made using the paired t-test. Repeated 
measures analysis of variance was also used for analysis of the
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exercise study data. Further analyses for inter-group 
comparisons were carried out using the Scheffe test. 
Correlations were carried out by linear regression analysis. 
Both the controlled alcohol study and the exercise study had a 
90% power of detecting a 16.5% change in intracellular free 
calcium concentrations. Results are expressed as a mean _+ SEM.
3.3 Results
3.3.1 Platelet intracellular free calcium concentrations from 
the alcohol pilot study
Platelet intracellular free calcium levels were unchanged 
after the control treatment. After alcohol consumption a 
significant increase was observed (p < 0.05). These results are 
shown in Figure 3.4.
3.3.2 Main alcohol study
3.3.2.1 Blood pressure
No significant alteration in either systolic or diastolic 
blood pressure was observed between the five separate 
measurements taken (Figure 3.5). Blood pressure appeared to be 
reduced in the post ethanol treatment group, but this was not 
found to be significant.
3.3.2.2 Heart rate
A significant increase in heart rate was observed within the 
five groups (p < 0.01). Further analysis showed that this 
difference occurred between the pre and post ethanol treatments 
(p < 0.05). These results are shown in Figure 3.6.
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Figure 3.4
Platelet intracellular free calcium levels from the 
alcohol pilot study 
[Ca^ +]i is intracellular free calcium concentration
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Blood pressure measurements from the alcohol study
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Figure 3.6
H^arh rate measurements from the alcohol study 
*p < 0.05 compared to pre-alcohol levels
3.3.2.3 Breath alcohol
No trace of alcohol was found in volunteers before or after 
dextrose treatment, before acute alcohol treatment, and after 
recent alcohol treatment (Figure 3.7). The mean breath alcohol 
level after acute ethanol ingestion was 36 +_ 2 ug/100 ml. This 
is just greater than the UK limit at which prosecution for 
driving is undertaken (35 ug/100 ml in breath, or 80 mg/100 ml in 
blood).
3.3.2.4 Platelet intracellular free calcium levels
Basal platelet intracellular free calcium levels for the 
five sets of results are shown in Figure 3.8. There was no 
alteration in platelet calcium throughout the study (p = 0.48).
3.3.2.5 Correlation between blood pressure and platelet 
intracellular free calcium levels
Over the narrow range of blood pressures available from this 
study, no correlation between basal platelet intracellular free 
calcium levels and either systolic (r = 0.024, p = 0.8, n = 120) 
or diastolic (r = 0.094, p = 0.3, n = 120) blood pressures was 
observed (see Figures 3.9 and 3.10).
3.3.3 Exercise study
3.3.3.1 Blood pressure
Systolic and diastolic blood pressure measurements were 
found to be significantly altered during the study when analysed 
by analysis of variance (p < 0.001 in both cases). Systolic 
blood pressure increased significantly immediately after
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Figure 3.7
Breath alcohol levels from the alcohol study
*p < 0.001 compared to pre-alcohol levels
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Platelet intracellular free calcium levels from the
alcohol study 
[Ca^ +j^  is intracellular free calcium concentration
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Figure 3.9
Graph of systolic blood pressure against basal platelet 
intracellular free calcium levels for all measurements made
throughout the alcohol study
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exercise, while diastolic blood pressure showed a trend towards 
elevation. Over the next 90 minutes both systolic and diastolic 
blood pressures fell significantly, with blood pressures lower 
than the pre-exercise levels. These results are shown in 
Figure 3.11. The significant alteration in diastolic blood 
pressure was found to be a reduction in blood pressure when the 
levels immediately after exercise were compared with those 90 
minutes after exercise (p < 0.01).
3.3.3.2 Heart rate
Heart rate was significantly altered during the study 
(p < 0.001). An increase was observed immediately after 
exercise, which gradually returned to pre-exercise levels during 
the 90 minutes rest after exercise. These results are 
illustrated in Figure 3.12.
3.3.3.3 Platelet intracellular free calcium levels
The results for platelet intracellular free calcium 
concentration are shown in Figure 3.13. There were no 
significant alterations in these measurements throughout the 
study (p = 0.78).
3.3.3.4 Plasma catecholamines
Plasma noradrenaline levels were significantly altered 
during the study (p < 0.001) with plasma levels rising from
2.2 +_ 0.2nM pre-exercise to 5.9 _+ 0.6nM immediately after 
exercise. After 30 minutes rest, plasma noradrenaline had 
returned to baseline levels. Plasma adrenaline levels were also 
found to be significantly altered during the study (p < 0.05) but
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Blood pressure (BP) measurements from the exercise study 
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Heart rate (HR) measurements from the exercise study
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[Ca2+]i is intracellular free calcium concentration
the difference occurred between the levels measured immediately 
after exercise (1.04 _+ 0.2nM) and after 90 minutes rest 
(0.62 _+ 0.06nM, p < 0.05). Plasma catecholamine levels fell to 
within the normal range for resting subjects within 90 minutes. 
These results are shown in Figure 3.14.
3.3.3.5 Plasma lactate concentrations
Lactate levels in the plasma were altered during exercise 
(p < 0.001). They were significantly increased after exercise, 
rising from a pre-exercise level of 1.0 _+ 0.06nM to 5.0 +_ 0.7nM 
immediately after exercise (p < 0.001). These elevated levels 
returned to baseline after 90 minutes rest. Plasma lactate 
results are shown in Figure 3.15.
3.3.3.6 Plasma calcium concentrations
Plasma calcium levels which had been corrected for the 
concentration of albumin present are illustrated in Figure 3.16. 
These changed significantly during the study (p < 0.001), with an 
elevation immediately post-exercise to 2.55 _+ 0.03mM from a 
baseline level of 2.43 +_ 0.03mM (p < 0.001). This increase in 
plasma calcium level had returned to baseline after 30 minutes 
rest.
3.3.3.7 Correlation between blood pressure and platelet 
intracellular free calcium concentrations
The possibility of correlations between blood pressure and 
basal platelet intracellular free calcium concentrations during 
exercise was explored using linear regression analysis. No 
correlation was observed between either systolic or diastolic
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Plasma calcium concentrations from the exercise study
*** p < 0.001 compared to levels measured before exercise.
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Graphs of diastolic blood pressure against platelet 
intracellular free calcium concentration from samples
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Figure 3.18
Graphs of systolic blood pressure against platelet 
intracellular free calcium concentration from samples
taken before, and immediately after exercise
blood pressure and platelet cytosolic free calcium levels, either 
before or immediately after exercise. Platelet calcium levels 
plotted against diastolic blood pressure for pre-exercise 
measurements (r = 0.155, p = 0.502) and measurements made 
immediately after exercise (r = 0.314, p = 0.165) are shown in 
Figure 3.17. Platelet calcium levels plotted against systolic 
blood pressure, again for pre-exercise levels (r = 0.533, 
p = 0.103) and levels immediately after exercise (r = 0.395, 
p = 0.077) are shown in Figure 3.18 (n = 21 in all cases).
3.4 Discussion
3.4.1 Effect of ethanol
Acute ingestion of ethanol showed a moderate reduction in 
blood pressure, which was not significant, and an elevation of 
heart rate. These haemodynamic alterations are consistent with 
the findings of Howes and Reid (1985) who administered a similar 
quantity of ethanol. The increase in heart rate is probably a 
compensatory reflex to either volume depletion, caused by an 
alcohol induced diuresis, or to vasodilation.
Ethanol ingestion had no significant effect on basal 
platelet intracellular free calcium concentrations. Ethanol has 
been reported to affect platelet function "in vitro". Haut and 
Cowan (1974) found that ethanol impaired the responses of 
platelets to a variety of aggregating agents. Kitagawa et al 
(1984) postulated that this inhibition of aggregation could be 
caused by perturbation of the lipid membrane by alcohols. Rubin 
et al (1 988) reported that ethanol alone produces a dose
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dependent elevation of platelet intracellular free calcium. 
However the "in vitro" concentrations used by these workers are 
far greater than the "in vivo" concentrations obtained after 
ethanol ingestion in this study. Higher concentrations of 
ethanol in the blood could have been achieved in this study, but 
it was decided that an adequate level had been attained where any 
expected changes observed from the pilot study should have 
occurred. The purpose of this study was to assess the effect of 
concentrations of alcohol which are found in a subject who has 
consumed a reasonably large quantity of alcohol, and therefore 
the results from this study cannot be directly compared with 
"in vitro" studies unless similar concentrations are used. 
However, from these high concentrations which were used in 
"in vitro" studies, it was expected that no elevations in 
platelet intracellular free calcium levels were observed in this 
study.
It can be concluded from the results of this study that the 
increase in platelet intracellular free calcium concentration 
which was observed in the pilot study could have been due to any 
of the uncontrolled factors that were present in the pilot study 
which have been mentioned previously. However, in reality, most 
volunteers and patients who would be included in a study would be 
more likely to drink alcoholic beverages which contain 
impurities, and not absolute ethanol, therefore restrictions must 
be implemented to prevent any other spurious results occurring 
which could possibly be due to consumption of some type of 
alcoholic beverage.
An effect of ethanol on platelet cytosolic free calcium
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levels either before 90 minutes after ingestion, or between 90 
minutes and 12 hours after ingestion, cannot be ruled out. 
However, there is no reason to assume that this is likely. It 
would be of great interest to observe the effects of chronic 
ingestion of alcohol as longterm blood pressure changes may 
affect platelet intracellular free calcium concentration.
3.4.2 Effect of exercise
The ability of volunteers to sustain the predetermined level 
of exercise varied and two of the volunteers failed to complete 
the full 30 minutes exercise. These two subjects appeared to 
have been vigorously exercised as indicated by their 
cardiovascular and biochemical measurements.
Systolic blood pressure was significantly increased by 
exercise in this study, with little effect seen on diastolic 
blood pressure. This is in agreement with other findings (Siess 
et al, 1981; Wilcox et al, 1982). Systolic and diastolic blood 
pressures were greatly reduced after 90 minutes rest. Systolic 
blood pressure was lower after 30 minutes and 90 minutes rest 
than the pre-exercise levels, and this has also been observed by 
Wilcox et al (1982). Heart rate was also found to increase with 
exercise and then return to baseline levels after 90 minutes 
rest, another haemodynamic alteration which has been previously 
observed by Wilcox et al (1982). The reason for these 
cardiovascular changes is the large increase in sympathetic 
activity that arises during exercise.
Plasma noradrenaline levels were found to be elevated after 
exercise whereas plasma adrenaline levels remained unaltered. In
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a study by Kotchen et al (1971), similar results were found. 
Dimsdale and Moss (1980), observed that psychological stress, 
such as public speaking, caused elevated levels of adrenaline 
with little effect on noradrenaline, whereas physical stress, 
such as exercise, caused an increase in plasma noradrenaline 
levels but no alterations in adrenaline levels. Increases in 
adrenaline levels were only observed in subjects who were 
exercised to exhaustion (Hawkey et al, 1975) and none of the 
volunteers in this study were exhausted at the completion of 
exercise. The difference between the levels of adrenaline 
occurred between the levels measured immediately after exercise 
and after 90 minutes rest, similar to the diastolic blood 
pressure measurements. The reason for this could have been that 
subjects' pre-exercise adrenaline levels were higher than normal 
due to an elevated adrenal response in anticipation of physical 
exertion.
Elevations in lactate levels have also been reported 
previously with exercise (Holmsen and Strom, 1959; Neilsen et al, 
1977), and the lactate concentrations in this study could have 
been predicted from other published work.
Total plasma calcium and plasma ionised calcium are elevated 
during exercise (Vora et al, 1983). This effect is in agreement 
with the results of this study and is thought to be due to 
metabolic acidosis caused by an increase in lactic acid, 
resulting in an increase in plasma calcium. Ljunghall et al 
(1984) also proposed that this elevation may be due to a decrease 
in plasma volume and an exercise stimulated influx from
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extracellular sources causing an elevation of plasma ionised 
calcium.
Despite the alterations in the haemodynamic and biochemical 
parameters, no alteration in basal platelet intracellular free 
calcium levels was observed during or after exercise in this 
study. After the completion of this work, Haller et al (1986) 
published a group of experiments very similar to this study. 
They also concluded that there was no alteration in basal levels 
of platelet intracellular free calcium. However, they observed 
that agonist-induced elevations of platelet cytosolic free 
calcium were reduced after exercise.
In conclusion, the acute effects of blood pressure and 
hormonal changes related to either ethanol ingestion or exercise 
are not associated with alterations in basal platelet 
intracellular free calcium concentration. However, it would be 
of interest to discover if chronic ethanol consumption, or 
regular moderate exercise have any influence over intracellular 
free calcium levels in platelets. It would also be advantageous 
to measure the effect of ethanol consumption and exercise on 
agonist stimulated intracellular free calcium levels.
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Chapter Four
Effect of age and sex on blood pressure and platelet 
intracellular free calcium concentration in humans
4.1 Introduction
Both age and sex can influence the blood pressure of an 
individual. The objective of this group of experiments was to 
establish if platelet intracellular free calcium levels are also 
dependent or either the age or the sex of patients, as this may 
affect the results of other studies.
In industrialised societies, mean blood pressure levels of 
the population are found to increase with age. This is probably 
due to a more stressful and less physically active lifestyle as 
this population becomes older, coupled with an unhealthy diet, 
compared to primitive societies which do not show any correlation 
of blood pressure and age (Kotchen et al, 1982).
Both systolic and diastolic blood pressures are found to 
increase with age (Stamler et al, 1976) and diagnosis of 
essential hypertension in the elderly is not uncommon. Systolic 
hypertension, accompanied by normal diastolic blood pressure, is 
prevalent in the elderly with an incidence of about 23% (Coope, 
1987), and this condition is defined as a systolic blood pressure 
greater or equal to 160 mmHg when the diastolic blood pressure is 
less than 90 mmHg (Gifford, 1987). Systolic hypertension is due 
to loss of elasticity in the aorta and major branches with age, 
so that when blood is pumped into these relatively rigid 
arteries, they do not stretch to accommodate this increase in 
volume, thus causing an inordinate elevation of systolic blood
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pressure. This elevation in systolic blood pressure is directly 
proportional to the age of the subject, whereas the elevation of 
diastolic blood pressure tends to plateau at the 50 - 59 years 
old age group (Stamler et al, 1976).
An increased probability of cardiovascular disease, with 
associated mortality and morbidity, exists as both age and blood 
pressure increase, and it is generally thought that older 
patients with blood pressures greater than 170/90 mmHg should be 
treated to reduce this incidence (Coope, 1987). It has been 
proposed that the blood pressure in a person at one age relates 
to their blood pressure at an earlier age. It may be possible 
that blood pressures of young adults may be predictive of their 
blood pressures at a later age, and therefore at risk groups 
could be identified in this manner, although this has not yet 
been conclusively proven (Kotchen et al, 1982).
A subject's sex also has an effect on their blood pressure. 
Kotchen et al (1982) observed that males had higher systolic 
blood pressures than females from 1 6 to 40 years old. Above 60 
years old, women had higher systolic blood pressures. 
Examination of the diastolic blood pressures showed that again 
men had higher diastolic blood pressures up to 60 years old after 
which both groups had similar diastolic blood pressures. The 
reason for these observations could be that the males with the 
higher blood pressures died younger, thus lowering the mean 
systolic and diastolic blood pressures for the group. However, 
Stamler et al (1976) have shown that males have consistently 
higher systolic and diastolic blood pressures compared to females
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at all ages.
As there is an obvious difference in blood pressure levels 
which is dependent on the age and the sex of the individual, it 
was thought that this difference in blood pressure may have some 
relationship to basal platelet intracellular free calcium levels. 
Therefore the aim of this study was to test if age or sex causes 
an alteration in platelet intracellular free calcium 
concentrations in normotensive subjects.
4.2 Methodology
4.2.1 Subject groups
Five groups of subjects were involved in this study. Two 
groups of male volunteers were studied, young and elderly males.
However, the female group was studied in more detail, as many
female patients were to be recruited for the pregnancy study 
described in chapter six. The three female groups were young, 
middle-aged and elderly. The criteria for the age groups were as 
follows:-
1. Young females between 18 - 30 years old.
2. Middle aged females between 35-60 years old.
3. Elderly females aged 65 years old or more.
4. Young males between 18-30 years old.
5. Elderly males aged 65 years old or more.
Blood was taken from women during the second half of the
menstrual cycle.
The young and middle aged subjects were volunteers. The 
elderly subjects were obtained from the geriatric wards and had 
been admitted to hospital for minor medical problems. All
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subjects were considered to be normotensive with blood pressures 
less than or equal to 160/90 mmHg, and had no history of 
cardiovascular disease. None had taken any medication known to 
affect platelet function for at least seven days.
4.2.2 Protocol
Subjects were allowed 15 minutes semi-recumbent rest before 
five blood pressure readings were taken. Blood pressures were 
measured by a Sentron semiautomatic sphygmomanometer (Bard 
Biomedical) in the young and middle aged groups. However in the 
two elderly groups, blood pressure was measured using a mercury 
sphygmomanometer. A blood sample was then withdrawn for platelet 
intracellular free calcium estimation. In most subjects only 
basal platelet calcium levels were measured. However in the 
young and elderly females, dose-response curves to 5HT and ADP 
were also constructed.
4.2.3 Platelet intracellular free calcium concentration 
Platelet intracellular free calcium levels were obtained by
the method described previously (see Section 2.2.1).
4.2.4 Pharmacological responses
Dose-response curves to 5HT and ADP were constructed for the 
young and elderly females using fresh washed platelet samples for 
each concentration of agonist. This was carried out in these 
groups only, as ADP and 5HT were to be used as agonists in women 
in the pregnancy study. Although these pregnant women were all 
within a narrow age range, this was carried out to eliminate age 
as a possible factor which might affect agonist stimulated levels
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in these women. The dose-response curve to 5HT was always 
measured before ADP, as 5HT responses are known to deteriorate 
more rapidly than ADP responses with time (Erne et al, 1984b). 
The slope, the EC^q (the concentration of agonist which produces 
half the maximum response) and the Emax (maximum response 
elicited) parameters were obtained by fitting these data into the 
Hill equation using a microcomputer programme.
4.2.5 Materials
All sources of materials and equipment have been mentioned 
in previous chapters.
4.2.6 Statistical Analysis
Statistical analysis was carried out using one way analysis 
of variance, and Scheffe's test was used for between group 
comparisons. Agonist stimulation for the young and elderly 
female groups was analysed using the unpaired t-test. 
Correlations were carried out using linear regression analysis. 
Results are expressed as a mean +_ SEM.
4.3 Results
4.3.1 Age
The ages of the volunteers obtained for this study were 
within the ranges outlined in the subject groups criteria, with 
the exception of the young males. The final ranges of these 
groups were 1 9 - 2 9  years for the young females, 38 - 57 years 
for the middle aged females, 65 - 8 8  years for the elderly 
females, 18-37 years for the young males, and 72 - 83 years for
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the elderly males. None of .these groups overlapped. The mean 
ages for the five subject groups are shown in Figure 4.1.
4.3.2 Blood pressure
A significant difference in both diastolic and systolic 
blood pressures existed between the five subject groups 
(p < 0.001). Inter-group comparisons showed that the differences 
lay between the young and the elderly groups. These results are 
shown in Figure 4.2. For diastolic blood pressure, the female 
and male blood pressures were increased in the elderly compared 
to the corresponding young levels (p < 0.01 and p < 0.05 
respectively). The systolic blood pressures were also 
significantly increased in both the female and male elderly 
subjects (p < 0.05 and p < 0.01 respectively). The middle aged 
females had blood pressures which were not significantly 
different from either the young or elderly females.
4.3.3 Basal platelet intracellular free calcium 
concentrations
The results for basal platelet intracellular free calcium 
levels are shown in Figure 4.3. There were no significant 
differences between any of the five subject groups.
4 .3 . 4  Stimulated platelet intracellular free calcium 
concentrations
The Emax, slope and EC5 0  values for 5HT and ADP stimulated 
platelet intracellular free calcium levels in young and elderly 
females are shown in Table 4.1. A reduction in the EC5Q values 
was observed with age for the 5HT dose-response curve with no
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Blood pressure measurements from the five subject groups 
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Platelet intracellular free calcium concentrations for 
the five subject groups
alterations of the other parameters. The dose-response curves 
for 5HT are illustrated in Figure 4.4. No significant 
alterations in these parameters were observed for the ADP dose- 
response curve (Figure 4.5).
No correlation was observed between age and any of the 
parameters shown in Table 4.1, with the exception of the EC5q 
values for the 5HT dose-response curves. Here a significant 
negative correlation was observed between age and EC^q values for 
5HT (r = -0.61, p < 0.01, n = 20). This is illustrated in 
Figure 4.6.
4.3.5 Relationship between age and diastolic blood pressure 
Linear regression analyses for diastolic blood pressure
against age illustrated that a positive correlation exists 
between these two parameters. Data were analysed for males and 
females both separately and in combination. For males a slightly 
better correlation existed between age and diastolic blood 
pressure than for females, with r = 0.612, n = 2 0  for males and 
r = 0.517, n = 30 for females, p < 0.001 in both cases. The 
combined data for this relationship are illustrated in Figure 4.7 
(r = 0.544, p < 0.001, n = 50).
4.3.6 Relationship between age and systolic blood pressure 
The positive correlation which was observed between age and
systolic blood pressure is a closer correlation than age and 
diastolic blood pressure. For males, r = 0.704, n = 20 and for 
females, r = 0.571, n = 30, with p < 0.001 in both cases. Again,
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Graph of age against diastolic blood pressure 
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a closer correlation is observed for the male group. The 
combined data for this relationship are illustrated in Figure 4.8 
(r = 0.544, p < 0.001, n = 50).
4.3.7 Relationship between diastolic blood pressure and basal 
platelet cytosolic free calcium levels
No correlation was observed between diastolic blood pressure 
and basal platelet intracellular free calcium concentration for 
either males (r =-0.149, p = 0.53, n = 20) or females (r = 0.189, 
p = 0.31, n = 30). The collective data are illustrated in 
Figure 4.9, and there was no evidence of a correlation when all 
the data were grouped together (r = 0.041, p = 0.77, n = 50).
4.3.8 Relationship between systolic blood pressure and basal 
platelet cytosolic free calcium levels
As for the diastolic blood pressure results, no correlation 
was observed between systolic blood pressure and basal levels of 
platelet cytosolic free calcium. For the male and female 
divisions, r = -0.044, p = 0.85 for males and r = 0.022, p = 0.9 
for females. These results are collectively illustrated in 
Figure 4.10. For both sexes combined r = 0.001, p = 0.99, 
n = 50.
4.3.9 Relationship between age and basal platelet cytosolic 
free calcium levels
These results are shown in Figure 4.11. No correlation was 
observed between age and platelet calcium levels (r = -0.05, 
p = 0.7, n = 50). When the subjects were split into males and 
females, no correlation was evident (r = -0.24, p = 0.3 for males
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and r = 0.05, p = 0.76 for females).
4.4 Discussion
The observation of Stamler et al (1976) that blood pressure 
increases with age has been confirmed in this chapter. A 
positive correlation between age and blood pressure was observed. 
However, no concomitant alteration in platelet intracellular free 
calcium levels was observed with age. This lack of change is in 
agreement with the observations of Haller et al (1986) who 
investigated the possible age dependence of platelet 
intracellular free calcium concentration as part of a larger 
study. They could find no alterations and no correlation between 
age and platelet calcium levels. However, these workers compared 
only four subjects in each of the four decades between 20-60 
years old, which may not have been sufficient to detect any 
subtle alterations in platelet calcium levels. Erne et al 
(1984a), Le Quan Sang and Devynck (1986) and Lindner et al 
(1987), also found no relationship between age and platelet 
intracellular free calcium levels as part of larger studies of 
essential hypertension. In contrast, Duggan et al (1988) have 
illustrated that a positive correlation does exist between age 
and platelet intracellular free calcium levels, and have shown 
that age appears to be more important than blood pressure in the 
determination of platelet calcium concentrations. This group of 
workers had a smaller subject number than this study.
The only effect of age on platelet intracellular free 
calcium levels in this study was observed upon 5HT stimulation. 
A reduction in the EC5 0 value for the 5HT dose-response curve was
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observed. This implies that a lower concentration of 5HT is 
required to stimulate elderly subjects' platelet calcium levels 
to elicit a response similar to a younger patient. This 
phenomenon could be due to an increase in the affinity of the 
5 HT2  receptors on platelets with age. As expected from this 
observation, a negative correlation was observed between age and 
the EC5 0  value for the 5HT dose-response curve.
No significant sex differences were observed between either 
blood pressure or platelet intracellular free calcium 
concentrations. Other workers (Le Quan Sang and Devynck, 1986; 
Lindner et al, 1987) have found no sex differences in basal 
platelet intracellular free calcium levels during studies of 
essential hypertension. The only evidence of sex differences 
observed during studies of platelet intracellular free calcium 
levels are those measured by Pedersen and Reichelt (1988). They 
showed that females had higher platelet calcium levels after ADP 
stimulation during ovulation, but at all other stages of the 
menstrual cycle ADP responses were equivalent to those found in 
males. Basal platelet calcium levels did not vary during the 
menstrual cycle and were similar to values found in males.
Therefore, this study has shown that alterations in basal 
platelet calcium do not appear to be associated with either the 
higher blood pressure observed in the elderly, or hormonal 
differences between sexes, and age and sex have no effect on 
basal platelet intracellular free calcium levels. However, age 
does appear to increase the affinity of 5HT2  receptors on 
platelets.
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Chapter Five
Platelet intracellular free calcium concentration 
in untreated essential hypertension
5.1 Introduction
It has been postulated that cytosolic free calcium levels 
may be elevated in hypertension (Erne et al, 1984a). This 
pathological elevation is thought to occur in vascular smooth 
muscle, resulting in an enhancement of the Ca^+ dependent 
contractile mechanism. This causes an increase in peripheral 
vascular resistance and an ultimate elevation of blood pressure. 
Research which has been carried out in this area in humans has 
been restricted mainly to blood elements due to convenience and 
the ability to obtain multiple samples easily compared to 
vascular smooth muscle. The main research into intracellular 
calcium levels has focused on platelets as they are known to 
possess many similar features to vascular smooth muscle cells. 
This chapter is concerned with elucidating if any alterations in 
basal platelet intracellular free calcium levels occur in 
untreated essential hypertensive patients.
The first report which illustrated an elevation of platelet 
calcium levels in essential hypertension was published by Erne 
et al (1984a). They showed that basal platelet cytosolic free 
calcium levels were elevated in borderline hypertensive and 
essential hypertensive patients compared to normotensive 
controls. These elevated levels were reduced with 
antihypertensive treatment. These workers also reported a close, 
positive correlation between blood pressure and basal platelet
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calcium levels, thus indicating that there appears to be some 
relationship between these two parameters. Le Quan Sang and 
Devynck (1986) confirmed this elevation in basal platelet calcium 
and its correlation with blood pressure although the correlation 
was much weaker than that of Erne et al (1984a). However a 
number of workers have been unable to reproduce this result.
Lenz et al (1985) found that there was a significant 
difference between platelet calcium levels in normotensive and 
hypertensive subjects. However, although the hypertensive group 
mean was higher, there was a large overlap between groups, and 
again only a weak correlation could be found between blood 
pressure and basal platelet intracellular free calcium levels. 
Lechi et al (1986a) and Cooper et al (1 987) also showed that 
although there was a statistically significant increase in 
platelet calcium levels in the hypertensive group, there was a 
wide overlap between groups. In addition, these workers could 
find no correlation between platelet calcium and blood pressure.
There appears to be a conflict in the literature concerning 
the magnitude of the difference in basal platelet intracellular 
free calcium levels in normotensive and hypertensive subjects, 
and the strength of the correlation between platelet calcium 
levels and blood pressure. The aim of the work in this chapter 
therefore was to discover what relationship exists between basal 
platelet intracellular free calcium levels and blood pressure 
under the experimental conditions used throughout these studies.
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5.2 Methodology
5.2.1 Patient protocol
Untreated essential hypertensive patients were attending the 
High Blood Pressure Clinic. All patients had either not received 
treatment for their condition, or had been withdrawn from 
treatment for various reasons. All patients withdrawn from 
medication had been without treatment for at least two weeks 
prior to the study day. Patients had at least five minutes rest 
in the semi-recumbent position before blood pressure readings 
were taken and a blood sample was withdrawn for platelet 
intracellular free calcium estimation. Age and sex matched 
normotensive controls were from either the staff of the hospital 
or volunteers from other studies. They were subjected to a 
similar protocol to the untreated hypertensive patients. The 
blood pressure criteria for the two groups were dependent on the 
age of the individual, as blood pressure tends to increase with 
age. A "normal" blood pressure for a 70 year old would probably 
be regarded as hypertensive in a 20 year old, therefore patients 
were assessed individually by the staff of the High Blood 
Pressure Clinic. For this reason, each hypertensive patient had 
an age-matched control. All subjects had avoided all forms of 
medication for at least two weeks prior to the study day.
5.2.2 Platelet intracellular free calcium measurements
Basal platelet intracellular free calcium levels were
measured as described previously in Section 2.2.1.
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5.2.3 Materials
The sources of all materials have been mentioned in previous
chapters. Blood pressure was measured by a Sentron semi­
automatic sphygmomanometer (Bard Biomedical).
5.2.4 Statistical analysis
Data were analysed using Students t-test for unpaired data.
Correlations were carried out by linear regression analysis. 
Results are expressed as a mean +_ SEM.
5.3 Results
There were nine females and nine males in both the 
normotensive and hypertensive groups.
5.3.1 Age
The groups were well matched for age with means of
45.5 +_ 2.9 years and 46.1 3.0 years for normotensive and
hypertensive groups respectively. The range of ages was 22 to 66 
years in the normotensive group and 24 to 67 years in the 
hypertensive group.
5.3.2 Blood pressure
Both systolic and diastolic blood pressures were 
significantly elevated in the hypertensive group compared to the 
normotensive group (160 +_ 4/94 jf 2 mmHg compared to 
128 + 3/73 _+ 2 mmHg, p < 0.001 in both cases). These results are 
illustrated in Figure 5.1.
5.3.3 Heart rate
No significant difference was observed between groups for
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heart rate measurements. The mean for the normotensive group was 
76 _+ 3 beats/min with 74 _+ 3 beats/min for the hypertensive 
group. These results are illustrated in Figure 5.2.
5.3.4 Basal platelet intracellular free calcium levels
No difference in basal platelet intracellular free calcium 
levels was observed between groups. The normotensive group had a 
mean of 89.5 _+ 5.3 nM and the hypertensive group had a mean of
96.1 _+ 6 . 6  nM. Figure 5.3 illustrates this data in the form of a 
scatter bar to illustrate the distribution of the values within 
groups.
5.3.5 Correlation of diastolic blood pressure and basal 
platelet intracellular free calcium concentration
A weak, but significant positive correlation was observed 
between diastolic blood pressure and basal platelet intracellular 
free calcium concentration (r = 0.345, p < 0.05, n = 36). This 
is illustrated in Figure 5.4.
5.3.6 Correlation of systolic blood pressure and basal 
platelet intracellular free calcium concentration
As for diastolic blood pressure, a weak correlation was 
observed between systolic blood pressure and basal platelet 
intracellular free calcium concentration (r = 0.366, p < 0.05, 
n s 36). This is illustrated in Figure 5.5.
5.4 Discussion
The results of this study have shown that no significant 
elevation in basal platelet intracellular free calcium 
concentration could be observed in untreated essential
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hypertension, although the hypertensive group had a slightly 
higher mean than the normotensive group. However, a weak, but 
significant correlation between blood pressure and platelet 
calcium levels was observed. The results of this study can be 
compared to the findings of other published work. Table 5.1 
shows the mean values for the normotensive and hypertensive 
groups, and the correlations found between blood pressure and 
platelet calcium levels for a selection of studies in this field. 
All other studies have found a significant elevation in basal 
platelet intracellular free calcium levels in hypertensive 
compared to normotensive subjects. However, the magnitude of 
these differences varies greatly, and most studies have shown 
that a wide overlap in basal levels exists for the two groups. 
One possible explanation for the small alterations observed has 
been put forward by Lenz et al (1985). They concluded that there 
is no positive evidence of an elevation of platelet calcium 
levels in a large proportion of essential hypertensive patients, 
and that only a minority possess elevated levels. The 
explanation for this is unclear. One reason for the differences 
observed between studies could be that platelet calcium levels 
are influenced by the varying criteria used to define high blood 
pressure in individual studies. In this study there was an 
overlap of normotensive and hypertensive blood pressures due to 
age weighting of this parameter. In addition, the results from 
this chapter may not have yielded a significant difference as the 
numbers in this study are at the lower end of the range compared 
to other studies, and as the differences in basal platelet
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calcium levels are now proving smaller than was first suggested 
by Erne et al (1984a), this study would probably have required 
more patients to detect a relatively small elevation in the basal 
levels.
Erne et al (1984a) also reported a striking correlation 
between diastolic blood pressure and basal platelet calcium 
levels. As can be seen from Table 5.1, no other group of workers 
has been able to reproduce a correlation between these two 
parameters that in any way resembles this. Most other workers 
have obtained a weak significant positive correlation which is 
similar to the correlation found in this chapter. A reproduction 
of the graph published by Erne et al (1984a) is shown in 
Figure 5.6, and comparison of this with Figure 5.4 clearly shows 
the difference in the power of the correlations obtained, 
although it should be noted that Figure 5.6 illustrates mean 
blood pressure, whereas Figure 5.4 is a plot of diastolic blood 
pressure. Cooper et al (1987) found this close correlation of 
Erne's difficult to interpret and makes the observation that a 
correlation between blood pressure measurements on two separate 
occasions rarely exceeds r = 0.7 as blood pressure varies from 
minute to minute, therefore it seems implausible that this 
extremely high correlation of r = 0.93 could exist between 
diastolic blood pressure and basal platelet calcium levels.
Failure to reproduce Erne's correlation does not detract 
from the pathophysiological significance of the elevations in 
basal platelet calcium levels which have been reported in other 
studies. There is obviously some trend towards an elevation of 
platelet calcium in hypertension which is real, although
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Figure 5.6 
Graph adapted from Erne et al (1984a)
quantitatively small. Further work is required to elucidate the 
mechanism which results in an elevation in platelet calcium 
levels in hypertension, and whether this increase in basal 
platelet calcium levels is the cause or an effect of the blood 
pressure elevation.
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Chapter Six
Platelet intracellular free calcium concentrations in the 
hypertensive disease states of pregnancy
6.1 Introduction
This chapter is concerned with the basal and stimulated 
platelet intracellular free calcium levels in normotensive and 
hypertensive pregnancies. Hypertension of pregnancy allows the 
study of the evolution and resolution of hypertension in the 
human, and thus enables the investigation of the functional 
changes which occur during the development of hypertension. Any 
conclusions which are drawn from experiments involving 
hypertension in pregnancy could be extrapolated to learn more of 
the mechanisms underlying the development of essential 
hypertension in the human. However, extrapolation of these 
conclusions should be approached with caution as pregnancy 
induced hypertension is a unique clinical condition involving a 
plethora of pathophysiological factors and may not be a suitable 
model for human essential hypertension.
In normal pregnancy, blood pressure usually falls during the 
first and second trimesters and reaches its lowest level about 
the end of the second trimester when diastolic blood pressure is 
on average 15 mmHg lower than levels measured before pregnancy. 
Blood pressure normally rises in the third trimester and reaches 
pre-pregnancy levels by term (MacGillivray, 1969). In the first 
6 - 1 0  weeks the cardiac output is increased by about 25-50% 
(Svensson, 1985) and this effect is mainly due to an increase in 
plasma volume of about 30-40% and an increase in heart rate, both
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of which occur in normal pregnant women (Lubbe, 1984). There is 
a marked decrease in peripheral vascular resistance and this 
results in a reduction in blood pressure. Oedema is a regular 
feature in about 75% of all normal pregnancies (Ferris, 1983).
Hypertension is found in about 2-5% of all pregnancies 
(Svensson, 1985). It is a significant cause of foetal and 
maternal complications and morbidity. Foetal mortality has been 
found to be significantly increased when maternal diastolic blood 
pressures were raised over 84 mmHg (Ferris, 1983). Pregnancy 
induced hypertension usually develops after 24 weeks gestation 
and is characterised by a rise in diastolic blood pressure of 
greater than 15 mmHg over first trimester levels. (Rubin, 1987). 
After delivery there is usually a prompt reduction in blood 
pressure to pre-pregnancy levels, although on some occasions it 
can take up to six weeks for the blood pressure to return to 
normal. As a group, women who are predestined to have 
hypertension in pregnancy have slightly higher .blood pressure 
levels before or early in pregnancy than women who have 
normotensive pregnancies, and of the women who develop pregnancy 
induced hypertension, 30-40% will develop clinical signs of 
hypertension within 10-15 years (Svensson, 1985). Children bom 
from hypertensive pregnancies have significantly higher blood 
pressures than normal children and may also constitute a risk 
group for future hypertension.
Pre-eclampsia has the features of pregnancy induced 
hypertension with additional proteinuria. This occurs in about 
1 % of all pregnancies, primarily in nulliparous women, who are 
six to eight times more susceptible to pre-eclampsia than
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multiparous women. When pre-eclampsia is diagnosed in 
multiparous women it is often found in women who have had pre­
eclampsia in a previous pregnancy. These women have a 25% risk 
of redeveloping pre-eclampsia in subsequent pregnancies. Other 
groups which have a higher incidence of pre-eclampsia are women 
who suffer from diabetes mellitus, migraine (Moore and Redman, 
1983) or who have a multiple pregnancy. There are also familial 
and racial tendencies to pre-eclampsia (MacGillivray, 1981). 
Pre-eclampsia is related to an increase in perinatal mortality 
rate, foetal asphyxia, and growth retardation of the foetus 
resulting in a higher incidence of low weight babies. 
Spontaneous pre-term delivery is common. This condition also 
greatly increases the risk of mortality in the mother.
Some of the cardiovascular features of pre-eclampsia include 
extreme vasoconstriction resulting in an increase in peripheral 
vascular resistance, constriction of radial and spiral arteries 
in the uterine wall and impairment of the uteroplacental blood 
flow (Lubbe, 1984), which can be up to a 60^70% reduction in 
severe pre-eclampsia (Svensson, 1985). Pre-eclampsia is also 
characterised by glomerular capillary endotheliosis (Fisher 
et al, 1981).
Both platelet number and function are altered during normal 
pregnancy and pregnancy complicated with pre-eclampsia. During 
normal pregnancy, platelet number declines progressively 
throughout gestation reaching a nadir at about 30 weeks (Sejeny 
et al, 1975). Other conflicting reports of an increase or no 
change (Tygart et al, 1986) in platelet counts are likely to be
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caused by inadvertent study design bias (Weiner, 1988). This 
decrease in platelet count in normal pregnancy is probably a 
result of the increase in blood volume (Pitkin and Witte, 1979). 
There is also an increase in the mean platelet volume and 
platelet distribution width in normal pregnancy (Sill et al, 
1985) which indicates that there is probably a reduction in 
platelet lifespan. However, Rakoczi et al (1979) have shown that 
the platelet lifespan in normal pregnancy, although slightly 
reduced, is not significantly different from non-pregnant 
controls.
Pre-eclampsia is associated with additional platelet 
changes. Redman et al (1978) reported a decrease in platelet 
count in pre-eclamptic patients compared to normotensive 
controls, and this observation has been verified by other groups 
(Giles and Inglis, 1981; Kelton et al, 1985). This fall in 
platelet count is an early and important feature of the pre­
eclamptic process which often antedates the development of more 
obvious clinical signs such as hypertension and proteinuria. 
Stubbs et al (1986) observed that there was a further increase in 
mean platelet volume and platelet distribution width in pre­
eclamptic patients compared to normal pregnant controls and 
Rakoczi et al (1979) demonstrated a significant reduction in 
platelet lifespan in pre-eclampsia compared to normotensive 
pregnancy. An increase in platelet activation has also been 
indicated by elevated levels of plasma beta-thromboglobulin, 
which is a release product of platelet activation (Redman et al, 
1977). These factors will result in a population of larger, 
younger platelets circulating in pre-eclampsia.
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From these previous observations by other workers, one of 
the aims of this study was to elucidate if alterations in 
platelet calcium levels were responsible for the abnormal 
platelet behaviour in pre-eclampsia. The other objectives were 
to assess if changes in basal or stimulated platelet cytosolic 
free calcium levels occur in normotensive and hypertensive 
pregnancies and to discover if a correlation exists between blood 
pressure and basal platelet calcium levels in normotensive and 
hypertensive pregnancies.
6.2. Methodology
6.2.1 Platelet intracellular free calcium measurements 
Blood was prepared for measurement of platelet intracellular
free calcium concentration as described in Section 2.2.1.
6.2.2 Pharmacological responses
In addition to measurement of basal cytosolic calcium 
levels, dose-response curves to 5HT and ADP were constructed 
using fresh washed platelet samples for each concentration of 
agonist. The dose-response curve to 5HT was always measured 
before ADP (see Chapter Two) as 5HT responses have been shown to 
deteriorate more rapidly than ADP responses with time (Erne 
et al, 1984b). The slope, the EC5Q (the concentration of agonist 
which produces half the maximum response) and the Emax (maximum 
response elicited) parameters were obtained by fitting these data 
into the Hill equation using a microcomputer programme.
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6.2.3 Patient criteria
The study involved sixty women aged between 18 and 35 years 
old. None had taken any medication known to affect platelet 
function or to have any cardiovascular effects for at least two 
weeks prior to the study day. None of the women had any other 
medical or obstetric abnormality other than the condition under 
investigation. None of the women were essential hypertensives 
and all became normotensive within six weeks post partum. The 
non-pregnant women and normotensive pregnant women were mainly 
outpatients and the two hypertensive groups were all inpatients. 
All gave written informed consent to participate in the protocol 
which was approved by the local Ethical Review Committee. Each 
patient was allowed 15 minutes' rest in the semi-recumbent 
position before blood pressure was measured using a Sentron 
semiautomatic sphygmomanometer. It is important to standardise 
the position in which blood pressure is measured as this will 
have a great influence on blood pressure, especially in late 
pregnancy. A mean of three readings measured at five minute 
intervals was used for data analysis. A blood sample was then 
withdrawn.
Fifteen women were studied in each of the following groups.
1. Normotensive, non-pregnant women were studied in the later 
half of the menstrual cycle. None were using the contraceptive 
pill at the time of study. The time of the menstrual cycle was 
strictly adhered to as it was feared that hormonal changes may 
influence either basal or stimulated platelet cytosolic calcium 
levels. A subsequent study (Pedersen and Reichelt, 1988) has 
shown that there is an increased intracellular calcium response
108
to ADP stimulation in ovulation compared to menstruation.
2. Normotensive, pregnant women were studied in the third 
trimester.
3. Women with pregnancy induced hypertension were studied 
during the third trimester. Pregnancy induced hypertension was 
defined as an increase in diastolic blood pressure of at least 
15 mmHg above the level measured at 10-15 weeks gestation.
4. Women with pre-eclampsia in the third trimester were 
studied. This group met the same blood pressure criterion as the 
pregnancy induced hypertensive group, plus proteinuria in excess 
of 0.5g/24 hours.
6.2.4 Materials
The sources of all equipment and materials used in this 
chapter have been outlined in previous chapters.
6.2.5 Statistical analysis
Results were examined by one way analysis of variance over 
the four study groups. Further inter-group comparisons were 
carried out using Scheffe's test. Correlations were carried out 
using linear regression analysis. Results are expressed as mean 
+ SEM, with n = 15 throughout the four groups. The study had a 
90% power of detecting a 2 0 % change in platelet intracellular 
free calcium concentrations between groups.
6.3 Results
6.3.1 Maternal and gestational ages and parities
Table 6.1 shows the mean maternal and gestational ages of
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the four study groups. There was no significant difference 
between either of these parameters, although the pre-eclamptic 
group had a slightly shorter gestational age at the times of 
platelet calcium measurements. There was also no significant 
difference in parity of the four groups with the majority of the 
subjects being either nulliparous or primiparous.
6.3.2 Blood pressure
The blood pressure results are shown in Figure 6.1. There 
was no significant difference between either systolic or 
diastolic blood pressures in the non-pregnant 
(118 jf 2/66 ± 2  mmHg) or n o r m o t e n s i v e  p r e g n a n t  
(125 3/71 _+ 2 mmHg) groups. However, significant elevations in
blood pressure were observed in the pregnancy induced 
hypertensive (150 _+ 3/94 +_ 2 mmHg) and pre-eclamptic 
(149 _+ 5/94 +_ 3 mmHg) groups compared to the two normotensive 
groups for both systolic and diastolic,blood pressure 
(p < 0.001). There was no difference between the blood pressure 
measurements for the pregnancy induced hypertensive and pre­
eclamptic groups.
6.3.3 Heart rate
There was a significant change in heart rate observed using 
analysis of variance for the four study groups (p < 0 .0 0 1 ). 
Further multiple comparisons showed that this was caused by an 
increase in heart rate in all the pregnant groups compared to the 
normotensive, non-pregnant control group. The increase in heart 
rate in the pregnant patients was not related to blood pressure. 
These results are shown in Figure 6.2.
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Blood pressure measurements from the four subject groups 
*** p < 0 . 0 0 1  compared to both normotensive groups.
HE
AR
T 
RA
TE
 
(b
ea
ts
/m
in
)
100-1
90
80
70-
60
* * *
NON
PREGNANT
NORMAL
PREGNANT
PREGNANCY
INDUCED
HYPERTENSIVE
P R E -E C L A M P T IC
Figure 6.2
Heart rate measurements from the four subject groups
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6.3.4 Basal platelet intracellular free calcium levels 
These results are illustrated in Figure 6.3. No significant
alterations were observed between normal controls and the 
pregnant or hypertensive pregnant groups. The mean of these four 
groups was around 70 nM, and ranged from 38.5 nM to 145.2 nM.
6.3.5 Stimulated platelet intracellular free calcium levels 
The dose-response curves for 5HT and ADP for the four study
groups are shown in Figures 6.4 and 6.5 respectively. Basal 
levels have been subtracted to illustrate absolute changes in 
intracellular free calcium levels. No significant alterations 
were observed in the slope or EC^q values obtained for either the 
5HT or ADP dose-response curves (see Table 6.2). However after 
5HT stimulation of platelet calcium levels, a significant 
decrease was observed in the maximal response which could be 
elicited (Figure 6 .6 ) and further multiple comparison tests 
showed that the significant decrease existed between the non­
pregnant controls and the pre-eclamptic patients (204.0 _+ 24.9 nM 
compared to 111.1 +_ 14.1 nM). Although the normal pregnant and
pregnancy induced hypertensive groups showed a trend to decrease,
\
this was not found to be significant. In contrast, the maximum 
response to ADP stimulation did not vary significantly between 
the four groups (Figure 6 .6 ).
6.3.6 Correlation between platelet intracellular free calcium 
concentration and blood pressure
Results for all four groups were combined and linear 
regression analyses were carried out comparing either systolic or
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Figure 6 . 6
Einaxvalues for 5HT and ADP stimulated intracellular free 
calcium levels for the four subject groups 
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stimulated with 5HT 
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Graph of diastolic blood pressure against intracellular free 
calcium levels which were maximally stimulated with ADP
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stimulated with ADP 
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Table 6.3
Results showing the lack of correlation between blood pressure
and platelet intracellular free calcium concentrations
r P>
Diastolic BP -0.012 0.93
vs basal [Ca +^]i
Diastolic BP vs
[Ca2+]i
-0.240 0.07
5HT maximally stimulated
Diastolic BP vs
[Ca2+]i
-0.110 0.42
ADP maximally stimulated
Systolic BP vs 
basal [Ca ]i
0.014 0.91
Systolic BP vs
5HT maximally stimulated [Ca2+]i
-0.200 0.13
Systolic BP vs 
ADP maximally stimulated [Ca2+]i
-0.080 0.54
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diastolic blood pressures with the calcium levels measured; 
either basal, 5HT or ADP maximally stimulated levels. There is 
no correlation between blood pressure and any of the platelet 
intracellular free calcium levels measured. The graphs 
illustrating the lack of correlation are shown in Figures 6.7 - 
6.12. The r values and significance levels of these linear 
regression analyses are shown in Table 6.3.
6.4 Discussion
The haemodynamic changes which were observed in this study 
were expected; that is an elevation in blood pressure was 
observed in hypertensive pregnancies, and an increase in heart 
rate in all pregnant patients was measured.
The results from this chapter have shown that no significant 
alterations occur in the basal platelet cytosolic free calcium 
levels in either pregnancy or the hypertensive disease states of 
pregnancy and that no correlation exists between blood pressure 
and platelet calcium levels. These results may simply indicate 
that hypertension in pregnancy is not a relevant model for 
essential hypertension when considering platelet cytosolic free 
calcium levels, as Erne et al (1984a) demonstrated an elevation 
in platelet calcium levels with blood pressure. However, an 
alternative interpretation is that a change in platelet calcium 
levels could be caused by longterm pathological changes in the 
cardiovascular system after hypertension has developed and this 
change cannot be observed in the relatively short-lived blood 
pressure increase in hypertensive pregnancies. This theory is 
further substantiated by the results from Chapter Three which
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showed that the acute blood pressure changes observed during 
exercise do not alter basal platelet intracellular free calcium 
concentration.
The lack of change in basal platelet cytosolic free calcium 
levels in pre-eclampsia indicates that alterations of platelet 
calcium levels may not be involved in the platelet activation 
process which is a feature of pre-eclampsia. This could also 
indicate that the changes in the platelet population that occur 
in pre-eclampsia, such as the fall in platelet count and the 
increase in mean platelet volume, have no influence over basal 
platelet cytosolic free calcium levels.
Other studies on calcium levels in hypertensive pregnancies 
have shown that no alterations in serum ionised calcium occurred 
in pregnancy induced hypertension (Richards et al, 1984) and that 
calcium fluxes and intracellular calcium concentrations in red 
cells were unchanged in pregnancy induced hypertension (Millar 
et al, 1987). These published data reinforce the findings in 
this chapter that no alterations in calcium handling has been 
observed in hypertensive pregnancies.
No alterations in the platelet calcium responses to the 
agonist ADP were observed throughout the four study groups. 
Although no other workers have carried out investigations of the 
same nature as this study, a large amount of literature on the 
effect of hypertensive pregnancies on platelet aggregation has 
been published. Howie et al (1971) demonstrated a reduction in 
the aggregatory response to ADP in severe pre-eclampsia, but 
later experiments from this group (Whigham et al, 1978) showed 
that although there was a slight trend for a reduction in ADP
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response, this was not significant. This group also observed an 
elevation of plasma adenine nucleotides in severe pre-eclampsia, 
suggesting previous platelet activation. More recent studies 
have shown that there are no alterations in ^  ^ C-serotonin release 
induced by ADP between normal and hypertensive pregnancies 
(Morrison et al, 1985), and no change in ADP induced aggregation 
between normal pregnancy and severe pre-eclampsia (O'Brien et al, 
1986). These results are in agreement with the findings of this 
chapter that no alterations in ADP induced elevations of platelet 
calcium levels were observed in either normotensive or 
hypertensive pregnancies.
In pregnancy, a trend for the maximal response to 5HT 
stimulation to decrease was observed, and this decrease was found 
to be significant in the pre-eclamptic group. Although there was 
a trend towards a decrease in the slope of the 5HT dose-response 
curve, there was no overall significant change in either the 
slope or the EC^q values of the dose-response curve, and these 
results would suggest that there could be a reduction in receptor 
number or an uncoupling of a post-receptor mechanism causing a 
decreased calcium release from internal stores or a reduction in 
calcium influx. This effect of pre-eclampsia is specific for the 
5HT receptor as no changes in ADP responses were observed. 
However, it is possible that "in vivo" activation of platelets in 
pre-eclampsia may have blunted the "in vitro" response to 5HT 
stimulation, as 5HT responses have been reported to be more 
sensitive to previous platelet activation than ADP responses, 
resulting in a loss of reactivity of platelets specifically to
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5HT (Erne et al, 1984b).
The concentration of 5HT in platelets of pre-eclamptic women 
has been shown to be reduced, and is in some cases undetectable 
(Whigham et al, 1978). This indicates that platelet activation 
and degranulation have occurred. Women with pre-eclampsia may 
have a lesser capacity to metabolise free plasma 5HT, as a 
reduction in monoamine oxidase activity has been reported in pre­
eclampsia (Gujrati et al, 1985). These two observations would 
imply that plasma 5HT levels may be elevated in pre-eclampsia. 
However an increase in plasma 5HT levels has not been reliably 
detected in pre-eclampsia (Weiner, 1987), which would dismiss the 
possibility of down regulation of 5HT receptors on platelets due 
to the presence of an elevated concentration of endogenous 
agonist. Studies on patients with chronic hypertension and 
superimposed pre-eclampsia have shown that the 5HT2 receptor 
antagonist, ketanserin, appears to act predominantly on the pre­
eclamptic component of hypertension (Weiner et al, 1984) and this 
may implicate 5HT as a mediator in the pathogenesis of pre­
eclampsia (Weiner, 1987). However the linkage between the 
observed decrease in 5HT maximal stimulation of platelet 
cytosolic free calcium levels in pre-eclampsia to the role of 5HT 
in the modulation of pre-eclampsia has yet to be ascertained.
In conclusion, no alteration in basal platelet intracellular 
free calcium levels could be identified in normotensive and 
hypertensive pregnancies, and no correlation between blood 
pressure and platelet calcium levels was observed. However, a 
decrease in the maximal response to 5HT was observed in pre­
eclampsia with no concomitant reduction in the ADP response.
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This could suggest a role for 5HT in the development of pre­
eclampsia although the precise mechanism has yet to be 
elucidated.
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Chapter Seven
Platelet Intracellular Free Calcium Concentrations in 
normotensive and Hypertensive Rabbits before and after 
Antihypertensive Treatment
7.1 Introduction
The controversy which exists in the literature over the 
relationship between human platelet cytosolic free calcium 
concentration and blood pressure has been discussed in previous 
chapters. However, a similar anecdote has been found to exist 
for animal models of hypertension, and in particular in 
hypertensive rats.
In one study comparison of spontaneously hypertensive rats 
(SHR) and Wistar-Kyoto (WKY) rats at four, eight and twenty weeks 
of age disclosed that there was no significant difference between 
the two strains at four weeks, but a significant increase existed 
in platelet cytosolic free calcium levels in SHR after eight and 
twenty weeks (Bruschi et al, 1985). The difference between the 
two strains showed a tendency to increase with age and was found 
to roughly parallel the divergence in mean arterial blood 
pressure. A similar trend was also observed in this study for 
lymphocytic cytosolic free calcium, but these changes were not as 
pronounced as the changes in platelets. These findings in SHR 
were reinforced by observations made by Baba et al (1987) who 
found that intracellular free calcium levels in platelets of SHR 
were significantly higher than WKY at four, eleven, and twenty- 
eight weeks of age. It is of interest to notice that in contrast 
to Bruschi et al (1985), this group found an increase in platelet
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cytosolic free calcium in four weeks old SHR, and the overall 
changes were not age related. However, Baba et al (1987) also 
investigated two other rat models of hypertension; 
deoxycorticosterone acetate-salt (DOCA-salt) hypertensive rats 
and two kidney, one clip hypertensive rats, and found that there 
was no change in platelet cytosolic free calcium levels eight 
weeks after the commencement of treatment for the DOCA-salt 
hypertensive rats, or eight weeks after the operative procedures 
for the two kidney, one clip hypertensive rats.
These results may suggest that changes in platelet 
intracellular free calcium are not a prerequisite for the 
development of an elevation in blood pressure in all animal 
models. To further substantiate this theory, both Murakawa et al 
(1986) and Zimlichman et al (1986) have been unable to find any 
alterations in platelet intracellular free calcium in animal 
models of hypertension. Murakawa et al (1986) found that no 
difference existed between thirteen week old SHR and WKY rats in 
contrast to both Bruschi et al (1985) and Baba et al (1987). 
However, in agreement with Baba et al (1987), no change between 
DOCA-salt hypertensive rats and Sprague-Dawley rats was observed.
Zimlichman et al (1 986) also found no significant 
alterations in platelet cytosolic free calcium levels between 
twelve week old SHR and WKY rats. Umegaki et al (1986) provide 
the final piece of evidence towards the controversy surrounding 
the relationship between platelet intracellular free calcium and 
blood pressure, by showing a significant decrease in platelet 
calcium levels in fourteen week old stroke-prone SHR compared to 
WKY rats.
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These discrepancies in the literature may be due to species, 
age and methodological differences and further research will be 
required to clarify these reports. The purpose of these studies 
was to examine the relationship between platelet cytosolic free 
calcium levels and mean arterial pressure using the rabbit 
perinephritis hypertension model. In addition to this objective, 
the effects of antihypertensive treatment on platelet cytosolic 
calcium were examined because Erne et al (1984a) observed that 
hypertensive patients who were treated with antihypertensive 
agents had significantly lower platelet cytosolic free calcium 
levels after treatment. The drugs selected for their anti­
hypertensive properties in these experiments were verapamil and 
prazosin. Verapamil was chosen as it is a Ca^+ channel 
antagonist, and as these experiments were involved with 
intracellular calcium levels, a calcium channel antagonist seemed 
appropriate. It is used therapeutically as an antihypertensive 
agent and functions by blocking the inward current of calcium 
into vascular smooth muscle cells and so reduces the contractile 
ability of these cells, causing vasodilation. Verapamil is not 
only used in the treatment of hypertension, but also as an anti- 
anginal and anti-arrhythmic, as it also has cardiac calcium 
channel blocking properties. Prazosin was chosen as it is an 
anti-hypertensive agent which acts by a different mechanism to 
verapamil. Prazosin is a specific alpha-] adrenoceptor antagonist 
which causes vasodilation by directly blocking alpha-] receptors 
on vascular smooth muscle. It is also used in the treatment of 
congestive heart failure.
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It has been previously mentioned that the perinephritis 
model of hypertension has been studied in this chapter. Rabbits 
were used in this study for two reasons. Firstly, in studies 
involving rats, to obtain sufficient blood the methodology 
involved opening the chest under anaesthesia and removing blood 
by intracardiac puncture, thus resulting in the ultimate death of 
this animal. For the requirements of this study, platelet 
calcium levels had to be measured before and after treatment and 
this required survival of the animal until completion of the 
treatment, therefore a larger animal, such as a rabbit, had to be 
utilised.
Secondly, no measurement of platelet intracellular free
calcium levels in rabbit perinephritis hypertension had been
cited in the literature, and as this is a commonly used animal
model it appeared to be worthwhile to further elucidate the
mechanisms of the development of hypertension in this model.
There is evidence to suggest that there is an altered calcium 
I
handing in this hypertensive model which will be discussed in 
detail in the next chapter.
Perinephritis hypertension in animals was first induced by 
Page (1939) when kidneys were wrapped in cellophane to prevent 
the development of renal cortical collateral circulation. He 
observed an increase in the arterial blood pressure within 
several days post-operation, which continued to increase until a 
peak was reached within five to eight weeks. Hypertension is 
thought to result from the renal ischaemia which is produced from 
the wrapping of the kidneys. The cellophane itself does not 
produce ischaemia as it is wrapped round the kidney without
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exerting a constrictive effect on either the kidney or the renal 
artery and vein. However, the cellophane produces an intense 
fibrocollagenous reaction after three to five days and within two 
to three weeks a constricting hull of this fibrocollagenous 
tissue has formed round the kidney. The cellophane by this time 
has fragmented and has been taken up by the surrounding tissues. 
The kidney is held under pressure by this capsule of scar tissue. 
Brace et al (1974) measured the pressure exerted on the kidney by 
the scar tissue in unilaterally nephrectomised dogs, four weeks 
post-operative, by implanting small cannulated balloons next to 
the kidneys wrapped in cellophane. They found that the scar 
tissue produced a mean pressure of about 30 mmHg. Further 
investigation of the mechanism of elevation of blood pressure in 
rabbits with bilateral renal wrap hypertension (Fletcher et al, 
1976) has shown that during the development of hypertension there 
is no change in heart rate, an increase in mean arterial pressure 
and peripheral vascular resistance and an initial transient rise 
in cardiac output. This rise in cardiac output can also be 
observed in the control rabbits, and is probably a non-specific 
consequence of the preceding operation. The autoregulation 
theory states that the early blood pressure elevation is due to 
an increase in cardiac output and this triggers a myogenic 
response in the resistance vessels resulting in an increased 
peripheral vascular resistance. This leads to a restoration of 
the normal cardiac output and eventually the blood pressure 
elevation is maintained entirely through the increase in 
peripheral vascular resistance. As there is no increase in
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cardiac output in bilateral renal wrap hypertension, the 
elevation in blood pressure is entirely resistance-mediated 
(Fletcher et al, 1976) and does not conform with the 
autoregulation theory, which has been identified as the mode of 
elevation in other models of experimental and human hypertension 
(Korner, 1979). This type of hypertension is thought to have 
similar properties to the one wrap kidney model used in this and 
the subsequent chapter. The main difference between these two 
types of experimental hypertension is that the bilateral renal 
wrap model produces a less marked and more gradual rise in blood 
pressure compared to the one wrap kidney model.
To reiterate, the major purposes of these experiments were 
to measure basal platelet intracellular free calcium in 
perinephritis hypertensive and normotensive control rabbits and 
establish if an elevation of platelet calcium occurs in this 
model of hypertension. The rabbits were also treated both 
acutely and chronically with the antihypertensive agents, 
verapamil and prazosin, to observe if the reduction in blood 
pressure caused alterations in basal platelet calcium levels. 
The relationship between mean arterial pressure and basal 
platelet intracellular free calcium was also examined.
7.2 Methodology
The animal studies described in this chapter were carried 
out using male New Zealand White rabbits. Groups of seven 
rabbits were used in all experiments.
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7.2.1 Preparation of animals for "in vivo'1 measurements of 
mean arterial pressure and heart rate, injection of 
drugs and removal of blood samples
A catheter was inserted into a peripheral vein of the rabbit 
ear under local anaesthesia (2% w/v lignocaine hydrochloride) and 
was flushed with heparinised saline (5 units/ml). Venous lines 
were used for the administration of general anaesthetic and bolus 
doses of drugs in the acute studies. A polypropylene catheter 
was inserted into the central ear artery for removal of blood 
samples, and measurement of blood pressure and heart rate. The 
arterial line was linked to a Statham P23 1D transducer and mean 
arterial pressure (mmHg) measurements were displayed on a Grass 
model 7B polygraph which was calibrated each day. Heart rate 
(beats/min) was counted directly from the pressure trace. All 
rabbits were allowed to rest unrestrained for at least one hour 
after this minor surgery prior to haemodynamic measurements being 
taken.
7.2.2 Perinephritis hypertension
A venous line was inserted as described in 7.2.1 and the 
rabbit was anaesthetised with sodium pentobarbitone (30 to 
40 mg/kg). Rabbits were divided randomly into two groups; half 
were operated to produce hypertension and half were sham operated 
for normotensive controls. Rabbits were shaved on the flanks and 
incisions were made parallel to the spine. A kidney was exposed, 
lifted from its bed and the fat was removed. Rabbits were made 
hypertensive by removing one kidney and wrapping the 
contralateral kidney in cellophane which was tied in place with
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silk in a figure of eight knot (Page, 1939). Control animals 
were subjected to a similar procedure involving the removal of 
one kidney while the contralateral kidney was mobilised and 
manipulated but not wrapped. All rabbits routinely received 
chloramphenicol (0.25 g intramuscularly) immediately after 
surgery, and were allowed to recover from the anaesthetic in 
their cages. Rabbits were studied six to eight weeks after this 
renal operation as after this time blood pressure elevations had 
stabilised.
7.2.3 Implantation of osmotic pumps for chronic drug 
infusions
Osmotic pumps (Alzet type 2ML1) were used to administer 
constant infusions of drugs to the animals over a period of seven 
days to achieve a constant level of drug in the blood stream 
throughout the study period. A diagram of the osmotic pump is 
shown in Figure 7.1. The volume of the reservoir of each pump 
was 2 mis. After insertion of the osmotic pump there is a four 
hour start up period, after which a constant level of drug is 
administered from the fourth hour of the first day until the end 
of day seven. All post treatment experiments were carried out on 
day five or six to allow time for a steady state of drug level in 
the blood to be achieved. Osmotic pumps were filled with the 
appropriate drug before use. At the concentration required, 
prazosin was sparingly soluble in distilled water, so to control 
for the vehicle, verapamil was also dissolved in distilled water.
A venous line was inserted in an ear vein as described 
previously in Section 7.2.1, and the rabbit was anaesthetised
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Figure 7.1 
Cross-section of an osmotic pump
with sodium pentobarbitone (30 to 40 mg/kg). Rabbits were shaved 
at the upper, inner aspect of the thigh, an incision was made, 
and the femoral vein was isolated. The flow modulator with a 
catheter attached was inserted into the previously filled osmotic 
pump. The vein was then cannulated with the catheter pointing 
towards the heart. The catheter was tied securely to the vein 
with surgical silk. The osmotic pump was then embedded between 
the muscle layers and the wound was closed. Rabbits were treated 
with chloramphenicol (0.25 g intramuscularly) after surgery and 
allowed to recover from the anaesthesia. The osmotic pump was 
left in place until the completion of the experiment. A blood 
sample was collected on the day of the experiment for analysis of 
drug levels.
7.2.4 Measurement of drug levels
A blood sample (5 mis) was collected in a lithium heparin 
tube, spun down to obtain plasma, and stored at -70°C before drug 
level analysis. Verapamil levels in the plasma were quantified 
using a high pressure liquid chromatography (HPLC) technique 
modified from Cole et al (1981). Prazosin was measured in whole 
blood also by an HPLC technique adapted from Yee et al (1979). 
Structures for verapamil and prazosin are shown in Figure 7.2.
7.2.5 Determination of the required doses of prazosin and 
verapamil
The dose of verapamil to be chronically administered was 
elucidated from preliminary experiments by increasing the doses 
gradually until sufficient reductions in blood pressure occurred 
and drug levels were detected in the blood. Initially rabbits
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Molecular structures of verapamil and prazosin
were administered 0.6 mg/day. This was calculated from the 
osmotic pump data sheet which stated that the flow rate was 
10 ul/hr giving a total of 240 ul/day, therefore verapamil at a 
concentration of 2.5 mg/ml was delivered at a rate of 0.6 mg/day. 
No trace of drug was detectable in blood samples and no reduction 
in blood pressure was observed. Osmotic pumps were then filled 
with 15 mg/ml of verapamil resulting in a dose of 3.6 mg/day. 
Drug levels of 12 ng/ml and 14 ng/ml were detected in the blood 
but the reduction in blood pressure was not considered to be 
sufficient. The final concentration of verapamil used was 
30 mg/ml delivering 7.2 mg/day to the rabbit and this was found 
to produce levels of 18 and 24 ng/ml of verapamil in the blood, 
and a reduction in blood pressure of at least 10 mmHg. This 
delivery of 7.2 mg/day was considered to be adequate for the 
purposes of the study.
Concentrations of prazosin to be chronically administered 
were determined from preliminary studies in a similar manner to 
verapamil and a concentration of 1 mg/ml of prazosin was used to 
fill the osmotic pump giving a delivery rate of 0.24 mg/day, and 
this was also found to produce a marked reduction of mean 
arterial pressure in hypertensive rabbits. Acute verapamil 
concentrations were identified from preliminary studies by giving 
incremental doses until a sufficient reduction in blood pressure 
was achieved at a dose of 0.2 mg/kg. Acute prazosin doses were 
taken from Hamilton and Reid (1981) where 0.05 mg/kg of prazosin 
caused reductions in mean arterial pressure, although slightly 
higher concentrations were required in this study.
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7.2.6 Estimation of rabbit platelet intracellular free
calcium levels
For these experiments a suitable methodology for the 
preparation of rabbit platelets for intracellular free calcium 
levels could not be found in the literature, so a method had to 
be developed. Initially a similar method of preparation as the 
human method was used (see 2.2.1), but it was found that the 
rabbit platelet intracellular free calcium levels could not be 
stimulated with agonists such as ADP, 5HT and thrombin at 
concentrations where large responses could be observed from human 
platelets. It was also observed that washed rabbit platelets 
obtained from this method did not respond to aggregation. The 
most likely explanation for this might be that fibrinogen is 
removed fom the platelet suspension during gel filtration, so it 
was decided that the centrifugation separation technique should 
be used in preference to the gel filtration technique. It has 
been reported that native fibrinogen is not removed by 
centrifugation (Ardlie et al, 1970) and is retained on the 
surface of the platelet.
A modification of the method from Ardlie et al (1970) was 
adopted after it was ascertained that gel filtration could not be 
utilised, although it is the more superior method as platelet 
activation during preparation is greatly reduced (Groscurth 
et al, 1987). Addition of prostacyclin (PGI2) before 
centrifugation to prevent platelet activation was adapted from 
Vargas et al (1982).
Blood (18 mis) from the rabbit ear artery was collected into
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acid citrate dextrose (2.2% sodium citrate, 0.8% citric acid,
2.2% dextrose) in a ratio of 9 parts blood to 1 part 
anticoagulant. The collecting tube was inverted to mix the blood 
and anticoagulant, and platelet rich plasma was obtained by 
centrifugation at 150 x g, 22°C for 15 mins. The platelet rich 
plasma was aspirated off and PGI2  with a final concentration of
_ 7
5 x 1 0  M was added to the platelet rich plasma and incubated for 
5 mins. at 37°C before centrifugation at 850 x g, 22°C for 15 
mins. to obtain a platelet pellet. The supernatant was discarded 
and the pellet was gently resuspended by sucking and blowing with 
a pasteur pipette in buffer 1 (see Table 7.1). Quin 2- 
acetoxymethylester was added at a final concentration of 20 uM 
and the platelet suspension was incubated for 30 mins. at 37°C.
Five minutes preceding the completion of the incubation, PGI2
_ 7
with a final concentration of 5 x 1 0  M was added. The platelet 
suspension was then separated from any extraneous dye by 
centrifugation at 850 x g, 22°C for 15 mins. The platelet pellet 
was again resuspended, this time in buffer 2, and incubated at 
37°C before use. Fluorescence was measured on a Perkin-Elmer 
luminescence spectrometer LS-3 with standard monochromator 
settings of 339 nm excitation and 492 nm emission. Four separate 
aliquots of each sample were used for basal platelet 
intracellular free calcium concentration measurement and the mean 
of these was calculated.
Basal intracellular free calcium was calculated from the 
fluorescence levels measured from the following equation,
Table 7.1
Composition of the two buffers used in rabbit platelet 
preparation. The figures are the final millimolar 
concentrations of the constituents
Buffer 1 
(mM)
Buffer 2 
(mM)
NaCl 136.9 136.9
KC1 2.7 2.7
CaCl2 - 1.3
MgCl2 2.0. 0.5
NaH003 11.9 11.9
Glucose 5.5 5.5
NaH2P04 0.32 0.32
The pH of buffer 1 was adjusted to 6.5, and buffer 2 to 7.4. 
0.35% Bovine Serum Albumin was added before use.
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where F is the basal fluorescence of the sample. ‘ Fmax is 
obtained by lysing the cells with 50 uM digitonin causing release 
of the intracellularly trapped Quin 2 and allowing this to bind 
to the extracellular calcium causing maximal fluorescence. Fm^n 
is obtained after Fmax by adding excess EGTA to which calcium 
will bind in preference to Quin 2, causing a minimal fluorescence 
level. 115 is the dissociation constant for the Quin 2-Ca^+ 
complex.
7.2.7 Comparison of human platelets prepared by two methods 
Initially in the development of the method for measurement 
of intracellular free calcium levels in rabbit platelets, there 
was some concern as higher calcium levels were obtained than in 
the human studies. This could have been due to the different 
methodology in preparation of the platelets, or to a species 
difference. Experiments were carried out to determine if the 
methodology was causing an artifactual increase in calcium levels 
as it was thought that this was the most likely cause. It was 
impractical to prepare rabbit platelets by the two different 
methods as rabbit platelets are not functional after preparation 
by the human method, so human blood (40 mis) was obtained and 
20 mis was prepared by the human method (see 2.2.1) and 20 mis by 
the rabbit method (7.2.5). These experiments were carried out on 
six volunteers. It was discovered that in every experiment, the 
platelet intracellular free calcium estimation was higher in 
platelets prepared by the rabbit methodology, compared to the 
human methodology (see Figure 7.3). The mean level for the human 
method was 73.6 + 3.1 nM and for the rabbit it was 236 +_ 29.1 nM,
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Figure 7.3
Comparison of human platelet intracellular free calcium 
levels using both the human and rabbit methodologies
and this was found to be significant (p < 0.001).
7.2.8 Dose-response curves for 5HT and ADP 
Dose-response curves for 5HT (n = 5) and ADP (n = 6) were
constructed. This was carried out to demonstrate that rabbit 
platelets were functional after preparation, as full dose- 
response curves could not be constructed for each rabbit in the 
main experimental protocol due to the time factor involved. 
However, in each experiment a single concentration was added to 
one aliquot of platelets to ensure each preparation was 
functionally viable. The dose-response curves for 5HT and ADP 
are shown in Figures 7.4 and 7.5 respectively. The basal levels 
have been subtracted from the stimulated levels in these figures. 
The basal levels were 225 +_ 21.4 nM for the ADP dose-response 
curve and 223 _+ 23.6 nM for the 5HT dose-response curve. These 
will be compared with the corresponding dose-response curves for 
human platelets in the discussion. Typical responses of the rise 
in rabbit platelet cytosolic calcium represented by an increase 
in fluorescence levels are shown in Figure 7.6, for 
concentrations of ADP and 5HT which produced half the maximal 
response, to illustrate the time course and differences in 
magnitude of the responses.
7.2.9 Materials
This section covers the materials in this chapter which have 
not been covered by the materials section in previous chapters.
New Zealand White rabbits were obtained from Cheshire Rabbit 
Farms, Tarporley. Alzet 2ML1 osmotic pumps were supplied by
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Dose-response curve for 5HT stimulation of platelet 
intracellular free calcium concentration in rabbits
Basal levels have been substracted.
For each point, n = 5.
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Dose-response curve for ADP stimulation of platelet 
intracellular free calcium concentration in rabbits
Basal levels have been substracted.
For each point, n = 6 .
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Figure 7.6
Alterations in fluorescence levels which occur after 
additions of agonists in rabbit platelets
i r
sosecs
Scientific Marketing, London. Lignocaine hydrochloride was 
purchased from Phoenix Pharmaceuticals Ltd., Gloucester, and 
sodium pentobarbitone (Sagatal) from May and Baker, Dagenham. 
Chloramphenicol sodium succinate (Chloromycetin) was obtained 
from Parke, Davis and Company, Pontypool, Gwent. Verapamil was 
obtained from Sigma, Poole, Dorset, and prazosin hydrochloride 
was donated by Pfizer, Sandwich, Kent. Sodium heparin was 
obtained from Leo Laboratories Ltd., Princes Risborough, 
Buckinghamshire. Prostacyclin (PGI2 ) was obtained from Sigma, 
Poole, Dorset.
7.2.10 Statistical Analysis
Results were analysed using the unpaired t-test for 
comparison of normotensive and hypertensive groups, and the 
paired t-test when pre and post treatments were compared. If the 
data were not normally distributed the appropriate corresponding 
non-parametric Wilcoxon test was enforced. Correlations were 
analysed by linear regression. Results are expressed as 
mean +_ SEM.
7.3 Experimental protocols for main study
A total of 56 rabbits were involved in these experiments. 
Rabbits were weighed and renal operations were carried out as 
described previously to obtain 28 normotensive and 28 
hypertensive animals. After 6 - 8  weeks to allow hypertension to 
develop the two groups were distributed evenly between the four 
separate treatment groups to result in seven normotensive and 
seven hypertensive animals in each group. The four treatment 
groups consisted of acute verapamil, acute prazosin, chronic
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Experimental protocols 
MAP - mean arterial pressure 
HR - heart rate
[Ca +^j^  - intracellular free calcium
concentration
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verapamil and chronic prazosin treatment. The experimental 
protocol is shown in Figure 7.7 for clarity. In the two chronic 
treatment groups, mean arterial pressure and heart rate were 
measured after at least one hours rest and then a blood sample 
was taken for platelet intracellular free calcium estimation. 
The next day osmotic pumps were inserted as described previously, 
delivering a predetermined dose of either 3.5 mg/kg/day of 
verapamil or 0.1 mg/kg/day of prazosin. Six days later the mean 
arterial pressure, heart rate and platelet intracellular calcium 
measurements were repeated, and in addition a blood sample was 
taken for plasma drug levels to ensure the osmotic pump was 
functioning. Rabbits were weighed after treatment.
For the acute treatment groups, the whole experiment was 
carried out on one day. Mean arterial pressure and heart rate 
were measured before a blood sample was taken for platelet 
cytosolic calcium levels and the rabbit was allowed to rest for 
an hour. An intravenous bolus dose of either verapamil 
(0.2 mg/kg) or prazosin (0.1 mg/kg) was administered and after 30 
minutes the mean arterial pressure, heart rate and platelet 
intracellular free calcium measurements were repeated. The 
rabbits were weighed at the end of the experiment. On each study 
day, one control normotensive rabbit and one hypertensive rabbit 
were examined simultaneously.
7.4. Results
In this section the results of the main study will be 
examined.
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7.4.1 Blood levels of prazosin and verapamil
In the chronic prazosin treatment group the mean blood level 
was 1.47 Hh 0.14 ng/ml of blood with a range of 0 . 8  - 2.0 ng/ml 
for the normotensive group. The hypertensive group had a mean of
2.3 +_ 0.55 ng/ml with a range of 1.1 - 5.5 ng/ml. This was found 
to be non-significant. In the chronic verapamil treatment group 
the mean blood level in the normotensive group was 
20.7 +_ 0.7 ng/ml, ranging from 1 8 - 2 3  ng/ml, compared to the 
hypertensive group, where the mean level was 19.7 +_ 0.9 ng/ml 
with a range of 17 - 24 ng/ml. The difference between these two 
groups was also not significant for chronic verapamil. There was 
no correlation between drug levels and the reduction in mean 
arterial pressure observed, nor was there a correlation between 
drug levels and the weight of the rabbit at the time of sampling.
7.4.2 Rabbit weights
Rabbits were weighed before the perinephritis operations and 
again on the day of drug administration for acutely treated 
rabbits. The chronic treatment group was weighed on the post
treatment day. There was no significant difference within each
treatment group between either the initial or final weights of 
the normotensive rabbits compared to the hypertensive rabbits. 
These values and the significance levels are shown in Table 7.2. 
However it was observed that comparison of the initial and final 
weights in each treatment group with normotensive and 
hypertensive rabbits grouped together showed that there was a 
significant increase in rabbit body weight (p < 0 . 0 0 1  in each 
group). There was no significant correlation between body weight
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and the reduction in blood pressure observed after treatment.
7.4.3 Heart rate
There was no significant difference in the heart rates 
between the normotensive and the hypertensive groups with means 
of 204 5 beats/min and 214 +_ 6 beats/min respectively. No
alterations in heart rate were observed in the acute verapamil 
(Figure 7.8) or the chronic verapamil or prazosin (Figure 7.9) 
treatment groups after treatment for either normotensive or 
hypertensive rabbits. However, significant increases in heart 
rate were observed in both normotensive and hypertensive rabbits 
after acute prazosin administration (Figure 7.8).
7.4.4 Mean arterial pressure
The mean arterial pressure for the normotensive rabbits was
89.4 +^1.3 mmHg whereas for the hypertensive group it was 
123.0 _+ 2.9 mmHg. This was found to be significantly different
(p < 0 .0 0 1 ).
Acute verapamil treatment caused a decrease in mean arterial 
pressure in both normotensive and hypertensive rabbits as did the 
acute prazosin treatment (Figure 7.10).
Chronic verapamil treatment was found to reduce mean 
arterial pressure significantly in the hypertensive group, but 
had no effect on the normotensive group. The reduction in blood 
pressure was on average about 1 5 mmHg in hypertensive rabbits. 
In the chronic prazosin group a similar pattern occurred; there 
was no change in the mean arterial pressure of the normotensive 
rabbits, and a significant reduction in the hypertensive rabbits 
which was of a similar magnitude to the chronic verapamil treated
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Heart rate in rabbits before and after acute treatments 
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Mean arterial pressure in rabbits before and after 
acute treatments
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Platelet intrace1lular free calcium levels of rabbits 
before and after acute treatments 
[Ca^ +]j[ is intracellular free calcium concentration.
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Figure 7.13
Platelet intracellular free calcium levels of rabbits before 
and after chronic treatments 
[Ca^ +3i is intracellular free calcium concentration.
* p < 0.05, compared to the corresponding pre-treatment group.
□  - normotensive rabbits
|^ j - hypertensive rabbits
7 5 0 -
platelet 
intracellular 
free 
calcium 
concentration 
(nM)
5 0 0 -
2 5 0 -
150100 20050
mean arterial pressure (mmHg)
Figure 7.14
Graph of mean arterial pressure against platelet intracellular 
free calcium concentration of pre-treatment measurements
in rabbits 
• - normotensive rabbits 
■  - hypertensive rabbits
group. These results are shown in Figure 7.11.
7.4.5 Basal platelet intracellular free calcium levels
Basal levels of platelet calcium were not found to be
significantly altered between the normotensive and hypertensive 
groups with means of 237.0 +_ 2 1 A  nM and 249.0 +_ 26.3 nM 
respectively.
No change was found between pre-treatment and post-treatment 
platelet calcium levels in the acute verapamil or prazosin groups 
(Figure 7.12), or the chronic prazosin group (Figure 7.13). 
However, an increase in platelet calcium levels was observed 
after chronic verapamil treatment (Figure 7.13), and this was of 
a similar magnitude for both normotensive and hypertensive 
rabbits. A plot of the pre-treatment mean arterial pressures 
against the corresponding basal platelet intracellular free 
calcium levels was constructed and is shown in Figure 7.14. It 
can be seen from this graph that no correlation was observed 
between the two parameters (r = 0.19, p > 0.1, n = 56).
7.5 Discussion
Preliminary experiments in this chapter showed that the 
method for preparation of rabbit platelets yielded higher levels 
of cytosolic free calcium than the method used for the 
preparation of human blood. However this could not be avoided as 
it was the best method available which resulted in washed 
platelets which were functional and responded normally to various 
agonists. Comparison of the standard ADP dose response curve for 
rabbits with the standard curve for human platelets showed that
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although the slope and the EC5 0  values for these two curves were 
similar, a higher maximum stimulation level was obtained from the 
rabbit platelets. However it is difficult to ascertain if this 
is a true observation, as the dose-response curve for ADP 
stimulation of human platelets has not reached a plateau, as 
higher concentrations of ADP could not be achieved due to 
experimental limitations. This apparently higher Emax value for 
ADP stimulated rabbit platelets is not due to the higher basal 
levels as these had been subtracted from the dose-response 
curves. Rabbit platelets were found to be less sensitive to 5HT 
stimulation as there was a marked shift to the right of the dose- 
response curve compared to the human platelet dose-response 
curve.
There was no overall difference between body weights of the 
normotensive and hypertensive rabbits, nor was there any 
difference found between any treatment group at any time. These 
observations are consistent with Hamilton and Reid (1983), and 
indicate that no treatment or type of renal operation showed any 
difference on the effect it had on weight, compared to any other 
treatment or operative procedure.
There was no variance in the heart rate between normotensive 
and hypertensive rabbits and this observation is in agreement 
with other published work (Fletcher et al, 1976; Hamilton and 
Reid, 1983). Acute prazosin caused a significant elevation of 
heart rate in both normotensive and hypertensive rabbits and this 
was probably due to the acute fall in blood pressure causing a 
reflex tachycardia. No significant change in heart rate was 
observed after chronic prazosin, and these results were also
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consistent with Hamilton and Reid (1981) who explained this as 
tolerance developing with long term prazosin treatment.
There was no change in heart rate with either acute or 
chronic verapamil treatment. The acute results contrast with 
previous reports with lower doses of acute verapamil causing 
significant increases in heart rate in both normotensive and 
hypertensive rabbits (Hamilton et al, 1987). In normotensive 
volunteers, acute verapamil treatment has been found to cause 
either no change in heart rate or tachycardia (McAllister and 
Kirsten, 1982). The possible explanation behind these 
observations is that the effect of verapamil peripherally is to 
decrease the peripheral vascular resistance causing a decrease in 
blood pressure and a reflex tachycardia. However verapamil also 
has a direct cardiac effect causing bradycardia. It is possible 
that the higher dose of verapamil in this study caused a decrease 
in heart rate which cancelled out the reflex tachycardia, whereas 
the dose from Hamilton et al (1987) was not high enough to have a 
direct effect on the heart, and therefore the increase in heart 
rate was not masked.
Acute treatment with both verapamil and prazosin resulted in 
a reduction in blood pressure of both normotensive and 
hypertensive rabbits. However, both chronic treatments produced 
a blood pressure lowering effect in the hypertensive rabbits 
only.
Verapamil is known to have a greater effect on hypertensive 
rabbits and this would support the role of calcium in 
hypertension. However this larger fall in the hypertensive
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animals could be due to the higher starting pressure. This was 
disproved by Hamilton et al (1987), who showed that the reduction 
in mean arterial pressure was greater in hypertensive than in 
normotensive rabbits when expressed as both real values and as a 
percentage change.
Pretreatment basal intracellular free calcium levels did not 
differ between the normotensive and hypertensive rabbits.
Also, no reduction in platelet cytosolic calcium was 
observed after any of the four treatments in either normotensive 
or hypertensive rabbits. These two points contrast with Erne 
et al (1984a), who observed firstly that essential hypertensive 
patients had higher platelet intracellular free calcium levels 
than normotensive controls, and secondly, that anti-hypertensive 
treatment reduced these elevated levels to within the normal 
range, in addition to lowering the blood pressure. This would 
suggest that perinephritis hypertension in the rabbit is not a 
good model for human essential hypertension. The salient feature 
of the cytosolic calcium results is the increase in platelet 
calcium levels after chronic verapamil treatment for both 
normotensive and hypertensive rabbits. This is difficult to 
interpret as in vitro verapamil is known to inhibit platelet 
aggregation and produce a dose-dependent reduction of platelet 
cytosolic calcium levels (Djaldetti et al, 1988). However it is 
possible that in vivo, the calcium channel blocking properties of 
verapamil are greater at the vascular smooth muscle cell, and 
thus verapamil prevents uptake into the blood vessels. This may 
lead to a slight excess of free calcium in the plasma which is 
taken up by the platelets causing an increased basal cytosolic
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free calcium level. It is also possible that verapamil may block 
the exit of calcium from the platelet. These are purely 
speculative hypotheses to endeavour to explain the increase in 
cytosolic calcium levels after chronic verapamil treatment. No 
correlation was found between pre-treatment mean arterial 
pressure measurements and basal platelet intracellular free 
calcium levels.
The results from this chapter reinforce and extend the 
observations made by Murakawa et al (1986) and Zimlichman et al 
(1986) in SHR and DOCA-salt hypertensive rats. In perinephritis 
hypertension in the rabbit, no alterations in basal intracellular 
free calcium levels were observed compared to normotensive 
controls. However this does not imply that changes in calcium do 
not occur in other species, but it could signify that alterations 
in intracellular free calcium levels are not a universal 
indicator of the development and presence of hypertension. It 
would be of benefit to study platelet cytosolic free calcium 
levels at different time points throughout the development of 
perinephritis hypertension to establish if alterations occur 
during the development rather than the maintenance of 
hypertension.
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CHAPTER EIGHT
INTRACELLULAR FREE CALCIUM LEVELS IN ENZYMATICALLY DISPERSED 
SMOOTH MUSCLE CELLS FROM THE CAROTID ARTERIES OF NORMOTENSIVE 
AND HYPERTENSIVE RABBITS
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Chapter Eight
Intracellular Free Calcium Levels in Enzymatically Dispersed 
Smooth Muscle Cells from the Carotid Arteries of Normotensive 
and Hypertensive Rabbits
8.1 Introduction
Calcium is probably the most important, but not the only, 
second messenger in vascular smooth muscle cells. It plays a 
major role in the contraction of these cells (Bolton, 1986), 
whereas the second messengers cyclic adenosine monophosphate 
(cAMP) and cyclic guanosine monophosphate (cGMP) have a role in 
the relaxation processes (Hofman, 1985).
Vascular smooth muscle contraction is caused by an increase 
in the cytosolic free calcium within the cell which will activate 
the actin and myosin filaments causing contraction of these 
structures and cell shortening. The increase in cytosolic free 
calcium is known to occur by three mechanisms in vascular smooth 
muscle; a voltage-dependent calcium channel; a receptor operated 
calcium channel, and release of calcium from intracellular stores 
by inositol trisphosphate (Hofman, 1985).
Vascular smooth muscle possesses an inherent tone and the 
mechanisms above serve to modify this continuous contractile 
activity in response to various stimuli. Arterial smooth muscle 
tone determines peripheral vascular resistance and thereby blood 
pressure. In hypertension, alterations in one or more of the 
factors described which control the contractile state of vascular 
smooth muscle are thought to occur producing a defect in the 
calcium handling in the hypertensive cell.
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It has been proposed that a general increase in the 
permeability of vascular smooth muscle cell membranes to calcium 
ions is an intrinsic defect of the pathogenesis of hypertension 
which occurs before the elevation of blood pressure (Kwan, 1985). 
This results in an increase in myogenic activity, including 
increases in basal tension, in spontaneous activity and in 
responsiveness to stimulation.
Hulthen et al (1982) have shown that the calcium channel 
antagonist, verapamil, induced a greater increase in forearm 
blood flow in essential hypertensive patients compared to 
normotensive patients, whereas no significant difference was 
observed between the two groups for the non-specific vasodilator, 
sodium nitroprusside. This illustrates that there is an 
increased dependency of the arteriolar tone on calcium influx in 
hypertension.
Calcium handling may also be altered in animal models of 
hypertension, including perinephritis hypertension in the rabbit, 
which is the model of hypertension used in these studies. 
"In vivo" experiments have shown that calcium antagonists produce 
a greater depressor response in hypertensive compared to 
normotensive rabbits when expressed both as absolute and 
percentage changes (Hamilton et al, 1987). "In vitro", aortic 
rings from hypertensive rabbits were found to be more susceptible 
to calcium channel antagonists, but less sensitive to the calcium 
channel facilitator Bay K 8644 than the normotensive preparations 
(Dong and Wadsworth, 1986). The same workers also observed an 
increase in the basal uptake of 4 5 Ca2+ in hypertension (Dong and 
Wadsworth, 1987), and noted that upon agonist stimulation, uptake
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of ^Ca^+ was reduced in hypertensive compared to normotensive 
rabbits. An increased efflux of ^Ca^+ in perinephritis 
hypertension has also been observed (Tomera and Harakal, 1982). 
This group previously showed a reduction in cAMP levels in 
hypertensive rabbits (Tomera and Harakal, 1980) and this 
observation would suggest that not only does an alteration in 
Ca^+ handling cause an increase in contractile tone, but a 
decrease in cAMP will result in a reduction in the ability of the 
smooth muscle cell to relax.
These observations all point to a generalised defect in the 
calcium handling of the vascular smooth muscle cell in 
perinephritis hypertension. Other workers have studied the 
effect of these changes on the calcium activities and cytosolic 
free calcium levels in vascular smooth muscle cells of the 
hypertensive rat. Zidek et al (1982a) found no difference 
between calcium activities in cultured aortic smooth muscle cells 
from spontaneously hypertensive rats and Wistar-Kyoto rats using 
a Ca^+ selective electrode. However the same workers (Zidek 
et al, 1983a) demonstrated that using enzymatic isolation of 
these cells, hypertensive rats had a significantly higher calcium 
activity compared to their normotensive controls. The authors 
explained this discrepancy as an absence of a humoral factor in 
the culture medium, and suggested that the enzymatic isolation 
procedure reflected a closer similarity to the actual calcium 
content of the cells "in situ". Nabika et al (1985a, 1985b) 
found no difference in cultured vascular smooth muscle cell 
cytosolic free calcium levels between normotensive and
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spontaneously hypertensive rats using the Quin 2 fluorescence 
technique, but they did observe that arg-vasopressin elicited 
larger increases of intracellular calcium in cells obtained from 
hypertensive rats (Nabika, 1985a).
Nickerson and Yang (1988) showed that intracellular free 
calcium was raised before hypertension had developed in DOCA-salt 
rats, although the total aortic calcium levels were unchanged. 
After hypertension had developed the total aortic calcium and 
intracellular free calcium levels had both increased 
significantly. These workers suggested that the elevation of 
intracellular free calcium in DOCA-salt hypertensive rats may 
precede the elevation of blood pressure and the pathological 
changes of blood vessels in hypertension.
In the preceding chapters, platelets have been used as a 
model for vascular smooth muscle cells due to easier availability 
and sampling techniques, particularly in the human studies. It 
has also been suggested that platelets closely reflect any 
functional alterations which occur in vascular smooth muscle 
(Erne et al, 1984a). However the validity of using platelets as 
a model for vascular smooth muscle is questionable, as although 
many common features exist, there are major differences. 
Platelets do not play a major role in the development of 
hypertension, therefore it is obviously more advantageous to use 
vascular smooth muscle cells as they are the site at which 
pathological changes will occur in hypertension.
The initial aim of this study was to modify and establish 
methodologies for enzymatic isolation and Quin 2 labelling of 
vascular smooth muscle cells from the carotid arteries of the
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rabbit, as no other similar studies had been performed in 
rabbits. It was then hoped to discover if an increase in 
intracellular free calcium in these cells is a consequence of the 
alterations in calcium handling which have been observed 
previously in perinephritis hypertension of the rabbit, and 
finally to find if a correlation exists between mean arterial 
pressure and vascular smooth muscle cytosolic free calcium levels 
in the rabbit.
8.2 Methodology
The animal studies in this chapter were carried out using 
male New Zealand White rabbits. The final number of rabbits in 
each group was eleven in the normotensive group and ten in the 
hypertensive group. Animals were prepared for administration of 
general anaesthetic, and measurement of mean arterial pressure 
and heart rate as outlined previously in Section 7.2.1. 
Perinephritis hypertension was induced as described in 
Section 7.2.2. Rabbits were studied 6 - 8  weeks after surgery to 
allow hypertension to stabilise.
8.2.1 Preparation of isolated vascular smooth muscle cells
This method is modified from work by Warshaw et al (1986), 
who isolated bovine carotid artery smooth muscle cells. Carotid 
arteries were selected as preliminary studies in various arteries 
including the abdominal aorta and the femoral artery showed that 
the carotid artery had fewer branches and was therefore the most 
suitable for the purposes of this study. The major modifications 
which were made for rabbit carotid arteries were an alteration of
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the incubation time and enzyme mix. The incubation time for 
digestion was changed as it was found that one longer incubation 
period of two and three quarter hours produced a better yield of 
cells than two one and a half hour incubations. The collagenase 
concentration was halved as digestion was found to be too rapid 
in rabbit arteries using the bovine enzyme mix. The method for 
concentrating the cells by centrifugation was also developed, and 
during preliminary experiments with various centrifugation times 
and speeds, the optimum conditions were found which did not 
appear to cause any visible damage by microscopic examination of 
the cells.
Rabbits were killed with an intravenous overdose of 
pentobarbitone sodium and an incision was made at the neck. The 
carotid arteries were isolated, removed by careful dissection, 
and placed in a petri dish containing low Ca^+ (0.5 mM) Krebs' 
solution (see Table 8.1) and gassed with 95% 0 2 /5 % CO2 - The 
arteries were cleared of adherent tissue and cannulated with a 
piece of tubing. Low Ca^+ Krebs' solution was flushed through 
the artery using a modified pipette tip as an adaptor between the 
tubing and a small syringe. The open end of the artery was then 
tied and air was pushed into the arterial sac to detect side 
branches and holes. The artery was cut where the leaks occurred, 
and recannulated to check for remaining leaks. The individual 
arterial sacs were firstly rinsed with low Ca^+ Krebs' and then 
flushed with an enzyme mixture modified from Van Dijk and Laird 
(1984) (see Table 8.2). This procedure was carried out using a 
syringe with a blunted needle and a piece of finely drawn out 
tubing attached. The arterial sac was then filled with the
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Table 8.1
Constituents of Krebs1 solutions used in the preparation 
of isolated vascular smooth muscle cells
Ca2+ poor Krebs' 
(uiM)
Ca2+ rich Krebs' 
(mM)
NaCl 115.5 115.5
NaHC03 21.9 21.9
KCl 4.6 4.6
MgS04.7H20 1.16 1.16
NaH2P04.2H20 1.16 1.16
CaCl2 0.5 1.0
Glucose 11.1 11.1
The pH of both buffers was adjusted to 7.5 before use.
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Table 8.2
Enzyme mix used in the digestion of carotid arteries. 
Modified from van Dijk and Laird (1984)
Collagenase 5.1 mg
Elastase 3.5 mg
Bovine Serum Albumin 75 mg
Trypsin inhibitor 5 mg
ATP 12.1 mg
Amino acids 65 ul
Glutamine 2.5 mM
Isoprenaline 1 uM
Made up to 5 mis with 0.5 mM Ca^+ Krebs' solution.
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enzyme mix until it was visibly distended using a plastic Pasteur 
pipette with a drawn out tip. The sac was then tied firmly to 
prevent loss of pressure and placed in a stoppered tube 
containing the low Ca^+ Krebs' solution. The segments were 
incubated at 37°C for two and three quarter hours in a shaking 
waterbath (20 shakes/min.) and were gassed every 15 minutes by 
blowing the surface of the Krebs' solution with 95% 02/5% 002* 
ensuring that the arterial sacs were not disturbed. After the 
incubation period the tube was placed on ice and the arterial 
segments were removed and cut open at one end. The artery was 
then cannulated with a modified Pasteur pipette containing a 
small amount of the low Ca^+ Krebs' solution, and a knot was tied 
firmly to prevent loss of cells. The arterial sac was then 
gently inflated and deflated to obtain a suspension of cells. 
These were collected in a siliconised glass test tube and the 
procedure repeated until no more cells could be harvested. The 
cell suspension was then concentrated by centrifugation at 
100 x g, 22°C for 3 minutes to reduce the volume to 0.4 mis.
8.2.2 Measurement of cytosolic free calcium levels
The method for Quin 2 fluorescence measurements in isolated 
vascular smooth muscle cells was modified from the method 
described previously for platelets (see Section 2.2.1). A higher 
concentration of Quin 2-AM was required with a longer incubation 
time to obtain a satisfactory level of fluorescence from the 
cells. This may have been due to the cell membranes of vascular 
smooth muscle having a lesser permeability to Quin 2-AM, or to 
the existence of cell clumps which may have slowed the rate of
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uptake into the cells. It was also found that a higher 
concentration of digitonin was required to produce cell lysis, 
and that MnCl2 produced a more stable Fmj_n reading than EGTA, 
therefore the method for obtaining fluorescence levels to 
calculate cytosolic free calcium concentration was also modified.
Quin 2-AM at a final concentration of 100 uM was added to 
the cell suspension and was incubated in a fast shaking water bath 
(60 shakes/min.) at 37°C for 60 minutes under an atmosphere of 
95% 02/5% CO2 . After the incubation the tube was filled with 
Ca^+ rich (1 mM) Krebs' solution (see Table 8.1), mixed and 
concentrated by centrifugation at 1 00 x g, 22°C for 3 minutes. 
This procedure was then repeated as it was necessary to remove 
any excess Quin 2-AM which remained in the buffer. The 
fluorescence of the final supernatant was measured to ensure that 
the background fluorescence was minimal. The final 0.4 ml cell 
sample was incubated at 37°C before use. In most experiments, 
only enough cells were obtained to measure one basal level of 
intracellular free calcium. However in preliminary experiments 
3-4 rabbits were killed in one day to allow more investigations 
to be carried out, such as duplicate basal readings and 
stimulation with noradrenaline. Basal intracellular free calcium 
concentration was calculated from fluorescence measurements using 
the following equation,
2+ F Fmin[Ca ]±(nM) = 115 ----------
Fmax ~ F
where F is the resting fluorescence of the sample, 115 is the 
dissociation constant of the Quin 2-Ca^+ complex, Fmax is
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obtained by lysing the cells with 1 mM digitonin, thus releasing 
all the unbound Quin 2 which will bind to the free extracellular 
Ca^+ and produce a maximal fluorescence signal, and Fm^n is 
produced after Fmax by addition of 10 mM MnCl2  to quench the 
Quin 2-Ca^+ signal.
8.2.3 Cell properties
Some cells were prepared for slides by fixing with 2% 
glutaraldehyde. In other experiments with unfixed slides, 0.2% 
trypan blue was added to the slide preparation to test for cell 
viability or noradrenaline was added to observe contraction.
8.2.4 Materials
The collagenase (Sigma type 1A), elastase, bovine serum 
albumin (fraction V), trypsin inhibitor, ATP, amino acid 
solution, isoprenaline and glutamine were all obtained from 
Sigma, Poole, Dorset, as were all other reagents from the Krebs' 
solutions which were of the analytical grade. Manganese chloride 
was obtained from BDH Chemicals, Poole, Dorset.
All other materials used in this chapter have been mentioned 
in previous chapters.
8.2.5 Statistical analysis
Data were analysed using the unpaired t-test. Correlations 
were carried out using linear regression analysis. All results 
cure expressed as mean _+ SEM.
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8.3 Results
8.3.1 Cell properties
Histological examination of the cells obtained by enzymatic 
digestion revealed that the cells existed either as isolated, 
single cells or as small groups of cells which varied in size. 
This is illustrated in Figure 8.1. Figure 8.2. shows the same 
field of view under a higher magnification. This shows that the 
majority of cells obtained were in a partially relaxed state and 
this was typical for most preparations. The cell population 
appeared to be predominantly smooth muscle cells with some 
endothelial cells present. Although no attempt was made to 
remove the endothelium before enzyme incubation it is probable 
that a substantial amount was removed by the rubbing involved in 
the cannulation processes. More systematic rubbing of the 
interior of the blood vessel to remove the endothelium could be 
carried out in further studies. Figure 8.3 shows the same field 
as Figure 8.2, but phase contrast was used to distinguish between 
smooth muscle cells and the partly digested collagen and elastin 
matrix. The final photograph of cells (Figure 8.4) illustrates a 
group of contracted cells and a group of relaxed cells. The 
relaxed cells were about 100 microns long, whereas the contracted 
cells were about one third of this size. The individual cells 
within these groups were probably functionally connected to other 
cells in the group by tight junctions as they tended to be in the 
same contractile state. It was observed that noradrenaline 
(10“^M) produced both a visible contraction of cells under the 
microscope and an elevation of cytosolic free calcium levels,
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Figure 8.1
Photograph of single and groups of smooth muscle cells obtained
by enzymatic digestion 
Magnification x 125
IOOjllta
Figure 8.2 
Photograph of smooth muscle cells 
Same field of view as Figure 8.1 under magnification x 250.
i i
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Figure 8.3 
Photograph of smooth muscle cells 
Same field of view as Figure 8.2, but phase contrast used.
Magnification x 250.
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Figure 8.4
Photograph of smooth muscle cells, showing one contracted 
and one relaxed group of cells
Magnification x 250
showing that the cells produced were pharmacologically responsive 
(see Figure 8,5). The concentration of cells found in the 
suspensions varied between 0.2 - 0.5 x 10^ cells/ml. In all 
preparations the cells were found to exclude Trypan blue which is 
a commonly used test for cell viability (Tennant, 1964).
8.3.2 Mean arterial pressure
Mean arterial pressure of the hypertensive group was 
significantly higher 6-8 weeks after surgery compared to the 
normotensive group with means of 127.0 _+ 4.6 mmHg and 
84.8 _+ 3.0 mmHg respectively (p < 0.001). These results are 
shown in Figure 8.6. The range of blood pressures for the 
hypertensive group was 1 00-1 45 mmHg, and for the normotensive 
group, 65-97 mmHg.
8.3.3 Intracellular free calcium levels in isolated vascular 
smooth muscle cells
The normotensive rabbits had a mean cytosolic free calcium 
level of 102.0 +_ 9.6 nM compared to a hypertensive mean of
118.0 +_ 8.0 nM. These results are shown in Figure 8.7 and the 
difference was not found to be statistically significant.
8.3.4 Heart rate
The heart rate results are shown in Figure 8.8. The mean 
heart rate value for the normotensive rabbit group was
209.0 ±  5.8 beats/min whereas the hypertensive group had a mean 
of 211.0 ±  6.3 beats/min. This was not found to be 
significantly different.
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Figure 8.5
Typical response obtained when isolated smooth muscle cells 
were stimulated with noradrenaline
i 1
SQSdCS
▲mean
arter ia l
pressure
(mmHg)
140 - 
120 -  
100 -  
80 
60 
40 
20 
0
* * *
Figure 8.6
Mean arterial pressure measurements for normotensive and 
hypertensive rabbits 
*** p < 0.001 compared to normotensive rabbits.
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Figure 8.7
Intracellular free calcium levels of isolated vascular smooth 
muscle cells of normotensive and hypertensive rahbits
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HI - hypertensive rabbits
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Figure 8.8
Heart rate measurements in normotensive and hypertensive
rabbits 
□  - normotensive rabbits 
M l - hypertensive rabbits
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Figure 8.9
Graph of mean arterial pressure against intracellular free 
calcium levels in isolated smooth muscle cells
[Ca^+]^  is intracellular free calcium concentration.
A - normotensive rabbits 
• - hypertensive rabbits
8.3.5 Relationship between mean arterial pressure and
intracellular free calcium levels in isolated smooth 
muscle cells
Linear regression analysis was carried out to determine if a 
relationship existed between mean arterial pressure and cytosolic 
free calcium levels. These results are shown graphically in 
Figure 8.9. No significant correlation was observed (n = 21, 
r = 0.17, p > 0.4).
8.4 Discussion
The group of experiments in this chapter has illustrated 
that functional vascular smooth muscle cells can be isolated from 
rabbit carotid arteries using an enzymatic digestion technique. 
When isolated, these cells can then be labelled with the 
fluorescent dye, Quin 2, to obtain estimations of the free 
calcium levels within the cells. The cell suspension consisted 
of mainly smooth muscle cells which were partially relaxed and 
existed as small groups or as individual cells. Some endothelial 
cells were present in the suspension.
The mean basal cytosolic calcium level from this chapter was 
102 nM for normotensive rabbits. This is similar to the value 
obtained by Nabika (1985a) who measured calcium levels using 
Quin 2 in cultured rat aortic smooth muscle cells. This group 
reported a mean level of 114 nM for Wistar-Kyoto rats. However, 
these levels are lower than other studies using cultured rat 
aortic smooth muscle cells. Brock et al (1985), observed that 
basal cytosolic free calcium levels in Sprague-Dawley rats were 
as high as 198 nM whereas Capponi et al (1986), who did not quote
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the strain of rat, but it will be assumed they were of a 
normotensive strain, measured levels of 153 nM. These other 
results would suggest that the cytosolic free calcium levels in 
this study were in the expected range. The variation in levels 
observed in different studies could be due to species or age 
differences, varying vascular tissues, and methodological 
differences in either the cell preparation or in the measurement 
of cytosolic free calcium levels. In this study, preliminary 
experiments suggested that higher cytosolic calcium levels were 
measured when higher centrifugation speeds were used.
No significant elevation in calcium levels was observed in 
the hypertensive rabbits compared to the normotensive rabbits. 
This supports the findings of Nabika et al (1985a), who compared 
cytosolic free calcium levels of cultured rat aortic cells in 
spontaneously hypertensive rats and Wistar-Kyoto rats and found 
no significant alterations with mean levels of 114 nM and 116 nM 
respectively. It has been reported in the literature that 
pentobarbitone sodium inhibits calcium uptake in rat aortic and 
portal venous smooth muscle, and that intracellular calcium is 
reduced in these cells (Altura et al, 1980). This occurs at 
concentrations which are used to induce anaesthesia, therefore 
pentobarbitone sodium could have had this effect when the rabbit 
was killed with an intravenous overdose. It is not known, 
however, if this would have affected the hypertensive and 
normotensive rabbits to the same extent, and if not this varying 
effect may have masked any real changes that occurred in this 
study. The method utilised by Nabika et al (1985a) to kill the 
rats was not described, therefore it is not possible to comment
on an explanation for the lack of change in this study. However, 
Zidek et al (1983a), suggested that the absence of a humoral 
factor in the culture medium may have masked any alterations.
No correlation was found to exist between mean arterial 
pressure and cytosolic free calcium levels in the vascular smooth 
muscle cells. Lechi et al (1986a) also failed to observe a 
correlation between these parameters in normotensive and 
hypertensive patients. However, other human studies (Lenz et al, 
1985) have shown that a weak correlation existed between blood 
pressure and platelet cytosolic free calcium levels. The 
conclusion of this study was that in a large proportion of 
essential hypertensive patients there was no evidence for an 
elevation of platelet calcium levels although some hypertensive 
patients had higher platelet calcium levels than others. Close 
examination of the graph in Figure 8.9 shows that some 
hypertensive rabbits had higher cytosolic calcium levels than 
others; in fact it appears as if the results may be bimodally 
distributed and two distinct groups exist, one with high calcium 
levels and the other with normal calcium levels. More 
investigation of this observation is required before any firm 
conclusions can be formed, but it is possible that cytosolic free 
calcium rises during the development of hypertension and then 
falls to within the normal range when hypertension becomes 
established.
In conclusion, therefore, no alteration in basal 
intracellular free calcium levels was found in dispersed vascular 
smooth muscle cells from the carotid artery of the perinephritis
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model of hypertension in the rabbit. This study illustrates that 
the alterations in calcium handling which were previously 
observed in perinephritis hypertension, and are evidence for a 
membrane defect in the calcium handling of the hypertensive cell, 
do not alter the basal cytosolic free calcium levels of the 
vascular smooth muscle cell.
Further studies will be required to obtain a greater yield 
of cells from each experiment, by either using different arteries 
from the same rabbit or by pooling a group of rabbit carotid 
arteries. This larger sample would enable investigation into 
agonist stimulation of cytosolic free calcium to elucidate if 
alterations occur in the hypertensive rabbit. It would also be 
of interest to observe basal and stimulated cytosolic free 
calcium levels throughout the development of hypertension.
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CHAPTER NINE
GENERAL DISCUSSION, SUMMARY AND CONCLUSIONS
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Chapter Nine 
General discussion, summary and conclusions
/
The discussions for each section of work have been examined 
in detail within each chapter. This chapter brings the results 
of chapters three to eight together to summarise and make general 
conclusions from these results. Proposals for other studies to 
extend the findings of this work in future research will also be 
considered.
In chapter three, the effect of alcohol ingestion on 
platelet intracellular free calcium levels was investigated, as 
preliminary results suggested that alcohol may affect platelet 
intracellular free calcium levels. Alcohol is also a known risk 
factor for essential hypertension. The effects of acute and 
recent alcohol ingestion were studied, and no alterations in 
basal platelet calcium levels were found. However, acute and 
recent alcohol consumption had little effect on the haemodynamic 
parameters measured. As chronic alcohol consumption is related 
to longterm blood pressure elevations, it would be of more 
benefit to study the chronic effects of alcohol ingestion on 
basal platelet intracellular free calcium levels in normotensive 
subjects. Agonist stimulated levels of platelet intracellular 
free calcium were not measured in this study due to the time 
factor involved. However, measurement of agonist stimulated 
levels of platelet intracellular free calcium levels after both 
acute and chronic alcohol ingestion would be of interest if the 
technical difficulties could be surmounted. Alterations of 
agonist induced responses where no changes in basal levels have
been recorded may elucidate some of the cellular effects of 
alcohol consumption. Studies of basal and stimulated 
intracellular free calcium levels in platelets from alcoholic 
patients may also reveal some of the mechanisms involved in the 
irreversible cardiovascular changes which occur during chronic 
excessive alcohol consumption.
The effects of acute exercise on blood pressure and its 
relationship to basal platelet intracellular free calcium levels 
were also studied in chapter three. No alterations in basal 
platelet intracellular free calcium levels were observed, and 
this implies that acute elevations in blood pressure and the 
hormonal changes related to exercise are not associated with 
alterations in basal platelet intracellular free calcium levels. 
As regular moderate exercise is known to decrease blood pressure 
and thus reduce the risk of cardiovascular disease, it would be 
of interest to study the relationship between blood pressure and 
platelet calcium levels after a longterm exercise programme in 
normotensive subjects. It would also be useful to study both 
basal and agonist stimulated levels of platelet intracellular 
free calcium levels in future studies.
In chapter four, the influence of age and sex on platelet 
calcium levels was examined. No alterations in basal platelet 
intracellular free calcium levels were observed for either age or 
sex. This suggests that the higher blood pressure associated 
with old age and the hormonal differences between the sexes do 
not affect basal platelet intracellular free calcium levels. 
However, it was discovered that platelets from older women 
required a lower concentration of 5HT to elicit a response
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similar to a younger patient. A negative correlation between 
EC5 0  values and age was observed. It is possible that an 
increase in 5 HT2  receptor affinity occurs with age, but further
research will be required to clarify this theory.
Chapter six was involved with the measurement of basal and 
stimulated platelet intracellular free calcium in normal and 
hypertensive pregnancies. No alterations in basal or ADP 
stimulated calcium levels were observed throughout the study. 
However, there was a decrease in the maximal response to 5HT 
throughout the pregnant groups which reached significance when 
normotensive controls were compared with pre-eclamptic patients. 
This suggests that a decrease in receptor number or an uncoupling 
of a post-receptor mechanism may occur in pre-eclampsia. 
Research has been initiated to define changes in 5 HT2  receptor 
number and affinity on platelets of normal and pre-eclamptic 
patients using as a radioligand. It has been postulated
that 5HT may play a major role in the development of pre­
eclampsia, but further research will be required to elucidate the 
precise mechanism and the relevance of the findings of this study
to this theory. This study on platelet calcium levels in
hypertensive pregnancy is part of an ongoing longitudinal study 
which was designed to measure platelet calcium levels at 
intervals throughout each patient's pregnancy in an effort to 
define the stage at which alterations are likely to occur. This 
study is as yet incomplete and more hypertensive pregnancies will 
be studied before any firm conclusions can be made.
Chapters seven and eight examined intracellular free calcium
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levels in platelets and vascular smooth muscle cells respectively 
in the perinephritis hypertension model in the rabbit. As with 
the human studies, no significant differences between basal 
platelet calcium levels of normotensive and hypertensive rabbits 
was observed. Further studies on animal work which could be 
initiated include a modification of experimental methods and 
design to enable agonist stimulated levels to be measured. A 
longitudinal study to assess if an increase in calcium levels 
occurs as part of the development of hypertension, but returns to 
normal when hypertension has developed, would be advantageous. 
Also, research into the mechanism by which chronic verapamil 
causes an elevation of platelet calcium levels would be 
interesting. The simultaneous examination of platelet and 
vascular smooth muscle cell intracellular free calcium levels 
from the same rabbit may uncover the usefulness of platelets as a 
model for vascular smooth muscle in this type of cardiovascular 
research.
The chapters discussed previously have all shown no 
alteration of basal platelet intracellular free calcium with 
blood pressure changes, and no correlation between these two 
parameters. However chapter five illustrated that although there 
was no difference between platelet calcium levels in normotensive 
and essential hypertensive patients, a weak, but significant 
correlation was observed between platelet calcium levels and 
blood pressure. The findings of other chapters suggest that 
increased intracellular free calcium concentration is not 
associated with acute elevations in blood pressure, nor is it a 
ubiquitous finding in all types of hypertension. Acute
alterations in blood pressure do not result in acute changes in 
basal platelet intracellular free calcium levels (chapter three). 
Hypertension in pregnancy and rabbit perinephritis hypertension 
may be models of hypertension in which the elevation of blood 
pressure is too short-lived to have any effect on basal platelet 
calcium levels. It is possible to conclude from these 
observations that an increase of platelet calcium levels may be a 
late effect of a chronic elevation of blood pressure, and 
therefore an elevation of platelet calcium levels may be a 
consequence, and not a cause, of hypertension. However, another 
more likely theory is the pathogeneses of hypertension in 
pregnancy and rabbit perinephritis hypertension are very 
different to the pathogenesis of essential hypertension, and 
elevations in intracellular free calcium concentrations may be a 
unique finding in essential hypertension. It is now evident that 
a large overlap of basal platelet intracellular free calcium 
levels exists between normotensive and hypertensive subjects. If 
there is an elevation in basal intracellular free calcium levels 
in hypertension, it is probably a smaller alteration than was 
initially proposed by Erne et al (1984a).
Some animal studies may be of use in developing theories of 
the alterations which occur in essential hypertension. However, 
human studies are required to confirm these results in essential 
hypertension. The most suitable tissue to use for research into 
vascular alterations in essential hypertension is vascular smooth 
muscle itself, obtained from hypertensive patients either by 
biopsy during surgical procedures or at post mortem examinations.
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Neither of these situations is ideal, and subjects would have to 
be selected with care, but this is perhaps the only way in which 
cardiovascular scientists will be able to unequivocally elucidate 
the mechanisms involved in the aetiology of essential 
hypertension.
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